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An Introduction to the Third
Annual Symposium on
Respiratory Failure
The rapid development of knowledge, techniques, and equipment in the area of respiratory
care has both greatly improved and complicated
the care of the patient with respiratory failure. Due
to this progress, the physician who has an intermittent opportunity to care for these types of patients is at a major disadvantage. Consequently,
over the past three years the Departments of Medicine of the Schools of Medicine at the Medical
College of Virginia and University of Virginia have
held an annual symposium to provide the practicing physicians in the state with the opportunity to
review the pathophysiology of respiratory failure
and become aware of the more modern techniques,
approaches, and available equipment for the
management of acute respiratory failure. This publication will reach a considerably wider audience
than had the opportunity to attend the symposium,
and we hope it will extend our program to many
other concerned physicians.
JAMES P. BAKER, M.D.

Associate Professor of Medicine
Medical College of Virginia
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Clinical Pathological Correlation of Chronic
Obstructive Pulmonary Disease {COPD)*
ORHAN MUREN, M.D.
Associate Professor of Medicine and Anesthesiology,
Medical College of Virginia, Health Sciences Division of
Virginia Commonwealth University, Richmond . Virginia

The two most common forms of COPD, chronic
bronchitis and pulmonary emphysema, will be briefly
reviewed.
Etiology. The causes of COPD are not definitely
known. However, there appears to be a statistically
significant correlation between the incidence of
COPD, cigarette smoking, and air pollution. This is
especially true for chronic bronchitis. In some cases,
genetic factors (alpha 1 - antitrypsin deficiency) may
be responsible for development of COPD. This is
called familial type of COPD or familial emphysema.
Chronic irritation of the tracheobronchial tree is
common to all cases of chronic bronchitis. Cigarette
smoking appears to be the single most important
factor in the development of chronic bronchitis.
Heavy cigarette smokers appear to be affected to a
greater extent than light smokers, and the symptoms
are worse in patients who give a history of long
cigarette smoking. However, not all cigarette smokers
develop chronic bronchitis. Individual susceptibility
may play a role in some people. The symptoms of
smoking are greater if a person lives in a heavily
polluted area and also if there is cold and damp
weather.
The Incidence. It has been estimated that there
are currently 15 million people suffering from COPD
in the United States. The incidence of COPD is
higher in industrial areas, especially among men
who engage in dusty jobs, such as coal miners.
Mortality. In the United States in 1969, 35,000
died primarily from chronic bronchitis and pulmonary emphysema. In 65,000 cases chronic bronchitis

* Presented by Dr. Muren at the Symposium on Respiratory F ailure, May 25, I 972, at Richmond, Virginia.
MCV QUARTERLY 9(2): 121-125, 1973

and pulmonary emphysema contributed to the demise
of the patients. Since 1950, the death rate from
emphysema has doubled every five years. The federal
government pays more than $200,000,000 annually
to respiratory cripples.
Definition. Chronic bronchitis is a clinical syndrome which is characterized by productive cough
on most days during at least three months a year
for two or more successive years. There is chronic
productive cough without known specific causes
such as tuberculosis or chronic suppurative lung
disease. It is more common in males.
There is excessive mucous production with hypertrophy and hyperplasia of the mucous secreting
glands including the Goblet cells. Bronchial mucous
glands are normally located in the bronchi which
contain cartilage in their wall. Hypertrophy of the
gland size can be measured as a gland to wall ratio,
and this is called the Reid Index. In normal people
over the age of four years, this falls below one-third.
In children under the age of four years, the ratio
is a little higher.
A high Reid Index is very suggestive of chronic
bronchitis, but there is no close correlation between
clinical chronic bronchitis and the degree of mucous
gland hypertrophy and hyperplasia. There is also an
overlap of the Reid Index between bronchitis and
non bronchitis.
Clinical and Functional Manifestations of
Chronic Bronchitis. The cardinal manifestation of
chronic bronchitis is productive cough. There is in
general a history of 20-30 years of cigarette smoking.
The disease in general has a slow onset. In the beginning, patients attribute the cough to cigarette smoking. The so-called "cigarette cough" is an early sign of
121
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bronchitis. In many patients there is also an associated chronic sinusitis. The cough may disappear
if smoking is stopped early enough.
The activity of cilia in the bronchial tree is inhibited by tobacco smoke. As a result of this, movement of mucous blanket is reduced significantly.
The mucous glands and Goblet cells are stimulated
and they produce more mucous. The result will
be chronic cough and expectoration.
Excessive mucous production increases the tendency to infection which causes further hypersecretion. There develops a vicious cycle of excessive
mucous secretion, infection, and more hypersecretion
results. Tobacco smoke also causes bronchoconstriction which may aggravate the symptoms of bronchitis.
Normally the lower respiratory tract is essentially sterile. This is primarily due to cough reflexes, mucociliary, and alveolar macrophagic
activity that eliminates bacteria or foreign particles
that may have been inhaled during inspiration.
In chronic bronchitis many organisms can be
isolated from the sputum which may be responsible
for acute exacerbations. However, viruses probably are responsible to a great extent for the acute
episodes in chronic bronchitis.
Following viral infections, as a result of damage
to bronchial mucous, growth of bacteria may be encouraged. Diplococcus pneumoniae and Hemophilus
influenzae appear to be important organisms; however, sometimes Staphylococcus aureus and the
Friedlander's bacillus may be responsible for acute
infection . Some patients trace the beginning of
symptoms to some acute episode of infection such
as bronchopneumonia.
In general there is fluctuation in the manifestations during the course of the disease. Symptoms become worse after exposure to cold, damp, or
foggy weather or to irritants. However, during the
end-stage of the disease the patients are, more or
less, continuously symptomatic. Death secondary to
pneumonia, congestive heart failure, or acute respiratory failure may occur 15 to 30 years after the
beginning of symptoms. In a typical bronchitic,
sputum is usually mucoid which becomes mucopurulent during acute bronchopulmonary infections.
Dyspnea may also occur during episodes of
acute bronchoconstriction secondary to infections,
irritants, and so forth. It may also indicate development complicating pulmonary emphysema. Intermittent wheezing may also be present.
Dyspnea, cough, and wheezing may awaken

the patient, and the picture may be confused
with paroxysmal nocturnal dyspnea due to left-sided
heart failure. But in bronchitis the symptoms are
generally improved by expectoration of sputum. The
body weight of thes'e patients is generally normal or
heavy.
Arterial gas abnormalities are quite common.
Many patients have hypoxemia alone. C0 2 retention
takes place late in the course of the disease or
during acute episodes of bronchopulmonary infection.
When hypoxemia and respiratory acidosis are
present, pulmonary hypertension develops which
may result in cor pulmonale.
There is a high incidence of erythrocytosis
resulting from hypoxemia. Many patients later in
the course of the disease have florid appearance
and cyanosis. Because of increased incidence of
congestive heart failure and cyanosis, the patients
are called "Blue Bloaters."
The amount of airway obstruction will influence the physical signs. In advanced stages, the
thoracic cage is in the inspiratory position. There
is kyphosis of the dorsal spine. The anteroposterior
diameter of the chest increases. There is excessive
use of accessory respiratory muscles. The degree
of scalene muscle contraction may give an idea
about the extent of airway obstruction. In general,
the breath sounds are normal. Ronchi are present
in most patients.
In the early stages of chronic bronchitis and
pulmonary emphysema, there is a significant degree of involvement of the small airways. It should
be emphasized that small airways (2 mm or less in
diameter) are only responsible for approximately
15 to 20% of the total airway resistance; thus,
marked increases in peripheral or small airways will
not be detected by the conventional tests such as
FEV 1 (forced expiratory volume in one second)
or MMFR (maximum mid expiratory flow rate).
In the early stages of these conditions, frequencydependent dynamic compliance studies and alveolararterial 0 2 tension gradient, A-a P 0 ,, may detect
pulmonary dysfunction. For clinical purposes, however, simple spirometric studies with measurements
of FVC (forced vital capacity), FEV 1 and MMFR
are satisfactory.
Improvements in flow rates after administration
of bronchodilating agents indicate the presence of
partially reversible obstruction.
In established chronic bronchitis, there is
over-expansion of the lungs with enlargement of
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residual volume and FRC (functional residual capacity). VC (vital capacity) is either normal or
decreased. The total lung capacity may be normal
or increased. The ratio between FEV 1 and FVC,
and the maximal mid expiratory flow rate are reduced.
Radiologic Findings. In simple or uncomplicated
chronic bronchitis, the chest x-ray may be normal.
There may be over-expansion of the lungs and the
diaphragm may be depressed.
Some cases would show "tram lines" or parallel
shadows and prominence of the lung markings mainly
at the bases. Prominence of the main pulmonary
artery may suggest pulmonary hypertension. Bronchograms may demonstrate tiny diverticulum-like
shadows in the large bronchi. Irregularity of the
caliber of segmental and subsegmental bronchi is
frequently seen.
Pldmonary Emphysema. Pulmonary emphysema
is accurately defined in morphologic terms only. It
is defined by increase beyond normal in the size
of air spaces distal to the terminal bronchioles,
with destruction of the walls of these air spaces. It
is a destructive process. There is reduction in elastic
retractive force of the lungs.
The portion of the lung distal to the terminal
bronchiole is called acinus, and it contains respiratory
bronchioles, alveolar ducts, alveolar sacs, and alveoli.
It is in this area that gas exchange takes place. For
this reason, acinus is considered as the basic functioning unit of the lungs which is analogous to the
nephron of the kidney.
In panacinar emphysema, there is involvement
of the entire acinus. In centriacinar emphysema,
only those alveoli near the center of the acinus are
affected. The centriacinar type is more common in
the upper two-thirds, and the panacinar is roughly
uniform, commonly affecting the basal regions of
the lungs.
Many patients have both types of emphysema
together; however, centriacinar is much more common than panacinar and is in general associated
with chronic bronchitis and chronic respiratory irritation. Dr. W. M. Thurlbeck found panacinar as
often in women as men, while the centriacinar was
more common in men.
Emphysema is more common in patients with
bronchitis than in nonbronchitics. There is also a
higher incidence of emphysema in patients with
extensive bronchiectasis. This is also true in other
chronic inflammatory diseases of the lungs, especially when both lungs are diffusely affected. On the

123

other hand, emphysema is rarely found in the postmortem studies of the lungs of patients with bronchial
asthma.
Clinical and Functional Manifestations. The
main symptom of emphysema is dyspnea which
has an insidious onset and becomes manifested on
exertion. Dyspnea gradually increases, and in advanced stages, ordinary daily activities may induce
severe shortness of breath.
Cough may be absent or insignificant during
the early course of the disease. Episodes of severe
dyspnea and wheezing may occur, usually during
acute bronchopulmonary infections or after exposure
to irritants. In general, the body weight is below
normal, and loss of weight is common in emphysematous patients.
The anteroposterior diameter of the chest is
increased. Breath sounds are distant. The heart
sounds are frequently inaudible. They may be heard
easily in the epigastric area. There is a higher incidence of peptic ulcer disease in patients with
emphysema. The exact cause of this is unknown at
the present time.
Airway resistance is increased especially during expiration. Static compliance of the lungs is
greater than normal. However, frequency dependent
compliance studies are generally abnormal. Residual
volume, FRC, and TLC (total lung capacity) are
frequently elevated. VC may be normal or reduced
due to increased RV and FRC. There is obstruction
to airflow. FEVi. MMFR, and MVV (maximal
voluntary ventilation) are diminished.
X-ray Findings. In mild pulmonary emphysema
the chest x-ray may be normal. In some cases there
is x-ray evidence of over-expansion of the lungs
which is a nonspecific finding that is seen in cases
of diffuse bronchial obstruction such as bronchial
asthma and chronic bronchitis. If, in addition to overexpansion, there is marked reduction or absence of
peripheral vascular markings associated with engorged hilar pulmonary vessels and blebs bullae,
presence of underlying emphysema is almost certain.
The heart shadow is usually Jong and narrow.
Arterial gas studies reveal only mild abnormalities
at least during early stages of the disease. Patients
attempt to maintain a relatively normal P 0 , and Pc 0 , .
Because of this, these patients are called "Pink
Puffers." The incidence of cor pulmonale is less
frequent in Pink Puffers as compared with Blue
Bloaters.
There are two primary factors responsible for
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TABLE 1.
MAIN MANIFESTATIONS OF PURE CHRONIC BRONCHITIS
OR PULMONARY EMPHYSEMA
(Blue Bloater)
Chronic
Bronchitis
Cough
Dyspnea
Body Weight
Arterial Gas
Abnormalities
Cor Pulmonale
Erythrocytosis
Breath Sounds

(Pink Puffer)
Pulmonary
Emphysema

++++

±

±

++++
thin

normal or
heavy
++++
++++
++++
normal

+
+(Terminally)
+
diminished

± : Insignificant
+:Increase
+ + + +: Significant increase

the development of pulmonary hypertension in patients with COPD: 1) Functional or reversible factors due to hypoxemia and hypercapnia, 2) Irreversible factors due to loss or occlusion of pulmonary
capillaries.
Functional factors are mainly responsible, and
they play a major role in the production of pulmonary
hypertension. Since there are in general more dis~
turbed arterial gas tensions in bronchitis, incidence of
pulmonary hypertension and cor pulmonale are
higher in bronchitics.
In over 90% of the cases of COPD, patients
have combined chronic bronchitis and pulmonary
emphysema. Some of these patients have predominantly chronic bronchitis and some predominantly
pulmonary emphysema. However, a very small percentage of . these patients would only have either
chronic bronchitis or pure pulmonary emphysema.

TABLE 2.
CAUSES OF ACUTE RESPIRATORY FAILURE IN COPD
1.
2.
3.
4.
5.
6.
7.
8.
9.

Bronchopulmonary infections.
Heavy sedation and anesthesia.
Improper use of oxygen.
Pulmonary edema and congestion.
Thoracotomy, abdominal surgery.
Atelectasis or pneumothorax.
Dehydration.
Pulmonary embolism.
Severe episode of air pollution.

TABLE 3.
THE FINDINGS THAT MAY INDICATE POOR PROGNOSIS
IN COPD
1.
2.
3.
4.
5.
6.

Recent significant weight loss.
Persistent tachycardia at rest.
Presence of cor pulmonale.
FEV, less than 750 ml.
Persistent severe hypoxemia and hypercapnia.
Marked reduction in pulmonary diffusion capacity.

If manifestations due to pure chronic bronchitis
or emphysema are appreciated, one may have some
opinion as to symptoms and signs primarily related
to either chronic bronchitis or pulmonary emphysema (Table 1). It has been shown that chronic
bronchitis does not necessarily always lead to pulmonary emphysema nor does pulmonary emphysema always lead to chronic bronchitis.
Table 2 shows causes of acute respiratory failure
in patients who have chronic respiratory failure
with COPD. Finally, Table 3 shows factors that
may indicate poor prognosis in patients with COPD.
Comment. There are currently 15 million people affected with COPD in the United States. It
appears that once the disease is well established or
advanced, the ultimate course cannot be altered
significantly. Emphasis should be given upon prophylactic measures. Discouragement of cigarette
smoking is probably the most important means to
reduce the incidence of COPD.
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The most important pathophysiologic aspects
of chronic and acute obstructive pulmonary disease involve disturbances in ventilation with resulting derangement of gas exchange in the lung.
There is considerable variability in the type of
abnormality, the time of its appearance in relationship to the history of the disease, and in the
progression of the abnormality in blood gases.
The usual sequence, however, is the following:
1 ) In the earliest stages there is no blood gas
abnormality at rest or with exercise, 2) With further progression of the disease the blood gas tensions are normal at rest but on exercise there is a
significant decrease in arterial blood P 0 ,, 3) In a
more advanced stage there may be minimal re-

* Presented by Dr. Patterson at the Symposium on
Respiratory Failure, May 25, 1972, at Richmond, Virginia.
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duction in arterial blood P o, at rest, while on exercise
hypoxemia is accentuated and arterial blood Pco,
rises, 4) In advanced COPD there is decrease in
arterial blood P 0 , and increase in arterial blood
Pco, at rest, with moderate or marked worsening of
these changes on exercise.
Hypoxemia results from one or more of the
following factors: disturbance in ventilation/ perfusion relationships of lung, hypoventilation, and,
to a degree, impaired diffusion. Hypercapnia results from alveolar hypoventilation. Ventilation/
perfusion disturbances of the lung may occur because obstruction of bronchi and bronchioles is
uneven, resulting in portions of the lung being
hypoventilated and other parts being hyperventilated. The mechanism of obstruction can involve
several of the following factors, all of which may
be unevenly distributed in different areas of the
MCV QUARTERLY 9(2): 126-129, 1973
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lung: tenacious exudate in the bronchi and bronchioles; edema of the bronchial wall and bronchial
or bronchiolar wall and mucosa; bronchiolar spasm;
loss of the normal radial (outward) traction on
the wall of the bronchi and bronchioles, owing to
loss of the normal pattern of the pulmonary
stroma through departitioning of the ' lung; and,
finally, varying degrees of fibrotic obstruction of
the airways. The loss of radial traction from departitioning of the lung, owing to breakdown of
alveolar septae, is perhaps the least appreciated
of these common mechanisms of obstruction. During expiration, the airways are normally held open,
in part, by the outward pull of the various elements
in the pulmonary stroma. When this outward pull
is diminished or lost, and particularly when the
other factors producing obstruction are operative,
including loss of integrity of the bronchial and
bronchiolar walls, some collapse or closure of
the airways after the early phase of expiration
is inevitable. As the chest becomes barreled and
assumes the position of hyperinflation, the radial
traction may be maintained to a greater degree
than if the chest had retained its normal contour,
although a price is paid in the form of a less efficient performance of the muscles of respiration,
including the diaphragm. The accessory muscles
of respiration, particularly the scalenes and less
importantly the sternomastoids, the upper trapezius, and the pectoral muscles, assume increasing
importance in the maintenance of ventilation,
particularly in the upright position.
Blood leaving the alveolus, which is underventilated in relation to the amount of blood flow,
tpus. has a low ventilation/ perfusion ratio (low
V A/ Qc), both in the oxygen and carbon dioxide exchange. Blood leaving this alveolus will have a
lowered oxygen tension and content and an elevated carbon dioxide tension and content. In contrast, certain alveoli are overventilated, since their
airways are less obstructed and they feel the effects of the increased respiratory efforts which
the patient commonly makes to overcome the
overall increase in airway resistance. Blood leaving the hyperventilated alveolus with a high ventilation/ perfusion ratio (high VA/ Qc ratio) will
have an oxygen tension slightly above normal.
Owing to the fact that the oxygen dissociation
curve is very flat at the arterial end of its normal
range, very little additional oxygen content is
gained by this increase in oxygen tension. Further-
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more, oxygen is relatively insoluble, with only
about 0.3 ml of oxygen normally dissolved in
100 ml of arterial blood. The gain in dissolved
oxygen from the small increase in oxygen tension
is almost negligible. On the other hand, much
more carbon dioxide is in solution in the plasma
and can be more readily moved under a given
diffusion gradient. The C02 dissociation curve is
steeper than the oxygen dissociation curve. As a
result, the blood leaving the hyperventilated alveolus has lost much more carbon dioxide than it
has gained oxygen. When these two blood streams,
one from an underventilated alveolus and the
other from an overventilated alveolus, are united,
the stream with low oxygen content, mixing with
the stream containing a minimally increased oxygen content, results in blood which has a reduced
oxygen content and tension. On the other hand,
the mixing of a stream with an elevated C02 content with one having a reduced C02 content can
readily result in blood with normal or near normal carbon dioxide content and tension. Therefore, we commonly observe arterial hypoxia, first
during exercise and later at rest, as the initial
blood gas abnormality during the progression of
chronic obstructive pulmonary disease. The elevation of carbon dioxide tension occurs later as alveolar
hypoventilation becomes widespread with further
deterioration of respiratory function.
Impairment of diffusion (the third major type
of respiratory insufficiency) is usually not marked
in COPD unless there is concomitant fibrosis of the
lung. In the centrilobular type of emphysema,
however, owing to dilatation of terminal airways,
diffusion may be impaired because of the longer
diffusion path ("distance barrier").
The heart is frequently secondarily involved
in emphysema. This introduces another abnormality in the oxygen delivery system. Impairment of
cardiac function results primarily from pulmonary
hypertension which eventually leads to chronic
cor pulmonale. The pulmonary hypertension is
due to increased pulmonary vascular resistance
which in turn is due to the following factors: 1)
loss of vascular bed as a result of destruction of
vascular channels, 2) increased intra-alveolar
pressure compressing the blood vessels in the lung,
3) vasoconstriction due to the reduced Po, of
the blood, primarily when acidosis is present. This
last factor is at present thought to be an important
reason for the development of pulmonary hyper-
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tension in emphysema, but operates primarily
when there is respiratory acidosis. Hypoxic constriction of pulmonary arteries and arterioles is
relatively weak when the blood pH is normal.
Cardiac function in emphysema may be further
impaired as a result of direct harmful effects of
the low P 0 , and high P co, on cardiac muscle
and also as a result of increased work of the heart
in the high cardiac output stage of the disease.
Impairment of cardiac function in emphysema may
be more severe if there is associated coronary
disease.
Chronic hypoxia of a severe degree in the
later stages of chronic obstructive pulmonary disease brings about a deterioration of function of
most organs of the body. A patient in late emphysema commonly loses weight, is depressed and
often confused, and has little or no tolerance for
exertion. Reduction of cardiac output with failure
of the right heart further increases tissue hypoxia.
The hypoxia does, however, stimulate two types of
tissue rather late in the disease: the chemoreceptors
of the aortic and carotid bodies (the function of
the glomus pulmonale at the bifurcation of the pulmonary artery is still unclear), and the bone marrow. The chemoreceptor stimulation is important in
offsetting the narcotic effects of high arterial carbon
dioxide tension on the respiratory center complex
in the brain stem. Therefore, too rapid or too large
a reduction of the hypoxia without adequate respiratory assistance can reduce the drive to respiration and rapidly worsen the elevation of arterial
C02 tension (hypercapnia).
Physiological Patient Management. In the application of physiology to patient care we seek to
use previously accumulated knowledge of physiological processes and mechanisms to plan our
therapy, with the aim of shifting abnormal processes and disease toward the normal. We also utilize the physiological approach in evaluating the
effect of management in a given patient on a day to
day, hour by hour, and, at times, moment to
moment basis, as well as in evaluating our past
performances so as to plan more effective therapeutic strategies for the future.
The application of cardiovascular and respiratory physiology to the management of a specific
patient rests upon the adequacy of quantitative
knowledge of physiological responses and mechanisms. If the information is not quantitative, effective "physiological" management may not be

possible. A difficult and ever present problem is
the effective application of knowledge of physiological processes and mechanisms obtained from
studies on other human beings and animals, both
normal and ill, to the ca.re of one particular patient;
the physiological responses may differ in important
respects, both qualitative and quantitative, from
those described in the literature.
As an example of the need for quantitative
information, we may cite the pulmonary vascular
response to hypoxia. It is not enough to know
that pulmonary vessels constrict on the influence
of arterial hypoxia and that this constriction is
greater during states of acidemia. One needs to
know the quantitative relations between hypoxia
and acidemia in the studies reported in the literature. From this information, an estimate can then
be made of the probable magnitude of the pulmonary vasoconstriction in the patient under treatment, given the data on his arterial blood gas tensions and pH. Certain additional questions must
be answered in order to plan effective therapy:
Is the magnitude of this patient's hypoxia and of
his acidemia by combined effect sufficient to produce a serious increase in pulmonary vascular
resistance and an increase in the work load of the
right heart? Are the hypoxia, the hypercapnia
(if present), and the acidemia acting to impair
the ability of the right heart to handle the increased work load? What other important factors,
for example, coronary arterial or pulmonary vascular disease, are present and how do they interact with the blood gas and pH abnormalities?
Is therapeutic intervention needed, and how urgently? What are the probable favorable and potentially unfavorable physiological effects of the
therapeutic options?
If only rough and approximate answers to
such questions can be given, which is commonly
the case, 'then some means of continuous or frequent discontinuous monitoring of the physiological state of the patient must be available. Such
monitoring can be instrumental, including biochemical, or human. The continuous human monitoring of the patient-the nurse at the bedside
of a single patient- is becoming less and less
common. The development of intensive care units,
providing the nurse with physical proximity to
more than one patient, makes possible effective
visual and auditory monitoring of two, perhaps
three, patients by one nurse. The more seriously
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ill the patient, the smaller his physiological reserves and the greater the need for continuous or
frequent discontinuous monitoring of basic functions. Such monitoring provides the essential feedback information required for precise adjustment of
therapy to the physiological state of the patient
and for the early detection and correction of errors in management.
A difficult challenge that must be met is the
devising of means of continuous and discontinuous
measurement of physiological processes in the individual patient that are sufficiently basic yet practicable to provide the data required for effective
therapy. At present, variables commonly and readily monitored are: intravascular pressures, the
electrocardiogram and the heart rate, the tidal
volume and respiratory rate ( althoug~ this last
presents some problems), and rectal temperature.
Continuous body weight recording can be done,
but these recording scales are at present expensive. Frequent discontinuous information on the
blood gas tensions and pH is, of course, readily
obtained but continuous recording of these variables still presents problems. Continuous information on other functions, including cardiac output and oxygen delivery to the tissues, is clearly
needed in many patients critically ill with cardiorespiratory disorders.
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The need is particularly great in relation to
the often rapidly changing clinical states of respiratory failure. This is not to say that in every
case sophisticated instrumentation is required, or
that it will provide all of the information needed
for optimal management. Sensitive clinical observation remains essential. For example, the human
face, particularly in the elderly in whom physiological reserves are low, is an exceedingly delicate
indicator of favorable or unfavorable terms of
physiological events. The greatest clinicians of the
past, or of today, appear to have an intuitive feeling of the pathophysiology in the patient, even
though they are not always able to articulate this
feeling. The present day clinician should not abandon efforts to sharpen his own sensitivities toward
the subtle summation of physiological processes
that result in changes in the appearance of the
patient's face, tone of voice, gesture, feel of tissue,
in favor of excessive reliance on sophisticated instrumentation. These methods of study of the patient are complementary, not usually exclusive.
One can safely predict that, for example, when
continuous recording of arterial blood gas tensions, pH, and cardiac output become commonplace in the management of critically ill patients,
these same measurements will make it possible to
sharpen our bedside observations and the conclusions
that we .draw from them.

Arterial Blood Gases:
Their Meaning and Interpretation* ·
WALTER J. O'DONOHUE, JR., M.D.
Assistant Professor of Medicine, Director of Inhalation Therapy,
Department of Internal Medicine, Medical College of Virginia,
Health Sciences Division of Virginia Commonwealth University,
Richmond, Virginia

The measurement of arterial blood gases is
essential in the management of respiratory failure
and in the diagnostic assessment of the nature and
severity of pulmonary disease. Adequate therapy
for patients with acute respiratory insufficiency
is often impossible without the information obtained from arterial blood gases. These studies must
be readily available around the clock, including
nights, weekends, and holidays and should not have
to depend upon a technician called in from home.
A ready knowledge of arterial blood gases in acute
respiratory failure is just as important to good
medical care as knowing the urine sugar and acetone in diabetic ketoacidosis or the blood count
in an acute infection. In the practice of modern
medicine, the lack of availability of arterial blood
gases is unjustified and unacceptable. No hospital
that maintains intensive care facilities or treats
acutely ill patients can afford to be without blood
gas equipment and properly trained personnel to
provide accurate measurements.
The techniques for obtaining arterial blood
samples are simple and can be done without difficulty by qualified laboratory technicians and
nurses. A 10 cc glass syringe with a 20 or 22 gauge
needle is flushed with aqueous heparin, and an
arterial sample is obtained without air bubbles from
a brachia!, radial, or femoral artery. A glass
syringe is preferable to one made of plastic be-

* Presented by Dr. O'Donohue at the Symposium on
Respiratory Failure, May 25, 1972, at Richmond, Virginia.
Reprint requests to Walter J. O'Donohue, Jr., M.D., Box
862, Medical College of Virginia, Richmond, Virginia
23298.
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cause the glass plunger moves more freely and
allows easy detection of arterial pulsation. After
the puncture, the artery should be compressed by
hand for no less than five minutes. If the blood
gas analysis is not done immediately, the capped
syringe should be placed in an iced container.
Equipment for blood gas analysis is readily available and relatively easy to operate. The cost of
basic equipment is approximately $3,000. An
arterial blood sample of 3-5 cc is sufficient for a
complete study. Micromethods are also available
for "arterialized" capillary blood obtained by puncture of a hyperemic ear or fingertip. Only arterial blood is of consistent value in detecting the
gas exchange in the lungs. Venous blood is unreliable because it has already passed through
the systemic capillaries where oxygen and carbon
dioxide exchange occurs. It is also influenced by
changes in tissue metabolism and regional changes
in circulation.
Oxygen and carbon dioxide are both physically
dissolved in blood, and each exerts a tension or
pressure (P 0 , and P c 0 ,) which, in the capillaries of
the lung, is in equilibrium with the gas pressures
within the alveoli. The oxygen tension in the alveoli
is determined by the partial pressure of the oxygen
in the atmosphere and averages slightly above 100 mm
Hg at sea level. The carbon dioxide in the alveolar
gas averages 40 mm Hg. It comes almost entirely
from the blood and reflects tissue metabolism (fig. 1).
The arterial oxygen tension is normally 5 to
10 mm Hg lower than the alveolar oxygen tension,
due to shunting of the unoxygenated blood into the
left atrium from the bronchial veins and the Thebesian
MCV QUARTERLY 9(2): 130- 133, 1973
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Fig. 1-Normal gas tensions in the inspired gas and blood.

veins of the heart. Alterations in the distribution of
ventilation and perfusion within the lungs also
contribute to this alveolar-arterial oxygen gradient.
As demonstrated in figure 2, during normal tidal
breathing, about four times more ventilation goes
to the bases of the lungs than to the apices. Perfusion
is also distributed regionally with about 18 times
more blood going to the bases than to the apices.
This unequal matching of ventilation to perfusion
accounts for lower tensions of oxygen and higher
tensions of carbon dioxide in the alveoli at the bases
of the lungs, and it is responsible for part of the
alveolar-arterial oxygen difference.
The alveolar surface of the lungs is about 60
to 90 square meters with the pulmonary capillary
volume approximately 70 cc. Gas exchange occurs
within about 0.3 of a second and because of the
enormous efficiency and reserve of this system,
arterial blood gases remain within normal limits
even with strenuous exercise when disease is not
present. The physically dissolved oxygen in the
arterial blood accounts for only a small fraction
of the total oxygen that is available to the tissues.
Sixty times more oxygen is carried by the red blood
cells than is physically dissolved in the plasma.
Venous blood returning to the lungs is about 753
saturated with oxygen. By the time it has traveled
about one-third the distance through the pulmonary
capillary bed, the hemoglobin has become fully
oxygenated, and oxygen tensions in the alveoli and
capillaries have reached equilibrium. Each gram of
hemoglobin is capable of carrying 1.39 cc oxygen
when fully saturated. In normal individuals with 15 g
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of hemoglobin the total oxygen content of arterial
blood is about 20 cc per 100 ml of blood. Only 0.3 cc
of oxygen is physically dissolved in each 100 ml of
blood when the arterial P 0 , is 100 mm Hg.
Hemoglobin saturation is calculated from the
oxyhemoglobin dissociation curve (fig. 3). At arterial
oxygen tensions ranging from 60 to 100 mm Hg, the
dissociation curve is relatively flat with hemoglobin
saturation changing only 83 (903 to 983). Arterial
oxygen tensions below 60 mm Hg are not normally
encountered during life, except at very high altitudes
and in disease. In systemic capillaries where oxygen
tensions are as low as 30 to 40 mm Hg, the hemoglobin
dissociation curve becomes quite steep, and oxygen
is readily released from the red blood cells. Changes
in pH, P 00 ,, and temperature all favor the release
of oxygen from hemoglobin in the tissues and increase
oxygen uptake by the red blood cells in the lungs.
Although the arterial P 0 , is the most important
blood gas indicator of oxygen transport, there are
multiple factors that must be considered in the
evaluation of tissue oxygen delivery. These include

Vol.

(O/o)
7

Fig. 2-Distribution of ventilation and perfusion in the
lungs. (Reproduced by permission of J. B. West, F. A.
Davis Co., and Blackwell Scientific Publications, Ltd. Ventilation/ Blood Flow and Gas Exchange, p. 42, 1965.)
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tissue oxygen consumption, cardiac output, and
arterial oxygen content. An outline of factors relating
to oxygen delivery is presented in Table I.
In reporting arterial blood gases, most pulmonary
laboratories make three direct measurements, which
are summarized as follows:
I) Pa 0 ,. This is the partial pressure of oxygen
that is physically dissolved in the arterial
blood; it is normally 5 to 10 mm Hg lower
than the oxygen tension in the average
alveolus. The normal arterial oxygen tension
is 90 to 100 mm Hg at sea level.
2) Pa co,. This is the partial pressure of carbon
dioxide that is dissolved in the blood and
indicates the state of alveolar ventilation. The
normal arterial carbon dioxide tension is 36
to 44 mm Hg.
3) pH. This is an expression of the hydrogen
ion concentration of the blood (negative

logarithm) and relates directly to the ratio
of the concentrations of bicarbonate and C0 2
in the blood. The normal range is 7.36 to 7.44.
In addition to these three direct measurements there
are other determinations which are based on calculations and are reported from nomograms. These
are summarized as follows:
I) Oxygen saturation of hemoglobin. This indicates the capacity of hemoglobin to carry
oxygen and is measured from the oxyhemoglobin dissociation curve using the Pa 0 , and
the pH determinations. The normal range
for arterial blood is 95 to 983.
2) Plasma bicarbonate (HC0 3 -). This is measured
from a standard acid base nomogram using
the Pa co, and pH determinations. The normal
range is 23 to 27 meq/ liter (fig. 4).
3) Some laboratories report the base excess
concentration. This is an expression of the
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TABLE 1.
OXYGEN TRANSPORT
A. Lungs
o, loading of RBC's
B. Cardiovascular System
1. Rate of blood flow.
2. Distribution of flow between body tissues.
C. Erythrocyte
1. Oxygen-carrying capacity of blood.
2. Hemoglobin affinity for 0 2 (0 2 release or loading at
a given P 0 ,).
D. Tissues
Rate of o, consumption

base excess in meq/ liter, as relates to a normal
value of 0 for blood with pH 7.40 and P co,
40 mm Hg. Negative values indicate a base
deficit or acid excess. The normal range is 0
plus or minus 2.3 meq/ liter.
In the diagnostic evaluation of pulmonary
disease, arterial blood gases provide a direct approach to ventilatory function since the primary
purpose of the lungs is to oxygenate the blood
and eliminate CO~. Arterial blood gases are usually obtained at rest, following exercise, and after
breathing 100% oxygen. This combination of
studies provides considerable information in the
evaluation of the nature and severity of respiratory disease. These data are much less influenced
by patient cooperation and performance than many
of the other tests performed in the pulmonary
function laboratory.
In the management of patients with respiratory failure, it is frequently impossible to judge
the level of alveolar ventilation or the adequacy
of oxygenation by clinical evaluation alone. All
of the signs and symptoms that suggest hypoxia
or hypercapnia may be absent at times, and only
by measurement of arterial blood gases can the
physician assess the degree of respiratory im~
pairment and render the appropriate therapy.
Once active treatment has begun with oxygen or
mechanical ventilation, it is important to evaluate
the effectiveness of such therapy by measuring

Fig. 4-Acid-base nomogram.

the arterial blood gases. Giving too much oxygen
may seriously damage the lungs, while mechanical
hyperventilation may cause severe alkalosis with
possible coma and death. The delicate balance
between too little and too much can best be reached
and maintained by a knowledge of the state of
the arterial blood gases.
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The Basic Principles of Acid-Base Regulation*
ORHAN MUREN, M.D.
Associate Professor of Medicine and Anesthesiology,
Medical College of Virginia, Health Sciences Division of
Virginia Commonwealth University, Richmond, Virginia

Acid-base homeostasis refers to those chemical
and physiological processes which maintain the hydrogen ion (H•) activity in body fluids at the levels
compatible with life and normal functioning. This is
an enormous task due to the fact that reactions which
produce H • and reactions which consume H• are
continously occurring in human beings.
On one hand there is acid production (fixed
and volatile acid) and on the other hand acid elimination (fixed and volatile acid). Normally in a given
time, such as in a day, acid elimination is equal
to acid production. Whenever there is imbalance
between input and output, acid-base disturbances
will occur.
Many biochemical processes require optimum
H• ion concentration. Changes in H• concentration
markedly affect the catalytic activity of enzymes.
Myocardial and muscular contraction, vascular tone,
central nervous system, and so forth all require
optimum H • ion concentrations to function properly.
This is why the regulation of hydrogen ion concentration is so important.
The relationship between extra- and intracellular
H• ion concentrations is still disputed because of
differences in opinion concerning the measurements
of intracellular pH. Intracellular pH has been found
to be 5.9 to 7 depending upon the method used.
Another problem in measurement of intraceJlular
pH is the multicompartmental structure of most
cells. It is believed that mitochondria, nuclei, and
cell sap have different pH. As a result of this,
intracellular pH is probably not homogeneous for a
given cell. For these reasons extracellular fluid ,
especially arterial blood, is used to study the acidbase status of the patients.

* Presented by Dr. Muren at the Symposium on Respiratory Failure, May 27, 1972, at Richmond, Virginia.
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In normal people, the concentration of H• is
approximately 40 nanomoles ( n moles) per liter of
plasma. One nanomole equals 10:-9 moles. However,
it would be more correct to indicate the thermodynamic activities rather than the concentrations,
the two being related as follows:
activity

- - - -.-

concentration

=

activity coefficient

At infinite dilution the activity coefficient is
equal to one. However, in concentrations in body
fluids, it is much less than one. The pH meter
electrode responds to hydrogen ion activity and not
concentration. However, it is customary to work in
concentrations, and values for the different equilibrium constants are adjusted accordingly, as indicated
by a prime after a symbol such as K'.
Since concentration of H • ions in arterial blood
is extremely small, the activity coefficient of H•
ions may be assumed to be equal to one. Therefore,
in this discussion the term H• ion concentration will
be used interchangeably with H• 'ion activity.
The body maintains H• ion concentrations between 44 to 36 nanomoles per liter of plasma
which correspond to a pH of 7.36 to 7.44. The
most extreme pH that is compatible with life ranges
between 6.8 and 7.8 which is equal to a ten-fold
change in H• ion concentrations.
As can be seen, the body could tolerate four
times an increase in H• ion concentrations and 2.5
times a decrease in H• ion concentrations, indicating
better tolerance to acidosis than to alkalosis. These
also indicate that H• ion regulation is not the most
precise regulatory mechanism in the body. A similar
change in potassium or sodium concentrations is
usually fatal (Table 1).
Since modern chemical formulation of acids
MCV QUARTERLY 9(2): 134-140, 1973
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1) Buffers:

TABLE 1.
SOME USEFUL CoMPARISONS OF PH AND NEQ / L

"Neutral" Solution at 37° C
Severe Acidosis
Neutral Solution at 25° C
Normal Arterial Blood
Severe Alkalosis

pH

NEQ/ L

6.8
6.9
7.0
7.4
7.8
8.0
9.0

160
125
100
40
16

JO
1

and bases by Br!6nsted, acid-base regulation has been
easier to understand. Br!6nsted defines an acid as any
molecule capable of donating H+ or a proton to a
base, and a base as any compound that will accept
a H ·. HCl, H 3 P0 4 , or H 2 C03 are acids since they
form H• ions in solution and can donate these protons to a base. HC03 - is considered a base, since
it accepts H • ions and produces H 2 C03 • Almost all
protons (H•) in aqueous solutions are reacted with
H 2 0 to form hydrated ions such as H 30 +, called
hydronium ions. It should be clear that what is
meant by the concentration of H • in body fluids is
hydronium ions or hydrated protons.
Since concentrations of free H• ions in plasma
of human beings are very small, in 1909 Sorenson
proposed the term of pH which he defined as the
negative logarithm to the base 10 of H• ion concentration:
pH = - log (H+)
H+ = 40 X 10- 9 Eq/ L
pH = - log (40 X 10- 9 )

= -

log 40 - log 10- 9
1.6 - (-9)

pH = 7.4
Distilled water molecules at 25 ° C dissociate
into very small amounts of H• ions and the same
number of OH- ions. The concentration of H• and
OH- is l(}-7 Eq/ L. Water is neutral and has a
pH of 7 .0. In normal plasma, there is a slight predominance of OH- ions resulting in a pH of 7.40.
Since the scale is logarithmic, a reduction of one
pH unit indicates 10 times an increase in H • ion
concentration.
The following are four primary mechanisms
which regulate H • ion concentration or activity
in the blood:

Hco -

b) Physiological- H 2 C~ 3

2) Pulmonary regulatory mechanism:
(13,000 - 20,000 m M/ day C02 of H2C03
eliminated)
3) Renal: 40 - 90 meq [H+] day secreted.
4) Exchanges of ions between intracellular and
extracellular fluid compartments.

Hydrogen ions are produced from oxidation of
sulfur containing amino acids, from oxidation and
hydrolysis of phosphoprotein compounds, and from
incomplete breakdown of fat and carbohydrate.
An average healthy man on a normal meat diet
produces 40 - 90 meq H • ions per day. The
reason that there are so few free H• ions in blood
is that the body has chemical and physiological means
of reducing the concentration of H• ions. Chemically,
the body has buffers that use up H• ions. Physiologically, normal lungs and kidneys excrete the acid end
products almost as fast as they are produced. Buffers
are substances that resist changes in pH when
acids or bases are added to them. A typical example
of a buffer is a weak acid (or a weak base) and
its salt:
NaHC03
H2C03

+ HCI

-t

NaCl

+ H2C0a

HCJ will react with the sodium bicarbonate to
form additional carbonic acid. Since carbonic
acid is a weak acid, it is only partly ionized, and
the above reaction decreases the concentration of
free H• ions in solution. A bicarbonate buffer system
functions as a chemical as well as a physiological
buffer system. It is physiological because it works in
an open system. The denominator of this buffer pair,
C02 , is constantly being produced in the tissues and
eliminated from the lungs almost as fast as it is
formed .
The body plays an important role in the regulation of H • ions by increasing or decreasing the
elimination of C02 through the lungs. This is why a
bicarbonate buffer system is very important. As a
matter of fact, bicarbonate buffer is the most important buffer in the plasma, and approximately
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50% of the entire buffering of whole blood resides
in the bicarbonate buffer system.
In an open system C02 produced during the reaction between HC03 and added H• (H + HC03 ~
C02 + H2 0) is eliminated by the lungs so, physically, dissolved C0 2 remains unchanged. However,
this is not possible in a closed system. Dissolved
C02 will be increased. Since pH is determined by
the ratio between HC03 and dissolved C0 2 , in a
closed system pH will be reduced to a greater extent
than in an open system (Table 2).
In the red blood cells, the hemoglobin is the
most important buffer. The other buffers of less
significance in red blood cells are proteins and phosphate compounds. In the body H2 C0 3 can only be
buffered by non-bicarbonate buffer systems which
consist of hemoglobin, proteins, and phosphate
buffers.
The buffer capacity of hemoglobin is far greater
than that of plasma proteins. This is partly due to
greater buffer value of hemoglobin and partly to
greater quantity of hemoglobin in a given volume
of blood as compared with plasma proteins. The
conjugate base of non-bicarbonate buffer pairs is
represented as Buf-; during the buffering of H2 C03
the following reaction takes place:

+ H20
t
H2COa + BuC- ~ H Buf + HC0

C02

3-

All the buffers in the body are in equilibrium
with one another. A change in one buffer pair
would immediately change the ratios in the other
buffers. Since it is easy to study the bicarbonate
system, this is used for the determination of H• ion
concentration.
The bicarbonate buffer system is described as
follows:

TABLE 2.
IO MEQ / L OF

STRONG Acm

[HCOa-1 = 24.0 meq/ L
S X P 00 , = 1.2mM/L
+IO meq/L
H+

[HCo,-1 = 14.0 meq/L
S X P 00 , = 11.2 m M / L
Closed System

Y1 = K1[H2COal

Ki is the rate constant. The rate of opposite reaction,
V2, is proportional to the product of the molar
concentrations of H• and HCQ3 -:
Y2 = K2[H+][HCOa -l

At equilibrium, V1

H+

[HCOa-1 = 14.0 meq/ L
S Pao, = 1.2 m M / L
Open System

2•

Hence,

The ratio of the two rate constants must also be
constant, and can be expressed as:
K = [H+][HCOa-l
[H2COal
if solved for [H+]:
[H+l = K [H2COal
[HCOa-l

obtaining the negative logarithm of both sides:
-

+
log [H l = -

[H2COal
log K - log [HCOa-l

since pH = - log [H+l and - log K = pK
_
[H2COal _
,
[HCOa -]
pH - pK - log [HCOa l - pK1
log [H2COal

+

The pKf for this system in blood is 6.1. This is the
pH corresponding to half neutralization and the point
of most efficient buffering. It represents the negative
logarithm of the apparent first ionization constant
of H 2 C0 3 corrected for the ratio of C0 2 to H 2 C0 3 •
Replacing the human value for pK (6.1) expresses
Henderson-Hasselbalch equation.
pH = 6.1

+ log

[HCOa-l
[H 2C0a]

Since the solubility constant of C0 2 is 0.03 total
H 2C03 pool = 0.03 X P 00 ,, where p is the partial
pressure of dissolved C0 2 • So final expression of
Henderson-Hasselbalch formula would be:

=

6'1

+ log

[HCOa-l
P 00 , X 0.03

As can be seen, the ratio between HC03and dissolved CO:! determines the pH. Normally,
24

+ log 40 X O.o3
24
pH = 6.1 + log Ll
20
pH= 6.1 + logl
pH= 6.1 + 1.3 = 7.40
pH

+IO meq/ L

=V

K1 [H2COa l = K 2[H+ l [HCOa -l
K1 _ [H+][HCOa -l
K2 [H2COal

pH

QUANTITATIVE REsPONSE OF 0..0SED AND OPEN SYSTEMS
TO ADDITION OF

If V1 is the rate of ionization of carbonic acid,
it is related to the concentration of H2 C03 .

=

6.1
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It should be emphasized that buffers are the
first defense lines in any acid-base disturbance. They
work within seconds; however, this effect is only
temporary. Restoration of normal acid-base status
depends upon the elimination of excess acid or
base and restoration of buffers to normal levels.
The lungs react to acid-base disturbances within
seconds to minutes by increased or decreased elimination of C0 2 • Renal compensatory mechanisms
are slow; it may take five to seven days before
efficient compensation can operate. Exchanges of
ions between intracellular (ICC) and extracellular
(ECC) fluid compartments also begin to operate
fast; however, full equilibrium may take a few hours.
For instance, in metabolic acidosis, intracellular K•
moves into plasma and H• ions from plasma move
into cells.

The Henderson-Hasselbalch equation:
p H = p K ,'

+ log

[HC03]
P co, X 0.03

The numerator of this equation, HC0 3- , is
primarily under the influence of the kidneys and is
the metabolic component. The denominator of this
formula, P co,, indicates the level of ventilation and
is primarily under the influence of the lungs. This is
considered a respiratory component.
component]
Bloo d p H a [metabolic
.
[resp1ratory component]

Normally the kidneys reabsorb more than
4,000 meq of bicarbonate daily. Only less than 5
meq of bicarbonate is found in the urine per day.
Approximately 85 % to 90 % of the filtered bicarbonate is reclaimed in the proximal tubule, and
the rest is reabsorbed from the distal tubules. HC0 3
is reabsorbed indirectly across the luminal tubular
membrane. When NaHCOa is filtered, Na• is actively reabsorbed in exchange for H• formed
within the tubule cells by the carbonic anhydrase
catalyzed hydration of CO ~. NaHC0 3 formed within
the tubule cells is reabsorbed into peritubular blood.
The secreted H• reacts with the HC03 - in the lumen
of the tubule, and the following reaction takes place:
HCOa-

+ H + ~ H 2C03 ~ C02 + H 20

The C02 produced diffuses back into the cell and
produces ft.iC0 3 • The pH of the fluid leaving the
proximal tubules is not significantly different frO!lJ
that of the initial glomerular filtrate.
This event conserves filtered HC0 3 - . However,
in order to maintain normal H• ion concentration,
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the kidneys must generate about 40 to 90 meq of
new HCoa- daily. This newly generated HC0 3 - replaces the HC03 - consumed daily to buffer fixed
acids produced from metabolism. Generation of
HC03 - is performed by excretion of 40 to 90 meq
of H• ion by the kidney as ammonium ions (NH 4' )
and titratable acids. The titratable acid represents
buffer reaching the tubular urine by glomerular filtration; on the other hand, NH 3 buffer is produced by
tubular cells.
The net quantity of acid eliminated in the urine
is equal to titratable acid plus NH/ , minus any small
amount HC03- that escapes into the urine. Normally,
NH4• is responsible for about two-thirds of the acid
excreted, and titratable acid for the rest of the onethird.
Acid-Base Abnormalities. There are four
simple or primary acid-base disturbances : respiratory
acidosis and alkalosis, and metabolic acidosis and
alkalosis. In addition, there are mixed or combined
acid-base disturbances which indicate the presence
of two independent acid-base abnormalities going
on at the same time.
Respiratory Acidosis. This is characterized by a
primary increase in Pco,, and it results when C0 2
production in the tissues exceeds the rate of its
removal by the lungs. In acute hypercapnia, the
body's defense mechanisms are very limited. The
pH is always acidotic. Blood (H+) increases linearly
as Pco, increases.
[H +] nano Eq/ L

=

0.76 P co, mm Hg

+ 9.3

When P co, increases from 40 mm Hg to 80
mm Hg, plasma HC0 3- increases only slightly (by
< 3 meq/ L). This small rise in plasma (HC0 3- ) is
almost entirely due to non-bicarbonate buffers of
blood, mainly hemoglobin.
In chronic respiratory acidosis, blood (H+) is
also a direct linear function of arterial P co,, but the
slope is less steep.
[H +] nano Eq/ L = 0.24 Pco, mm Hg + 27 .2
At any given arterial P co,, plasma (HC03-)
is higher and blood (H+) is lower in chronic hypercapnia than during acute hypercapnia. During hypercapnia, renal acid elimination (ammonium +
titratable acid) increases, thus generating more new
HC0 3- . Increased generation and absorption of
HC0 3 from the kidneys may bring pH towards
normal. It may take from 5 to 7 days before pH
may come within normal range.
In chronic respiratory acidosis at a P co, of
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50 mm Hg, 753 of the patients may have pH values
in the normal range. At a Pc o, of 60 mm Hg, approximately 153 of the patients may have low
normal pH values; at a P co, of 70 mm Hg, less
than 13 of the patients may have low normal pH
values.
In summary, body buffers play a major role
against acute hypercapnia; however, this buffering is
limited. On the other hand, renal mechanisms play
a major part against chronic hypercapnia, and pH
may reach within low normal range.
Respiratory Alkalosis. This is characterized by a
primary decrease in arterial Pc 0 , . When C02 elimination by the lungs exceeds C0 2 production in the
tissues, the result will be a lowering of arterial Pco, .
During acute hypocapnia, blood (H +) is again a linear
function of arterial Pco,.
[H +] nano Eq/ L = 0.74 Pco, + 10.4
During acute hyperventilation, the tendency for
H + ion activity in the body fluids to decrease is
somewhat opposed by buffers. Approximately onethird of the extracellular fluid HC0 3 - reduction
seen in vivo with acute hyperventilation is due to
blood buffers, mainly hemoglobin; the remaining
two-thirds is due to tissue buffering. During acute
hyperventilation, there is a slight increase in blood
lactate and to a lesser degree, pyruvate; the r~le
played by these organic acids in regard to the buffering is small. When P co, falls acutely from 40 to 20
mm Hg plasma HC0 3 - falls, on the average, by
7.5 meq/ L.
.
Chronic hypocapnia causes lowering of the
renal HC0 3 - threshold and a retention of the chloride ion by the kidneys. Patients with chronic respiratory alkalosis do not appear to have increased
lactate in the plasma. The pH tends to be slightly
high but may be normal. In chronic respiratory
alkalosis, low plasma HC0 3 is associated with
hyperchloremia. The same electrolyte composition
is seen in patients with hyperchloremic metabolic
acidosis. However, the pH tends to be high in chronic
respiratory alkalosis and lowered in hyperchloremic
metabolic acidosis.
Metabolic Acidosis. This is characterized by increased H + ion activity in the extracellular space due
to increased concentration of fixed acids. There is
primary reduction in plasma (HC0 3 - ) concentration.
Decreased pH stimulates respiration, thus lowering arterial P co,. If kidneys are normal , they secrete
more H + into the final urine. There will be more
complete titration of filtered phosphate. As the
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duration of metabolic acidosis becomes longer, pulmonary compensation is reduced. This is probably
due to the fatigue of the respiratory muscles secondary to the excessive work required. Arterial Pco,
would have a tendency to rise toward normal. Kidneys
increase renal acid secretion by increasing urinary
NH. + content. Provided acid loads are not excessive
(> 500 meq per day), renal acid secretion may reach
acid production, hence increasing plasma HC0 3 - and,
for a short time, exceed towards normal.
In simple metabolic acidosis, the ventilatory
response is probably the most predictable. Predicted
Pco, can be calculated by the following formula :
Pco, = 1.54 X [HC0 3 -] + 8.36 ± 1.1
If the Pco, is markedly lower than that predicted
by the above equation, there is probably also a primary respiratory alkalosis. If measured Pco, is
markedly higher than Pco, predicted by the above
equation, then there is a complicated respiratory
acidosis.
Metabolic Alka!osis. This is characterized by a primary increase in plasma bicarbonate concentration.
This should not be confused with elevation of plasma
(HC0 3 - ) concentration secondary to chronic hypercapnia, which represents a renal compensatory
mechanism for a primary respiratory dysfunction.
Hypoventilation is a compensatory mechanism in
metabolic alkalosis.
In general, respiratory compensation is poor.
In most of the patients arterial Pco, rises by 5 mm
Hg; however, in rare occasions Pco, may reach
60 or 65 mm Hg. An arterial Pco, higher than 65 mm
Hg virtually always indicates primary respiratory
acidosis rather than hypercapnia secondary to
primary metabolic alkalosis.
The following are common causes of metabolic
alkalosis:
1) Loss of acid (vomiting, gastric suction) .
2) Excessive alkali administration.
3) Chloride depletion.
4) Post hypercapnic alkalosis.
5) Mineralocorticoid excess syndrome.
6) Severe potassium depletion.
7) Contraction alkalosis.

In clinical medicine, more than one factor is
generally responsible for metabolic alkalosis, for
instance in a patient with pyloric stenosis who has
been vomiting. He is losing not only acid and potassium but he is also volume depleted.
Chloride depletion is an important and common
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cause of metabolic alkalosis. Sodium is actively
reabsorbed in renal tubules. Multiple factors influence
how much sodium is reabsorbed, such as: effective
plasma volume, aldosterone, filtration fraction, and
so forth. The amounts of sodium reabsorbed as NaCl
and in exchange for H • or K• depend mainly on
the amount of chloride, the only permeant anion
present in glomerular filtrate .
In chloride depletion, the amount of sodium
reabsorbed in exchange for H + and K + increases. It
should be remembered that for every meq of H +
secreted into the urine, the same amount of HC0 3enters into the blood, either by indirect reabsorption
of HC0 3- or by generation of new HC0 3- in the renal
tubular cells. During this increased cation exchange,
some potassium will also be lost. The result will be
hypochloremic metabolic alkalosis. The serum potassium level may also be reduced. Diuretic induced
metabolic alkalosis is primarily related to the chloride
depletion and volume contraction. In these simple
acid-base disturbances, the stimulus for compensation
is the change in pH brought about by the primary
change in Pco, or HC03- .
Since abnormal pH is the stimulus, normal
compensation should not over-correct or overcompensate. It should not even return pH to control
levels; however, this does not mean that in simple
acid-base abnormalities, normal pH cannot be observed. Since the normal pH range is 7.36- 7.44, a
slight acid-base disturbance, once compensated,
might return pH to the normal limits.
A pH value opposite to that expected by the
initial disturbance indicates a mixed acid-base disturbance. And again , if there is a marked disturbance
in a primary acid-base disorder, there will be less
likelihood of a normal pH. A normal pH in this
instance strongly suggests the presence of a mixed
acid-base disorder.
A lack of any compensatory response strongly
suggests a mixed acid-base disorder. However, there
are two exceptions: very little, if any, increase in
plasma (HC0 3- ) occurs in acute respiratory acidosis,
and only a slight or moderate rise in arterial Pco,
occurs in acute or chronic metabolic alkalosis. It
should be pointed out that pulmonary compensation in metabolic acidosis is reduced as metabolic
acidosis continues, and renal compensation in hypercapnia becomes more efficient with time. Because of these last two points, the use of 95% confidence bands cannot truly reflect the expected
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responses m acute and chronic acid-base disturbances.
From serum total C0 2 content alone, one cannot draw any definite conclusion. At least two unknown factors in the Henderson-Hasselbalch equation
should be measured. The third can be calculated. For
instance, in acute respiratory acidosis the total C0 2
content may be entirely normal. For example, a serum
total C0 2 content of 24 meq/ L in a patient may suggest
normal acid-base status. The pH might be found to be
7.2 which is equal to [W] = 40 23 = 63 nano Eq/ L.
If one uses a rearranged Henderson's equation,

+

p

_ [H +][HC03]

co, -

0.03 X K

K = 800
[H +] is given in nano Eq/ L
[H +][HC03]

Pc o, =

24

In the above example, Pco, will be:
p

- 63 x 24
co, 24

63

For intelligent interpretation of the acid-base
status of the patients the following points should
be checked:
1. Clinical information should include history
and physical examination, medication taken,
therapeutic measures undertaken such as assisted mechanical ventilation, limited salt
intake, and so forth.
2. Routine serum electrolytes. It should be
known that serum C0 2 content in m M / L
represents almost entirely HC0 3- . The total
H 2 C0 3 pool (H 2 C0 3 and physically dissolved
C0 2) is equal to 0.03 X Pco,.
Pco, and pH should be known. Anion gap or
undetermined anion fraction should be calculated.
This is normally less than 12 - 14 meq/ L which
represents phosphates, sulfates, anionic proteins, and
organic anions normally present. It is measured by
subtracting the sum of the plasma chloride and
(HC0 3 - ) concentrations from the plasma sodium
concentration.
The following are causes of increased anion
gap:
I) Azotemic renal failure .
2) Diabetic ketoacidosis.
3) Lactic acidosis.

MUREN: ACID-BASE REGULATION

140

4) Ingestion or administration of:
a) methyl alcohol.
b) salicylate.
c) ethylene glycol .
d) paraldehyde.
In chronic azotemic renal failure alone anion
gap seldom exceeds 20 meq/ L. Undetermined
anion fractions above 25 meq/ L are usually observed only in salicylate, methanol, ethylene glycol
poisoning, and lactic or diabetic ketoacidosis.
Serum potassium levels may be useful in predicting arterial pH. In acidosis, there is a tendency
for serum potassium to rise unless there is underlying potassium depletion or acidosis was secondary
to loss of K HC03 which occurs in diarrhea, acetazolemide (Diamox®) administration, and renal
tubular acidosis.
Other laboratory findings such as blood sugar,
BUN, urinalysis, liver function studies, and so
forth should be examined for an explanation of
acid-base disorder. For instance, in a patient with
metabolic alkalosis, in the absence of diuretic administration, lack of urinary chloride is virtually diagnostic of metabolic alkalosis due to chloride depletion.
In summary, arterial gas studies including pH
determinations can be vitally important in the diagnosis and management of patients with a va-

riety of serious medical problems. These studies
should be interpreted in the light of clinical and
other necessary laboratory findings.
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Non-Ventilator Management of Respiratory
Failure: The Ventimask*
WILLIAM B. HUNT, JR., M.D.
Associate Professor of Internal Medicine, Allergy-Pulmonary Division,
University of Virginia School of Medicine, Charlottesville, Virginia

The Problem-Acute Respiratory Failure in
Chronic Obstructive Pulmonary Disease. In a
recent review the authors comment on acute respiratory failure complicating chronic obstructive
pulmonary disease. They state that because of
the tolerance to chronic hypoxemia, the recurrent nature of the lung failure, and the increased
number of complications during mechanicai ventilation, "artificial ventilation is not indicated until all other attempts have failed to reverse hypoxemia without causing hypocapnia" (2).
This paper will detail the conservative management of acute respiratory failure in patients
with chronic respiratory failure due to chronic
bronchitis and emphysema. It is important to recognize that this is a very specific group of patients.
They have had chronic hypoxia and hypercarbia
for months or years preceding their current episode
of acute respiratory failure. There occurs a further
drop in arterial P 0 , (Pa 0 ,) and usually a further
rise in arterial Pco, (Pac 0 .). The baseline arterial
Pa 0 ,, Paco,, and pH_in _sucb_patients_ar.e usually
as follows:
50 mm Hg
Pa 0 ,
Paco, = 45 mm Hg
pH
7.4
Because of infection, sedation, heart failure, associated asthma, and so forth, they usually pre-

* Presented by Dr. Hunt at the Symposium on Respiratory Failure, May 26, 1972, at Richmond, Virginia.
1 The ventimask can be obtained from The Bethlehem
Corporation, 225 W. Second Street, Bethlehem, Pennsylvania.
MCV QUARTERLY 9(2): 141-144, 1973

sent to their physician with increasing dyspnea,
cyanosis, disorientation, and commonly the following arterial gases and pH:
Pao, = 40 min Hg
Paco, = 55 mm Hg
pH
= 7.35
Remember that the statements in this paper do
not apply to asthma, only to chronic bronchitis and
emphysema.
The Therapeutic Goal. The physician must
increase the Pa 0 , "significantly" with "little increase" in Paco, and " little decrease" in pH. While
this stopgap measure keeps the patient alive, therapeutic efforts are directed toward complicating
diseases responsible for the acute respiratory failure.
An attempt will be made to define the vague term
"significant decrease" in Pa 0 ,, and "little decrease"
in pH.
The Tool-'the Ventimask.1 Since this group
of patients has had an elevated Paco, for varying
periods of time, ventilation is keyed to the low
arterial oxygen, rather than to the C0 2 partial
pressure. The usual methods of oxygen delivery, the
nasai catheter and face mask, deliver 303 to 403
oxygen, enough to lethally depress ventilation.
The ventimask represents a method by which
the physician can deliver low fiow oxygen inexpensively and with safety. Because of the Venturi effect,
the 1003 oxygen that fiows into the mask will entrain
room air (213 0 2 ) through the side ports of the
mask (fig. 1). Four liters of oxygen fiow per minute
is necessary to achieve the 243 0 2 concentration in
the mask. However, further increases in fiow will
merely draw more 213 oxygen into the mask, and
by clever engineering the oxygen concentration in
the mask is therefore kept constant at 243. The 283
141
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24" 02 FI02

700
168.00 mmHg pl02
-40.00 mmHg pAC02

128.00 mmHg pA02

100,.

ALVEOLUS

Fig. 1-The 24% ventimask.

ventimask is similar in all respects except that the
final F1 0 , is 283.
Guidelines for Arterial Gases.
Arterial Oxygen. When the Pa 0 , falls below
50 mm Hg, pulmonary capillary vasoconstriction
occurs, and pulmonary hypertension occurs or is
accentuated. Pa 0 , below 40 will decrease sodium and
free water excretion and may depress ventilation.
In this range (40 or below) digitalis intoxication is
markedly accentuated and ventricular arrhythmias
occur.
In practice then, the immediate goal of therapy
should be to increase the Pa 0 , from 30- 40 mm Hg
to the 45- 55 mm Hg range. This frequently can be
done with the 243 ventimask, remembering that an
increase in inspired oxygen concentration (F1 0 ,)
from 213 (room air) to 243 is really 33 of an
atmosphere (760 mm Hg) or approximately 21 mm Hg.
Since in patients with chronic bronchitis and emphysema ventilation is usually reduced to many
alveoli, the alveolar 0 2 (Pa 0 ,) of 128 mm Hg (as in
fig. l) is usually reduced so that the increase m
Pa 0 , is more like 10 mm Hg than 21 mm Hg.
But it is very important to note that this lO
mm Hg change in Pa 0 , is on the steep portion of the
oxyhemoglobin dissociation curve (fig. 2) and will

actually nearly double the oxygen delivered at the
tissue level.
Guidelines for Paco, and pH. Except for its
narcotic properties, Pa c o, elevation per se is probably
not important but may be used as a guide to oxygen
delivery. If the 243 ventimask therapy results in a
lO mm Hg increase in Pa 0 , and at the same time
elevates the Pa c o, greater than 5 mm Hg, further
increase in oxygen concentration should not be
attempted. If the Paco, remains the same or is
reduced then one can safely go on to a 283 ventimask
and another 43 (28 mm Hg) increase in F1 0 ,. A
Pac o, greater than 65 mm Hg may decrease salt and
free water excretion, but this can usually be overcome
with the use of diuretics (Lasix® not ethacrynic acid).
The pH, however, is critical. Many vital enzyme systems do not work as the pH falls below
7 .2, and hydrogen ion elevation will also cause
pulmonary capillary vasoconstriction.
If the pH can be kept between 7.3 and 7.4
and does not remain consistently below 7.2, and
if the patient remains conscious and able to cough,
then conservative therapy should be continued.
General Measures. Dr. E. J. M. Campbell
has said, "controlled oxygen therapy plus ineffectual nursing is better than uncontrolled oxygen
plus ineffectual nursing only because the patient
gets into less trouble" (I). The most important factor immediately is nursing care.
The patient should be:
I. Jn a chair, not flat in bed.
2. In a lighted room or corridor for the first
24 hours for observation and stimulation.

-
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Arterial Oxwen Press.n mm Hg

Fig. 2-Jncrease in Pa .." on 24% ventimask. "Available"
means available at the tissue level (modified after Campbell) .
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3. Receiving chest physiotherapy each hour
from the floor nurse or relatives or at least
encouraged to cough and breathe deeply
every 15 minutes.
4. Encouraged to use a pressure regulated
IPPB machine (Bird or Bennett) five
minutes out of every 30 or 60 minutes
(without Isuprel®). This is for "stir-up,"
cough, and stimulation not specifically for
ventilation.
Specific Therapy. In general, there is no
"specific therapy" for chronic bronchitis . and ei_nphysema, so that complications or associated diseases must be diligently searched for and vigorously treated if present. One must not blindly
and mindlessly treat each patient with chronic
bronchitis and emphysema with digitalis, antibiotics, diuretics, steroids, and broncholytic agents.
Mucolytics. There are none that are effective.
Acetyl cysteine (Mycomyst® ) may actually aggravate any bronchospasm that may be present.
Robitussin® should be reserved for your grandmother who has a "tickle in her throat."
Look for and treat:
1. Left ventricular failure. This is most easily diagnosed by an upright chest x-ray showing
pulmonary venous engorgement in the upper lobes
or Kerley B lines (fig. 3) . Obvious pulmonary
edema, whether unilateral or mild, should be
suspected and searched for. Treat vigorously with
Lasix® and replace K losses with KCI not K-Triplex. Digoxin should be used judiciously. The right
ventricle will respond to digitalis, but toxicity may
occur at half the usual digoxin level when the
Pa 0 , is below 50 mm Hg.
2. Asthma. Eosinophils in the blood or on
Hansel stain 2 of the sputum suggest a diagnosis
of asthma. Suspect this diagnosis if the patient
does not smoke, is under 50, or has a childhood
history of asthma. If asthma is not present, Isuprel® can accentuate hypoxemia and in the already
hypoxemic individual, aminophylline, adrenalin,
and ephedrine may cause dangerous arrhythmias.
In the patient with chronic bronchitis and emphysema in respiratory failure without prior evidence
of a good response, certainly Isuprel® and prob-

2 Hansel stain may be obtained from Lide Laboratories,
6828 Oakland Avenue, St. Louis, Mo. 63139-$7.50 for 8
ounces.

Fig. 3-The arrows indicate the position of Kerley B lines.
The pulmonary veins are shown in black.

ably the other bronchodilator drugs are contraindicated.
Steroid therapy (prednisone 40-60 mg daily)
in patients with associated asthma may be life
saving. An intermediate PPD should be done on
every patient on admission prior to the institution of steroids and, if positive, isoniazid therapy should be considered, depending on the duration of the steroid therapy and the appearance
of the chest x-ray.
3. Infection. The sputum should be observed,
stained (both Gram and Hansel), and cultured
if grossly purulent. Infrequently, grossly purulent
sputum can be due to the presence of eosinophils
alone. Usually acute purulent bronchitis is the
the cause. The most common pathogens found are
the pneumococcus or hemophilus influenza. Since
probably 10% of all strains of streptococcus pneumonia are resistant to tetracycline, ampicillin 2 g
daily is the treatment of choice (unless penicillin sensitivity is present).
4. Pneumonia: A chest x-ray must be obtained. The use of a stethoscope alone in the examination of the emphysematous chest is grossly
inadequate. The presence of pneumonia in the patient with acute respiratory failure constitutes a
medical emergency. Unless the overwhelmingly
predominant organism can be identified by gram
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stain and quellung3 as a pneumococcus, cephalothin and gentamycin should be used for 48
hours until the results of the sputum culture are
available. You do not have time to be wrong,
then switch.
5. Cor pulmonale. Rapid, effective, specific
therapy for the right heart failure of cor pulmonale in these patients is not available. The patient has right heart failure primarily because he
is hypoxemic, and you cannot rapidly relieve his
hypoxemia or he will underventilate, become unconscious, needing intubation and mechanical
ventilation, and this is what you are trying to
avoid. As mentioned above, digitalis will improve
the function of the right ventricle but must be
used cautiously. If the patient has not been given
digitalis in the past, digoxin 0.25 mg daily without a loading dose is the preferable technique.
A reduction in pulmonary blood volume, ascites,
and pleural effusion all may improve pulmonary
function so that aggressive diuretic therapy may
be indicated. Ethacrynic acid may produce underventilation and should be avoided. Currently
Lasix® is the drug of choice. Thoracentesis may
produce a lethal pneumothorax and should be
avoided unless a massive effusion is present. There
is no evidence that phlebotomy is an effective
method of therapy under these circumstances.
Sedation. If over sedation with morphine or
pentazocine is suspected, naloxone (narcan) is specific therapy and can be given without risk of further
sedation. If other drugs (Valium®, meprobamate, and
so forth) are known to have been primarily responsible for the respiratory depression, then it becomes even more imperative that vigorous attempts be made to keep the patient awake for the
first 24 hours of therapy. It should be noted here
that it is self-defeating to keep patients awake
continuously for more than 24 hours. At the end
of that time, alternating naps with arousal every
30 minutes to one hour becomes necessary.
8 Quellung reagent may be obtained as "Omniserum"
from Statens Seruminstitute, Amager Boulevard 80, DK2300, Copenhagen S, Denmark.

HUNT: VENTIMASK

When to Intubate. Reduced consciousness
and an inability to cough are the major indications for intubation and ventilation. Inability to
achieve an arterial Pa 0 , greater than 30 mm Hg
or maintain a pH greater than 7 .2 after 24 hours
of therapy are relative indications for intubation.
But, one should never act precipitously on a single number obtained from the laboratory that
does not fit the clinical course that has been observed.
Emergency tracheostomy should never be
done without prior intubation. Ideally a period of
mechanical ventilation with achievement of good
oxygenation and reversal of the respiratory acidosis should be accomplished prior to tracheostomy.
Summary. Low flow oxygen therapy should
be given a trial in all conscious patients presenting
with acute respiratory failure due to chronic bronchitis and emphysema. The tolerance of these
patients to hypoxemia and hypercarbia make this
means of therapy possible. The ventimask is an
effective, inexpensive method of administering low
flow oxygen, with the added attraction that the
oxygen concentration cannot be inadvertently increased. Nursing care and aggressive therapy of
complicating or associated medical problems are
the key to successful management.
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With the increasing complexity of ventilatory
equipment and the rapid development of new
techniques for respiratory care, it has become progressively more difficult for the average physician
to keep pace with clinical and technical advancements. The management of acute respiratory failure
is now a demanding art which requires a broad
knowledge of cardiopulmonary physiology and
sophistication in the use of complicated equipment.
Careful attention to detail is often the critical
factor that determines survival. The mortality from
acute respiratory failure has been substantially reduced in respiratory intensive care units where there
are well trained teams of physicians, nurses, and
technicians to manage patients during life-threatening episodes of ventilatory failure (6).
In many hospitals such facilities and specialized
teams do not exist. The busy physician often finds
that he has neither the time nor technical skill to
provide optimum patient care. Valuable assistance
can be provided by medical personnel, such as
inhalation therapists, who have been trained in
respiratory physiology, principles of good patient
care, and the proper application of mechanical devices to aid in the management of respiratory
disease. With the continuing shortage of physicians
and nurses trained in pulmonary disease, the inhalation therapists can be expected to assume a
larger role in the care of respiratory patients. The
practicing physician must be aware of the services
available and be able to utilize these to the best
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possible advantage to improve the quality of c_are
for patients in the hospital and at home. A review
of some of the basic principles of inhalation therapy
is presented.
Intermittent Positive Pressure Breathing (IPPB).
Intermittent positive pressure breathing is commonly
employed in the treatment of atelectasis, bronchi.tis,
and pneumonia and may be useful for the prevention
of postoperative respiratory complications. Its effectiveness in these areas is a subject of considerable
controversy and any beneficial effects appear to be
related more to the technique of administration than
to any other single factor ( 1) . The routine use of
IPPB without adequate patient instruction and without a well trained person to administer therapy
appears to be of little benefit ( 5) . Long-term home
treatment with IPPB in patients with chronic obstructive lung disease has failed to demonstrate
measurable improvement, as indicated by arterial
blood gases and pulmonary function testing; yet
many of these patients feel that IPPB helps them
to raise secretions, breathe more easily, and live more
comfortable lives ( 3). Aerosol bronchodilators may
be delivered very effectively by IPPB equipment.
These agents are of benefit in reducing bronchoconstriction and aid in the removal of secretions.
IPPB is also indicated in the management of acute
pulmonary edema with severe hypoxemia.
Aerosol Therapy. Aerosol therapy is of considerable importance in helping to facilitate removal
of abnormal secretions. Accumulation of thick,
tenacious secretions represents one of the most important reversible factors in acute and chronic re. t"
spiratory disease. The terms " aeroso l" an d " mis
imply that water or a liquid substance is deliv~red
as small particles suspended in air. Water particles
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are generally unstable and are deposited primarily
in the upper airways. Ultrasonic nebulizers deliver
a high-density mist with relatively small particles.
They are effective in thinning secretions in the upper
airway but may be poorly tolerated by some patients
and are potentially hazardous with prolonged continuous use ( 4). Mist tents are commonly used
in pediatrics for the management of pneumonia,
bronchiolitis, and cystic fibrosis. Heated aerosols
from reservoir nebulizers are often helpful for removal of secretions in patients with bronchitis,
asthma, and acute respiratory failure. Induced
sputum specimens may also be obtained for diagnostic studies. When gas is heated, more water may be
transported in the gaseous state, significantly increasing the humidity. Careful attention to the
principles of humidification is important in mechanical ventilation and frequently may mean the
difference between success and failure in the management of patients with endotracheal tubes and
tracheostomies.
Oxygen Therapy. Many of the physiologic
alterations present in acute respiratory failure occur
as a result of hypoxia. Oxygen is therefore one of
the most important drugs used in managing this
disease. Like any other drug, it must be ordered
and administered with care, and its effects must be
observed carefully. Oxygen transport to the tissues
depends upon multiple factors, including cardiac
output, arterial oxygen content, and metabolic requirements. All of these factors have to be considered
for safe and intelligent administration of oxygen
therapy. Excessive oxygen may result in damage
to the lungs or depression of ventilation in patients
with respiratory failure and hypercapnia. In the
treatment of patients with acute ventilatory failure, the proper administration of oxygen may mean
the difference between successful conservative management or failure of such therapy with endotracheal intubation or tracheostomy necessary for
survival. The inhalation therapist may provide assistance in all areas of oxygen therapy.
Respiratory Monitoring. Patients in respiratory
failure need careful monitoring, regardless of whether
they are being managed conservatively or with mechanical ventilatory support. Clinical evaluation of
the patient by a trained observer is essential with administration of bronchodilators, oxygen, mechanical
ventilation, or other forms of therapy that may
result in cardiac or respiratory alterations. Bedside
spirometry can aid in determining changes in lung
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volumes and minute ventilation. Portable oxygen
and carbon dioxide analyzers are valuable for monitoring inspired and e~pired gas mixtures. Evaluation of lung mechanics, particularly when patients
are on respirators, can detect significant changes in
airway resistance and lung compliance. Arterial
blood gases are the ultimate laboratory guide to
therapy and must be available at all times to adequately manage patients with acute respiratory
failure.
Mechanical Ventilation. The indications
for mechanical ventilation are frequently based on
a combination of clinical observations and physiologic changes which can be measured at the bedside with equipment that is readily available and
familiar to the inhalation. therapist (2). Once mechanical ventilation has been instituted, continuous
observation is necessary and adjustments in therapy
must be made, as indicated by arterial blood gases
and clinical response. Advances in the design of
ventilators and in techniques of ventilation have
resulted in increased survival and less morbidity
for patients requiring artificial ventilation. Continuous positive pressure ventilation has proved to be
of considerable value in managing the adult respiratory distress syndrome and acute pulmonary
edema when severe hypoxemia is present. With such
therapy the effects on venous return, cardiac output,
and oxygen delivery must be known and fully appreciated. Careful physiologic evaluation is necessary
to determine when the patient is ready for weaning
from the respirator and to follow his progress during
the weaning period. Improper weaning often results
in rapid deterioration of the patient and reversal
of much that has been previously accomplished by
good respiratory care.
Home Care. Home care is often neglected in
the comprehensive medical management of patients
with respiratory disease. The respiratory equipment
and techniques for home care must be individualized
for each patient, depending upon his disease and
needs. Often simple and inexpensive equipment will
give results equal to or better than more expensive
and complicated devices. Instruction in cleaning
and maintaining respiratory equipment at home is
best given by persons who constantly concern
themselves with these problems. Discharge from
the hospital is sometimes dependent upon the ability
of the family to render appropriate respiratory care
at home. Some families are able to manage extremely
complicated situations when good training and su-
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pervision are provided by interested respiratory
nurses and inhalation therapists. Home visits are
often necessary to assure that the best possible care
is given and to assist with problems that may be
unrecognized by the patient, family, and physician.
Frequently the practicing physician has neither the
time nor awareness for the inany technical and
mechanical aspects of home care. Techniques for
chest physiotherapy should be taught to the patient
and family when indicated, and continued instruction
and supervision are necessary for maximum effectiveness of this therapy. The multiple problems
of outpatient care are best handled by a team of
respiratory specialists, but when such a team is not
available, much can be accomplished with the aid of
the well trained inhalation therapist of today.
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How to Get Patients On and Off Respirators*
TERRING W. HEIRONIMUS, Ill, M.D.
Professor of Anesthesiology, University of Virginia
School of Medicine, Charlottesville, Virginia

This title implies that one has already decided
that one's patient needs to be artificially ventilated,
that is, that he is in respiratory failure. How does
one diagnose respiratory failure? Much of what I
have to say in this regard is in terms of arbitrary
limits, values, arid guidelines. Since these guidelines
are arbitrary, there may exist legitimate grounds
for differences of opinion about some of them. However, we have found these guidelines to be quite
helpful, and experience would indicate that they
are reasonable.
,
Let us first define what we are talking about.
Respiratory insufficiency, which is the first step in
the departure from normal pulmonary function, is
the failure to maintain normal blood gases without
persistent tachypnea, cough, or both. Hence, it can be
seen that a patient may be in respiratory insufficiency
and still have normal blood gases, that is, a patient
in severe status asthma may be maintaining essentially normal blood gases but only with the expenditure of considerable effort and energy manifest
as tachypnea and dyspnea. When the patient is
inspmng room air normal blood gases are a P 0 ,
of 90 to 95 mm of mercury, a P co, of 40 mm of
mercury, and a pH of 7.4. Mixed venous blood,
as it is taken from the pulmonary artery under
normal circumstances, contains a P 0 , of 40 mm of
mercury, a P co; of 46 mm of mercury, and a pH of
approximately 7.38 to 7.39. Thus it can be seen tliat
while venous blood may give a fairly accurate representation of the patient's acid-base balance, it is of
virtually no use in determining the state of oxygenation. The main function of the lungs is to convert
venous blood into arterial blood, and in order to
evaluate this fi.lnction one must look at the finished
product, not the raw material. Respiratory insuffi-

* Presented by Dr. Heironimus at the Symposium on
Respiratory Failure, May 26, 1972 at Richmond, Virginia.
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ciency can be said to have progressed to a state of
respiratory failure when the P 0 , is below 50 mm of
mercury or the P c o, is above 50 mm of mercury, at
which time the pH may or may not still be near
normal. Depending upon the etiology of the respiratory failure, some patients may need the institution
of artificial ventilation at this point; others may not.
Regardless of the etiology of the respiratory failure,
when the P 0 , remains below 50 or the Pco, remains
above 50 in conjunction with an arterial pH at or
below 7.25, mechanical ventilation is indicated. There
may be a few exceptions to this degree of ventilatory
impairment, but they are few indeed. In this outline,
one can see a summary of the indications for respiratory support, which are: a respiratory rate of greater
than 35 per minute, a vital capacity of less than 10 to
15 ml per kg of body weight, an alveolar-arterial
oxygen tension gradient of greater than 400 mm of
mercury (an arterial P 0 , of less than 200 mm of
mercury on 1003 oxygen), a dead space to tidal
volume ratio of greater than 603 , and an arterial
carbon dioxide tension in excess of 60 mm of mercury,
except in the case of patients with chronic hypercapnia.
It is arterial oxygen tension or P 0 , that we speak
of and that we think about, but in actuality, the
thing that we are concerned about is the delivery
of an adequate amount of oxygen to the tissues,
a determination which is not directly or easily
measurable. However, if by means of the oxyhemoglobin dissociation curve, one relates arterial
oxygen tension to oxygen saturation and in turn
relates oxygen saturation into total oxygen content,
implying a normal oxygen carrying capacity, such
as an hematocrit of 353 or better, and if one can
then derive at least indirect evidence of an adequate
cardiac output, one can then assume that oxygen
delivery to the tissues is adequate. The point to be
made here is to stress the fact that an adequate
arterial oxygen tension may indeed exist in the
MCV QUARTERLY 9(2): 148-153, 1973
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presence of a grossly inadequate oxygen supply to
the tissue, such as with either severe anemia or an
inadequate cardiac output, or both. The arterial
oxygen tension is what we measure, but with few
exceptions it is not the arterial oxygen tension per
se in which we are interested. Arterial oxygen
saturation is quite satisfactory even down to an
arterial oxygen tension of 60 mm of mercury, and
indeed hemoglobin does not reach 503 saturation
until a P 0 , of approximately 26 mm of mercury is
reached.
We can therefore summarize the following
factors as indications for immediate intubation and
ventilation:
1. A consistently rising arterial carbon dioxide
tension.
2. A pH at or below 7 .25.
3. A previously alert patient who becomes somnolent and unresponsive.
4. An alveolar-arterial oxygen tension gradient
on 100% oxygen of 400 mm of mercury
or more.
5. A respiratory rate of above 35 per minute
or more.
6. A tidal volume of less than 3 to 4 ml per
kg.
7. A vital capacity of less than 10 ml per kg.
How do we measure an alveolar-arterial oxygen
tension gradient? This is no more than the alveolar
oxygen tension minus the arterial oxygen tension
measured in millimeters of mercury. This measurement is accomplished by giving the patient 100%
oxygen to breathe for a minimum of 15 minutes.
In some patients with severe degrees of shunting
due to pneumonia or pulmonary edema and the like,
as much as 30 minutes of 100% oxygen breathing
may be required to completely denitrogenate the
lung because of severe ventilation/ perfusion inequalities. At the end of this arbitrary 15 to 30
minutes of 100% oxygen breathing, one then measures the atmospheric pressure and draws a blood
gas sample. The arterial carbon dioxide tension
can be assumed to completely equilibrate with the
alveolar carbon dioxide tension, and this, plus the
alyeolar water vapor tension, determined as a function of body temperature, is subtracted from atmpspheric pressure. The difference must be the
alveolar oxygen tension since one can assume that
the oxygen breathing for 15 to 30 minutes has completely eliminated all alveolar nitrogen. When this
maneuver is performed upon healthy patients, one
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will find an arterial oxygen tension of between 575
to 600 mm of mercury, implying a shunt of about
3 % of the cardiac output, which is the normal anatomic shunt. The alveolar-arterial oxygen tension
gradient, or the A-aD02, can therefore be said to be
75 to 100 mm of mercury on 100% oxygen and 5 to
10 mm of mercury on 21 % oxygen, that is, room
air. Both of these A-aD02's imply a difference in
oxygen content or oxygen saturation of precisely the
same amount, that is, 3 % of the cardiac output. The
difference in the numerical values of the two calculations is due to the shape of the oxyhemoglobin
dissociation curve.
The initial steps in instituting mechanical ventilation in most, but not all patients, are:
1. Produce a tidal volume of approximately 12
to 15 ml per kg, realizing that in the great
majority of patients in respiratory failure it is
necessary to achieve an initial tidal volume of
approximately 2 times that of normal, in
order to compensate for the ventilation/ perfusion inequalities present. (This would be
excessive in patients with chronic obstructive
pulmonary disease).
2. A cycling rate of approximately 12 to 15
times per minute.
3. An inspired oxygen concentration of FI02 of
1003.
4. Mechanical dead space may be added at this
time if it is anticipated that such large tidal
volumes will produce an abnormally low level
of arterial carbon dioxide tension.
5. Sedation is often necessary especially at the
outset of mechanical ventilation.
6. Arterial blood gases should be done after
approximately 15 minutes of ventilation with
these settings in order to determine the
future needs and appropriate settings of the
ventilator. Since the patient was started on
1003 oxygen, the first set of blood gasel) will
allow one to calculate the A-aD02 on 1003
oxygen. This value can then be put into the
following formula in order to calculate the
minimal desired inspired oxygen concentration:
D

+

. d F
_ (A-aD0 2)
100 mm Hg X lOO
esire
10 , p atmos.

In tl\is fashion one determines the least amount
of oxygen that will adequately saturate the
patient's hemoglobin without running undue
risk of pulmonary oxygen toxicity; one is using
oxygen as a drug.
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Next one must be prepared to look at certain
parameters of the cardiovascular and respiratory
systems to note the response to therapy. Among
these observations are:
1. The electrocardiograph oscilloscope should
be used in patients with arrhythmias, congestive heart failure, those critically ill or hemodynarnically unstable.
2. Intra-arterial pressures may need to be
measured when cuff pressures are unobtainable or unreliable.
3. Central venous pressure measurements are
of value in determining the effective circulating blood volume and when myocardial
efficiency is in question.
4. The F1 0 , should be measured at least daily
or when altering oxygenation parameters.
5. The tidal volume, respiratory rate, and minute volume of ventilation should be measured
while the patient is on the ventilator approximately every 1 to 4 hours.
6. When the patient is breathing spontaneously,
the tidal volume, respiratory rate, and, in
conscious patients, the vital capacity should
be measured every 1 to 4 hours.
7. The A-aDo2 on 100% oxygen should be
measured at least daily or as necessary.
8. The VD/ VT ratio-the dead space to tidal
volume ratio-should be measured daily or
as necessary.
What is the dead space to tidal volume ratio,
and how is it measured? The VD/ VT ratio is that
percentage of tidal volume which is wasted in the
total of the anatomic dead space and the alveolar
dead space, that is, areas of lung parenchyma which
are ventilated but not perfused, or at least ventilated in excess of the amount of perfusion present.
This value in normal patients is 30% . The observation is performed by dividing the difference between alveolar and mixed expired carbon dioxide
tensions by alveolar carbon dioxide tension.
VD/ VT

= (PAcoJ - (PEco, )
(PAcoJ

As the ratio increases, it means that the patient's
ventilation/ perfusion inequalities are increasing and
that he is wasting more and more of each tidal
volume in ventilating areas of the airway and lung
which are not perfused and which therefore contribute nothing to the exchange of gas. As the VD/ VT
ratio increases, one must increase his minute ven-

tilation to higher and higher levels in order to maintain a normal carbon dioxide tension of 40 mm of
mercury. At VD/ VT ratios above 60%, the curve
begins to rise in an exponential fashion, and above
this level of dysfunction patients can no longer breathe
enough volume to maintain normal carbon dioxide
tensions, and respiratory acidosis begins to occur.
The VD/ VT ratio can be measured both on and
off the ventilator, but measurements made while
the patient is being ventilated tend to run slightly
higher than those when he is breathing spontaneously,
especially during high inspiratory flow rates.
Nursing routines are important for physicians
to know and understand for one reason only. If
the nurse is unaware of the problems attendant
to the management of respiratory failure, no one
other than the physician can make her knowledgeable in this respect. The physician must know what
he wants in order to tell the nurse what to do and
what not to do. I do not wish to under-emphasize
the importance of intelligent physician care in the
management of such patients; nonetheless, the successful treatment of respiratory failure is largely a
nursing venture. If nursing care is less than optimal,
patients are unlikely to survive regardless of the
degree of sophistication and intelligence of their
physicians.
The following nursing routines are therefore
recommended:
1. The patient is NEVER left unattended.
(This is virtually impossible except in an
ICU setting.)
2. Sterile technique in airway care and suctioning is of utmost importance in order
to prevent iatrogenic contamination and
infection.
3. Endotracheal and tracheostomy tube cuffs
should be pre-stretched or of the soft cuff
design to avoid tracheal trauma.
4. Daily weights must be obtained and recorded.
5. Intake and output must be accurately recorded daily.
6. The arterial pressure, pulse rate, temperature, and central venous pressure are recorded at intervals.
7. The patient's position in bed should be
changed hourly while he is awake or hourly
around the clock if comatose.
8. Attention should be directed to the care
of the skin of the dependent parts. Heels,
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knees, and elbows should be padded if
deemed appropriate.
9. Chest physiotherapy should be coordinated
with position change, airway suctioning,
and IPPB treatments, if utilized. The frequency of this is to be determined according to the severity of the disease.
10. All joints in comatose or paralyzed patients should be put through a passive full
range of motion daily.
11. The color and approximate quantity of
tracheal aspirate are recorded.
12. An extra sterile tracheostomy tube and
cuff of the appropriate size are kept at the
bedside at all times.
13. Water condensing in ventilatory tubing is
drained each hour.
14. The humidifier is checked and refilled every
8 hours or more often if necessary. The
volume of water required to do so is recorded. This is done in an aseptic fashion.
15. Oxygen lines and flow meters are checked
hourly to be sure that they are properly
connected and functioning as ordered.
16. The house officer is notified immediately in
case of a change in the level of consciousness or the occurrence of tachycardia, hypotension, confusion, agitation, tarry stools,
or arrhythmias.
Appropriate laboratory studies during the
maintenance of artificial ventilation include:
1. A chest x-ray is taken initially, following airway placement or change, daily to every 3
days, frequency to be determined by the
severity of the disease.
2. The hematocrit is determined daily.
3. All stools are examined for occult blood.
4. Electrolytes, BUN, creatinine, sugar, total
protein, and albumin are measured initi ally
and as necessary.
5. The white blood count and differential are
determined initially and as necessary.
6. Tracheal aspirate obtained with sterile
technique for Gram stain smear, culture,
and sensitivities is accomplished initially and
every 3 to 5 days as necessary.
The inability to maintain good nutrition is one
of the primary problems faced by patients suffering
from long-term respiratory failure. The average
patient on intravenous maintenance fluids alone can
maintain his own state of caloric need for only
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approximately two days by means of glycogenolysis.
After this the patient must utilize his own protein
stores, thereby developing negative nitrogen balance. When the patient is taking nothing by mouth
maintenance fluids should total 40 to 45 ml per kg
per day of which one-third can be dextrose 5% in
normal saline or dextrose 5% in lactated Ringer's
solution, and the other two-thirds dextrose 5 % in
water. These figures must be adjusted upward for
fever, for abnormal fluid loss, or in the presence
of hypovolemia. They should be adjusted downward
appropriately for patients in congestive heart failure,
or those with limited renal function. Their content
must be adjusted for electrolyte abnormalities. The
average adult, when taking nothing by mouth, and
on maintenance fluids only, should lose approximately
1h kg per day. Intake and output and daily weights
must be carefully observed to make sure that this
weight loss is taking place. Patients who are alert
and cooperative, who exhibit normal gastrointestinal
integrity, and who have audible bowel sounds, can
and should eat. Patients who are comatose or paralyzed but with normal gastrointestinal integrity
should have a high protein, high carbohydrate diet
per nasogastric tube or gastrostomy. Patients with
compromised gastrointestinal integrity lasting
more than one week should receive parenteral
hyperalimentation. The serum albumin should be
kept above 2.0 g%, preferably above 3.0 g% in
order to avoid the complication of pulmonary extravascular fluid sequestration. Starving patients cannot
effectively breathe indefinitely. Successful weaning
from prolonged controlled ventilation requires
positive nitrogen balance.
Prolonged ventilatory support is attended by
various complications which need to be anticipated
and prevented if at all possible. Included in this list
are the following:
1. The lowest inspired oxygen concentration
possible should be used in order to prevent
the adverse effects of pulmonary oxygen
toxicity.
2. Sterile airway care is the hallmark of the
prevention of iatrogenic pulmonary infection.
3. Soft cuffs or intermittently deflated cuffs
on endotracheal and tracheostomy tubes
should be used in order to prevent damage
to the tracheal mucosa.
4. Prophylactic antibiotics should not be given
routinely. Antibiotics should not be used
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merely in the presence of positive airway
cultures, but reserved for those cases where
actual pulmonary or other infection exists.
5. Diuretics and serum albumin should be used
as necessary for the management of interstitial pulmonary edema.
6. Anemia is not well treated with oxygen.
Anemia should be corrected by the administration of additional red cells.
7. Patients who are persistently hyperventilated and thus rendered hypocapnic tend
to lose potassium in the urine, and if digitalized at the same time, tend to develop
arrhythmias.
8. Hypotension occurring during artificial
ventilation is often due to hypovolemia.
9. Patients in chronic respiratory failure with
preexistent hypercapnia should not be
vigorously hyperventilated, as this form of
treatment may produce dangerous degrees
of metabolic alkalosis.
10. In patients with the adult respiratory distress syndrome, fluids and crystalloids
should be restricted.
11. In patients with large shunts and an alveolar-arterial oxygen tension gradient in excess of 500 mm of mercury, the use of
positive end expiratory pressure (PEEP)
should be considered.
12. When hyperventilation and PEEP fail to
lower the alveolar-arterial oxygen tension
gradient, oxygen consumption must be decreased by use of morphine, curare and/ or
hypothermia.
13. When administered through an artificial
airway, all inspired gas must be warmed
and humidified appropriately.
14. Following long periods of parenteral nutrition, the resumption of oral intake must
be preceded by some attempt to determine
that the patient is capable of swallowing
without aspirating.
15. The appearance of sudden tachypnea,
cyanosis, hypotension, or arrhythmia
should lead to the suspected diagnosis of
either pulmonary embolism or pneumothorax.
Getting a patient off a ventilator implies that
he has survived his bout of respiratory failure and
is approaching that point at which he no longer
needs respiratory support. When ideally ventilated

and oxygenated on a ventilator, patients may indeed
appear clinically well and yet be totally unable to
maintain adequate spontaneous .ventilation once
the ventilator is discontinued. Some appraisal must
therefore be made of the patient's ability to oxygenate, to eliminate carhon dioxide, and to mechanically
move air in and out of his chest for an appropriate
period of time in order to insure that he can breathe
spontaneously. The attempt to discontinue mechanical ventilation without obtaining this information previously may result in an otherwise "unexpected
cardiac arrest." The requirements for weaning include the following 8 points:
1. The etiology of the respiratory failure must
be sufficiently reversed.
2. The
alveolar-arterial
oxygen
tension
gradient on 100% oxygen must be below
350 mm of mercury.
3. The dead space to tidal volume ratio must
be below 0.6.
4. The tidal volume must be above 3 ml per
kg.
5. The vital capacity must be above 8 to 10
ml per kg to commence the weaning
process. It must be better than 15 to 20 ml
per kg to complete the weaning process.
6. The patient must be in positive nitrogen
balance if he has been in negative nitrogen
balance for any longer than one week previously.
7. The spontaneous respiratory rate in adults
must remain below 35 per minute.
8. The hematocrit must be at least above 30% ,
preferably 35%.
The technique in weaning may be one of
several. The following technique has been successful
for us. The patient must have met the requirements for weaning already delineated.
1. The patient is in the sitting or semi-sitting
position.
2. The ventilator is disconnected.
3. With the tracheostomy or endotracheal tube
cuff still inflated, the tidal volume, rate,
minute ventilation, and vital capacity are
measured and recorded.
4. The cuff is deflated and 100% oxygen is
administered for a period of 5, 10, or 15
minutes depending upon how long one expects the patient to be able to breathe
spontaneously and to do so adequately.
5. At the end of this time an arterial sample
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6.

7.
8.

9.

l 0.

11.

of blood is drawn to be analyzed for Po,,
Pco,, and pH.
The artificial airway cuff is re-inflated, and
the previously mentioned ventilatory functions are remeasured and recorded.
The patient is then reconnected to the
ventilator.
On the basis of the blood gas analysis and
the ventilation studies, one then determines
the duration of subsequent spontaneous
trials at ventilation and the appropriate inspired oxygen concentration to be used during those spontaneous trials.
The patient should progress to continuous
spontaneous ventilation for one entire day
before the same is attempted during sleep
at night.
After 24 continuous hours of spontaneous
ventilation with acceptable blood gases, acceptable ventilatory function, and the patient not being excessively tired, he can be
considered weaned from the ventilator.
A higher inspired oxygen concentration
should be utilized when the patient is breathing spontaneously than that which is used
on the ventilator during the weaning process.
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12. Assisted ventilation may be substituted for
controlled ventilation during the weaning
process if considered necessary.
In closing, I would like to remind you that the
experience of an episode of ventilatory failure with
the vigorous and sometimes heroic treatment that is
required for successful management, and the stresses
that go along with a stay in an average intensive
care unit, are poorly tolerated by most patients. In
addition to intelligent and sophisticated medical
care and dedicated nursing care, these patients
need compassion and respect for the fact that they
are human beings undergoing a period of extreme
stress. They will not only survive but they will survive
as much more grateful patients if we all can remember to treat them as individuals with a disease
rather than as disease entities alone. With this in
mind, I would commend to you the following admonition which, I think, is said as beautifully as
it can be said: "From inability to let well alone;
from too much zeal for the new and contempt for
what is old; from putting knowledge before wisdom,
science before art, and cleverness before common
sense; from treating patients as cases, and from
making the cure of the disease more grievous than
the endurance of the same; Good Lord deliver us."

Complications of Mechanical Ventilation*
ORHAN MUREN, M.D.
Associate Professor of Medicine and Anesthesiology,
Medical College of Virginia, Health Sciences Division of
Virginia Commonwealth University, Richmond, Virginia

With increasing utilization of mechanical ventilation during the past decade or so, complications related to its use have also increased. Ventilators are primarily indicated when acceptable
safe levels of oxygenation and ventilation cannot
be maintained by other means.
The goal of assisted mechanical ventilation
should be to improve arterial oxygen, C02 tensions, and pH to acceptable safe levels compatible
with life or normal functioning.
The following are the complications which
may occur during assisted mechanical ventilation:
1) Reduced venous return and cardiac output.
2) Complications related to endotracheal
tubes and tracheostomies.
3) Atelectasis.
4) Infection.
5) Oxygen toxicity.
6) Acid-base, fluid, and electrolyte disturbances.
7) Gastrointestinal problems.
8) Technical and mechanical problems.
9) Emotional stress.
10) Miscellaneous: cardiac arrhythmias, pulmonary emboli, pneumothorax, and so
forth.
Reduced venous return and cardiac output
are commonly observed in patients with significant volume depletion. It is important that blood
pressure and urine output should be checked at
regular intervals. A central venous pressure catheter may need to be inserted for proper fluid
replacements. The two other common causes of decreased venous return are prolonged severe hy-

* Presented by Dr. Muren at the Symposium on Respiratory Failure, May 26, 1972, at Richmond, Virginia.
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poxemia and impaired sympathetic nervous system activity.
Normal people can compensate for the decreased venous return by a reflex increase in venous tone and pressure provided: 1) mean airway
pressure does not go above approximately 15
mm Hg, 2) effective blood volume is adequate,
3) sympathetic nervous system function is unimpaired. If any one or a combination of any of the
above factors is not met, mechanical ventilation
results in decreased cardiac output and lowering of
arterial blood pressure.
Proper adjustments in ventilators to reduce
the mean intrathoracic pressure may need to be
performed to improve decreased venous return.
In this respect, volume cycled respirators are probably advantageous over pressure cycled respirators.
Negative pressure during exhalation may
occasionally be used to improve venous return
to the heart. However, this is somewhat contraindicated in patients with chronic obstructive pulmonary disease. It may cause closure of airways
leading to clinical or subclinical atelectasis.
The following complications are related to
endotracheal intubation and tracheostomies:
1) Tube in right main bronchus which causes
massive atelectasis of the left lung. If not
recognized this usually causes rapid deterioration of pulmonary function.
2) Dislodgement, kinking of the tube, obstruction by secretions, laryngeal edema and
damage, herniation of cuff over end of the
tube.
3) Complications related to tracheostomy:
bleeding, infection, necrosis, tracheal
stenosis, erosion of vessels, obstruction,
and tracheoesophageal fistula.
MCV QUARTERLY 9(2): 154-156, 1973
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The incidence of atelectasis is increased
especially in patients requiring prolonged assisted
mechanical ventilation. The administration of high
concentrations of 0 2 in inspired air causes further
increase in the incidence of atelectasis.
Adequate humidification of the inspired gas,
chest physiotherapy, proper suction, and hydration are essential in prevention and treatment of
atelectasis. Bronchoscopy should be performed
if atelectasis does not improve with conservative
measures.
Atelectasis may be first manifested by decreasing compliance and increased alveolar-arterial 0 2 pressure gradient.
To prevent atelectasis, a proper breathing pattern to obtain optimum ventilation should be maintained. Intermittent sighing is also an important
therapeutic measure to prevent atelectasis. Inflation hold and continuous position pressure ventilation are additional steps that may be used in
prevention and treatment of this problem.
As to 0 2 toxicity, two factors are primarily
responsible for 0 2 toxicity in the lungs: 1) high 0 2
tension in inspired air, 2) prolonged exposure to high
inspired 0 2 tension. Patients may be at risk of developing 0 2 toxicity if they are given inspired air containing
503 or greater 0 2 concentration for prolonged time.
There seems to be an individual susceptibility. As a
general rule, just enough 0 2 concentration in the
inspired air should be given to maintain a safe and
adequate level of oxygen tension in the arterial blood
for a given patient.
It should be noted that most pressure cycled
ventilators administer higher 0 2 concentrations
than one may think. On the air dilute setting,
these ventilators usually deliver somewhere between 60 to 95% 0 2 in inspired air.
This is prevented by running the ventilator
with compressed air and bleeding 1 to 3 L of 0 2
into the system. By measuring inspired 0 2 concentration, proper adjustments should be made to
administer the desired 0 2 concentrations in the
inspired air.
Infection, especially with gram negative organisms, may be a dangerous problem. Nebulizers,
humidifiers, and tubes with warm, humid inspired
gases may be a source of a good culture media for
many gram negative organisms.
The respiratory tubing should be changed at
least once daily and sterilized before it is used
again. No respirator should be used for another
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patient unless proper sterilization techniques have
been utilized.
Acid-base, fluid, and electrolyte disturbances:
one of the common iatrogenic complica"tions of
assisted mechanical ventilation is post-hypercapnic
metabolic alkalosis. This is observed in patients with
chronic respiratory acidosis. As a result of rapid
lowering of P co,, pH may become alkalotic, since
HC0 3 cannot be lowered significantly under these
circumstances.
Severe alkalosis can cause confusion, convulsions,
coma, and even death. To prevent this, arterial pH
should be monitored, and increased P co, should be
reduced gradually in chronic hypercapnia.
Marked hyperventilation with severe respiratory alkalosis alone can cause tetani with symptoms and signs related to it. And again, arterial gas
tensions and pH need to be monitored to prevent
this problem.
Some patients on prolonged assisted mechanical ventilation may develop fluid retention and
even pulmonary congestion and edema, primarily
interstitial type.
Another complication of mechanical ventilation is the development of inappropriate ADHlike electrolyte abnormality in some patients. This
appears to be related to stimulation of ADH
through thoracic volume chemoreceptors by positive pressure breathing. Therefore, patients should
be weighed and electrolytes should be checked
repeatedly.
Gastrointestinal complications consist of
acute gastrointestinal bleeding, acute gastric dilation, ileus, and chronic aspiration during assisted
ventilation. The physician should always consider
these problems, and if they occur, proper steps
must be taken.
Technical and mechanical problems arise
quite often. A physician or inhalation therapist
should be prepared to cope with a respirator in case
it becomes disconnected from the patient or malfunctions or in case the tube becomes obstructed.
These complications can be disastrous for the patient
within a few minutes. The ventilatory and 02
requirements of these patients change quite often, so necessary adjustments must be made accordingly.
Emotional problems quite often arise from
the inability to talk and communicate properly
with people. Sincere understanding of the patient's
problem and taking time to explain to the patient
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what is being done is extremely important in stabilizing the patient's emotional status. In general,
patients receiving intensive respiratory care have
a tendency to develop many cardiopulmonary problems such as pulmonary emboli, cardiac arrhythmias, digitalis intoxication, and so forth . Other complications of assisted ventilation are pneumothorax
and mediastinal emphysema, which may cause further deterioration of the pulmonary function; these
must always be considered whenever pulmonary
function of the patient becomes worse.
Lastly, weaning the patient from ventilation
may be a problem. The following guidelines are
somewhat useful in deciding when to start weaning a patient:
1) Tidal volume should approach 5 to 6 ml/kg
and vital capacity exceeds 10 ml/kg.
2) Alveolar-arterial 02 pressure gradient
should be less than 300 mm Hg on 100%
breathing.
3) The ratio between dead space and tidal volume (VD/VT) should be less than 50%.
4) Inspiratory negative pressure should be
more than 20 cm H20 negative pressure.
Weaning is in general complete when vital capacity
reaches 20 ml/kg. It should be noted that many
patients may require additional 02 for some days
or for weeks after weaning.
Proper humid!fication must be provided when
the patient is off the ventilator. Frequent short
periods of spontaneous ventilation, that is, five to
ten minutes per hour, should be attempted. As
the patient's tolerance increases, time off the respirator is frequently increased. Vital signs, general appearance of the patient, and arterial gas
studies are examined during these periods. The
patient should not be allowed to sleep without
assisted ventilation until he has tolerated three to
four hour periods of spontaneous breathing dllring the day.

During the weaning period, emotional support
is extremely important. A patient who can communicate can get better emotional support. We insert
a plastic tracheostomy tube which can be plugged
to permit the patient to talk during the period of
weaning. This has been very useful during this
critical period.
In conclusion, it must be recognized that
properly trained physicians, nurses, and inhalation
therapists are necessary for the care of acutely
and critically ill patients with major pulmonary
problems, to prevent and treat complications. Team
work is essential for the proper management of
those patients who require assisted mechanical
ventilation.
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Recognition of the Asthmatic Component of
Respiratory Failure*
JOHN L. GUERRANT, M.D.
Professor of Internal Medicine, Chief of Allergy-Pulmonary Division,
University of Virginia School of Medicine, Charlottesville, Virginia

Definitions. In this discussion we shall understand each other better if we define two important
terms first. They are "respiratory failure" and
"asthma." It is not too difficult to define respiratory failure . Asthma is much more of a problem.
The word has been used since the time of Hippocrates; yet contemporary authors do not agree
on what it means.
Respiratory Failure. The "50-50 rule" is
easy to remember and very satisfactory. Respiratory failure is present when the arterial blood
Po, is less than 50 mm Hg, or the P co, is greater
than 50 mm Ilg.
Asthma. We shall consider definitions from
two recent books and from the American Thoracic Society. Bates, Macklem, and Christie ( 1)
insist that asthma "denotes a condition of usually
intermittent episodes of bronchospasm, with symptom free periods, in a subject with a history or a
family history of an allergic condition." They also
recognize that some patients with chronic bronchitis develop such severe bronchospasm during exacerbations of infection that their symptoms appear
similar to spasmodic asthma. This definition is too
restrictive. Also, if we consider only patients with
evidence of allergy or infection we shall seldom
have a problem of recognizing asthma, and such
patients rarely develop severe respiratory failure.
Dr. Swineford ( 4) has a very simple definition: "Asthma is a complex pulmonary syndrome characterized by wheezing." Many of us
find this definition too broad in that it includes
conditions with fixed or localized airway obstruction unresponsive to any treatment.
''' Presented by Dr. Guerrant at the Symposium on
Respiratory Failure, May 27, 1972, at Richmond, Virginia.
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·:The American Thoracic Society's (2) definition has been widely accepted. "Asthma is a
disease characterized by an increased responsiveness of the trachea and bronchi to various stimuli
and manifested by a widespread narrowing of the
airways that changes in severity either spontaneously or as a result of therapy." This is a more
satisfactory definition because it recognizes that
the difficulty is due to a generalized airway obstruction that may respond to treatment.
We cannot insist on strict adherence to any
definition because we are considering the asthmatic component in respiratory failure. Few patients with pure asthma will develop dangerous
respiratory failure. We are chiefly concerned with
individuals who have one of the acute or chronic
lung diseases but who also have an element of
generalized
reversible
bronchial
constriction.
When there is an asthmatic component, if it is
recognized early, treatment should prevent the
development of respiratory failure. If it is recognized at any time, treatment should prevent the
death of the patient.
Causes of Respiratory Failure. There are a
number of diseases that may cause respiratory
failure and may also be confused with or complicated by asthma. The common ones are: chronic
bronchitis and emphysema, pulmonary fibrosis,
pneumonia,
infectious
bronchitis,
pulmonary
edema, pulmonary embolism, carcinoma or other
lung tumor, and foreign body in the bronchus.
Whenever a physician is dealing with patients
manifesting any of these conditions he should
think of 'and look for evidences of asthma.
Recognition of Asthma. An asthmatic component is usually easily recognized if considered.
The history, physical examination, chest roent157
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genogram, blood and sputum examination for
eosinophils ( 3), and pulmonary function studies
may be helpful.
The history is important. A story of hay
fever, a family history of allergic disease, seasonal symptoms and previous relief from the use
of epinephrine, isoproterenol, xanthine, or steroids suggest asthma.
The physical examination is often not helpful since wheezing is common in so many patients
with airway obstruction. However, pale, moist,
swollen nasal membranes and inspiratory whee'.?ing suggest asthma.
Likewise, the chest roentgenogram is oft<;!n
not helpful. However, if the lungs look almost
normal, the heart is of normal size and shape, and
the signs of heart failure are missing, asthma becomes an important consideration.
The ~putum and blood examination is of
critical it11portance. Blood eosinophilia suggests
asthma. Sputum eosinophilia is the single rriost
important sign of asthma and is a strong indiq~tion
that steroid ·treatment will lead to improvement.
For proper study the sputum should be fresh.
The physician should separate out strands of
thick mucus or a bronchial cast, spread the material on a slide, and stain it with Hansel stain1 .
Even small clumps in which most of the cells are
eosinophils are significant. The higher the percentage of eosinophils the more likely that asthma
is contributing to the symptoms.
In the presence of respiratory failure it is
usually not possible to do ventilatory tests or diffusion studies. If there is a record of a recent good
CO diffusion or a good response to isoproterenol,
asthma deserves serious consideration. Blood gas
measurements are essential for the proper management of any patient with respiratory failure.
Treatment. If respiratory failure is of short
duration and if there is an as.thmatic component
treatment with isoproterenol by nebulizer, subcutaneous epinephrine or IV, aminophylline may be
effective. All of these drugs may contribute to
ventricular irregularity and should be used cautiously in patients with coronary artery disease.
1 Lide Laboratories, Inc. 6828 Oakland Avenue, St.
Louis, Missouri 63139.

In most patients steroids will be needed and effective. Prednisolone or prednisone is commonly
used. If a patient with respiratory failure has used
steroids in the past, if there is convincing evidence that asthma is present, if he is obese, if the
asthma began in middle life or later, or if the
arterial blood P 0 , is falling or the Pco, is rising
in spite of treatment, steroid treatment should be
started promptly and used aggressively ( 5). The
ideal dose is not known. Fifty to 100 mg of prednisone or prednisolone every two hours until improvement begins is a reasonable dose. In respiratory failure due to asthma the presence of
tuberculosis or other infection, diabetes, heart failure, or hypertension do not contraindicate the
use of steroids. Other forms of treatment such as
the use of assisted ventilation, antibiotics, or
treatment of heart failure should be used as
needed.
Summary. Respiratory failure from various
causes is occasionally associated with or confused
with asthma. Therefore, asthma should be considered and looked for in all patients with r~
spiratory failure. Sputum eosinophilia when present is the most important indication that asthma
may be important. Steroids used early and aggressively are usually indicated and effective.
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Management of Severe Asthma*
WILLIAM B. HUNT, JR., M.D.
Associate Professor of Internal Medicine, Allergy-Pulmonary Division,
University of Virginia School of Medicine, Charlottesville, Virginia

In this summary of therapy for severe asthma
there is no mention of etiologic factors. The author
presumes that if infection is the primary factor in
the progression to severe asthma that this will
be recognized and appropriately treated. A chest
x-ray must be an initial laboratory study for the
recognition of pneumonia or complicating pneumothorax. However, unlike respiratory failure due
to emphysema, here the specific therapy of the
altered pulmonary physiology is of paramount
importance. Attention to the inciting factors is of
minimal therapeutic benefit once infection can be
ruled out. After the patient can breathe comfortably again the role of allergy can be investigated.
Premature investigation of emotional factors can
be a lethal therapeutic error in the ill asthmatic.
The treatment of asthma at the University of
Virginia Hospital can be divided into three rather
specific periods (Table 1).
Mystery Period. Until 1962 arterial blood
gas and pH measurement were not routinely available as a clinical tool in our laboratories. Most patients with severe asthma did well with our routine management. Other patients who looked the
same might die suddenly with no major change in
their clinical course. The mystery revolved around
our inability to judge precisely who had life
threatening asthma and who did not.
Measurement and Aggression 1962-1968.
(Table 2). As soon as arterial puncture became a
routine procedure the mystery cleared somewhat.
Many patients with severe asthma were found to
our surprise to have severe hypoxemia and hypercarbia. It is presumed that the prior mystery
deaths were most likely due to respiratory failure
with C02 narcosis or hypoxemia-induced fatal ar-

* Presented by Dr. Hunt at the Symposium on Respiratory Failure, May 26, 1972, at Richmond, Virginia.
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rhythmias. These patients were recognized usually
late in their disease. Immediate tracheostomy was
done; many were hyperventilated with a volume
controlled ventilator into frightening states of
alkalosis, and the hospitalization was prolonged
for two to three weeks. The patients did not die
from asthma, however, and survived their respiratory care (3).
Measurement and Intensive Care. Employing the lessons learned from our middle period,
since 1968 our management of severe asthma has
changed (Table 3). In the period 1965-1967,
10 patients with severe asthma were ventilated following tracheostomy and all survived. From 1968
to 1971 there were 299 admissions of asthmatics
to the University of Virginia Hospital. Of these
patients, 50 were judged to be in status asthma,
and 36 had a P co, greater than 45 mm Hg. Despite
the serious nature of their disease, only 8 patients were intubated, 6 were briefly ventilated,
and only 1 patient needed a tracheostomy. No
deaths occurred ( 4) .
Common Errors in Management. (Table 4).
A review of patients previously reported with tracheostomy and our current series since 1968 revealed the same errors in management with the
difference being one of degree.
Steroids. In the prior series, two patients received no steroids at all prior to tracheostomy. In
our current patient group, several who were intubated received steroids late in their clinical course
and in small amounts.
Sedation. The use of sedation continues to
be an identifiable factor probably responsible for
the deterioration and intubation in at least half of
the patients intubated since 1968. Valium® and
other tranquilizers are replacing the barbiturates as
major offenders. Sedatives have no place in the
management of severe asthma.
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TABLE I.
MANAGEMENT OF SEVERE AsrHMA
University of Virginia Hospital
Mystery Period- Until 1962
Measurement and Aggression 1962- 1968
Measurement and Intensive Care 1968-Present

Oxygen. The indiscriminate use of high flow
oxygen is not as devastating to the asthmatic in
acute respiratory failure as to the patient with
chronic bronchitis and emphysema. An attempt
should be made to keep the arterial oxygen in the
physiologic range (70-110 mm Hg) which generally means the use of no more than 28-35%
oxygen.
Nursing Position. Classically, the patient with
asthma is immediately put flat in bed, and, to
make sure he stays there, intravenous fluids are
begun apparently to facilitate rapid drug administration. Like the patient with emphysema, the
asthmatic is much more comfortable breathing
in a chair. IV fluids should be replaced with oral
medication usually within 24-48 hours except in
unusual circumstances. This can be of immense
psychological benefit as well as prevent painful
phlebitis.
Tracheostomy. From our current experience
and that of others ( 2), tracheostomy should rarely
be necessary in the management of asthma.
The morbidity associated with the procedure itself and the prolongation of hospital care, coupled
with the short clinical course of aggressively treated
asthma, all make nasotracheal tube intubation
the procedure of choice when respiratory failure
supervenes.
Patients at Risk. Who are the patients who are
in the most danger of progression to respiratory failure? The same group (Table 5) appears in every
series.

TABLE 2.
MEASUREMENT AND AGGRESSION 1962- 1968
Arterial Gas Measurements Begun in 1962
Usually Obtained Late in Course
Serious Nature of Disease Recognized
Usually Immediate Tracheostomy
Frequently Hyperventilated
Two to Three Week Hospitalization

TABLE 3.
MEASUREMENT AND INTENSIVE CARE 1968-PRESENT
Arterial Gas Measurement Early in Suspicious Cases
Review of Prior Medication Imperative
Uncomplicated Asthma- Low P 0 ,- LO'V P co,
Severe Asthma-Normal Pco, a Grave Prognostic Sign

How to Evaluate Severity of Asthma.
Prior Medications. A patient who is in marked
respiratory distress with asthma, and who has taken
only a few tablets in the prior 24 hours, is in a different prognostic category than the patient with
the same degree of airway obstruction who has
tried Tedral®, aminophylline suppositories, and 20
mg of prednisone two hours before. An assessment of prior therapy then enables you to plan
current therapy and escalate from theophylline,
ephedrine and adrenaline, to high dose steroid
therapy and hopefully avoid respiratory failure
and intubation.
Arterial Blood Gases. The major initial defect
in asthma is hypoxemia, as large areas of the lung
that have excellent perfusion get progressively less
ventilation, shunting poorly oxygenated blood into
the arterial circulation. Initially, the asthmatic in
respiratory distress can easily overventilate the uninvolved areas of the lung lowering arterial C02
(Pac 0 ,). The classical arterial gases of the dyspneic,
but non-fatigued asthmatic, are a low Pa 0 , (5060 mm Hg) and a low Paco, (20-30 mm Hg). As
the patient tires, is sedated, gets worse, and is restrained in bed, he will begin to move less air, and
underventilation will begin with the Paco, approaching normal. This is a grave prognostic sign.
If the arterial oxygen rises as the Pco, rises
and the patient is more comfortable, all is well. If
the arterial oxygen falls and the Pco, approaches
normal, you should immediately escalate your therapy (Table 6).

TABLE 4.
COMMON ERRORS IN MANAGEMENT
Too Little Steroids Too Late
Sedation
High Flow Oxygen
Patient Put in Bed
Tracheostomy
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TABLE 5.
PATIENTS AT RISK

Tired
Old
Fat
Chronic Bronchitis and Emphysema
Heart Disease

Escalation of Drug Therapy.
Combination Tablets and IsuprefJ9. Most patients with asthma who present to the physician
with a severe episode have already tried regular
therapy with one of the phenobarbital, theophylline, or ephedrine combinations such as Tedra!® or
QuadrinaJ®. They have generally used, and at
times have overused, an Isuprel® preparation.
These drugs then have little place in the management of the severe asthmatic. It is important, however, to obtain specific historical facts about their
use in planning therapy. A patient who has had
little or no prior medication can be expected to
respond more rapidly to less medication.
One investigator has found that patients with
severe asthma are specifically unresponsive to
IsupreJ®, so that response to Isuprel® was a measure not only of the severity of the disease, but
also an index of the patient's response to other
therapy, primarily steroids. More and more Isuprel® is then used by the worsening patient with
less and Jess results. At times the Isuprel:lil has
been shown to have been responsible for increasing the asthma and may actually cause hypoxemia.
Epinephrine and Aminophyllin. The response
to 0.3 cc of epinephrine subcutaneously can at
times be magical and should always be tried. The
effect occurs within minutes and may last an
hour. If no results are obtained after three doses

TABLE 6.
BOTH STATES MAY BE AssoCIATED WITH REDUCTION
IN WHEEZING AND A QUIET PATIENT

P 0 ,-50

P 0 ,-60

Pco,-30
pH-7.48

-+

Pco,-40
pH-7.4

!

Po,-70
Pco,-40
pH-7.40

REJOICE!

WORRY!

ACT!

repeated at 15 minute intervals, a response will
usually not be obtained. The response to IV aminophyllin may be equally as rapid and last for
hours, frequently as long as six. The dose must
be large-500 mg for an adult-and must be
given over 15-45 minutes, not over hours in a
large bottle of fluids. Two methods are equally
acceptable:
1. 500 mg (a 20 cc ampule) given intravenously by syringe, over a 10 minute
period. This is excellent if you have
the time.
2. 500 mg in 250 cc glucose and water
given by IV drip over a 30-60 minute
period may be equally effective.
Decisions. Only the consultant the next morning has the benefit of the clearly outlined flow
sheet documenting blood gases, clinical state, and
t!me of the therapeutic maneuvers. In actual practic~, the patient arrives in respiratory distress, artenal gases are obtained, and the above medications are given-epinephrine X2 followed by
500 mg of IV aminophyllin. This takes approximately one or one and one-half hours. The initial blood gases become known to the physician
ab~ut hal.f way through this therapy. He usually
waits until 15-20 minutes after the aminophyllin
is given and repeats the arterial gases and pH.
Initial Gases. If the Paco, is below 50 mm Hg,
supplemental oxygen is begun (24 or 283 ventimask).
If the Pa co, is greater than 40 mm Hg and the patient
has not obtained evident clinical improvement from
?is initial therapy, 250 mg of hydrocortisone is given
mtravenously in addition to the other drugs previously
described.
Second Arterial Gases. These results have
usually been obtained at a time when full therapeutic benefits will have occurred from epinephrine and aminophyllin therapy. A lack of clinical
response by the patient and a lack of significant
reduction in Paco, dictates that aggressive steroid
therapy should be begun. If the Paco has dropped
into the 30 mm Hg range, therapy with aminophyllin
and epinephrine can be continued and a maintenance
drug such as Tedral® SA begun at an appropriate
time.
Steroid Therapy.
General Considerations. There is no reason
to give hydrocortisone except for the initial dosage.
There is theoretical evidence that the therapeutic
effect of hydrocortisone should be more rapid
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than prednisolone, but there is little data. I am in
agreement with Sheehy et al. that airway resistance is reduced by steroids "in several hours"
( 4). This has been shown to be true by the studies of Pinkerton and Van Meter (1).
This brings up the practical consideration that
by the time one decides to escalate to steroid
therapy one must wait one to two hours for therapeutic effect. One must then give steroids one or
two hours before they are needed. This is why
250 mg of hydrocortisone is given if the initial
gases indicate even slight C02 retention instead
of awaiting the second set two hours later. Pinkerton and Van Meter (1) could show little difference in the dose response curves of oral and IV
steroids. However, in a seriously ill patient who
may vomit, the intravenous method is preferable.
Dosage Schedule. As long as the patient is in
respiratory distress and the Paco, is 44 mm Hg
or above, prednisolone 50 mg should be given every
two hours. If the Paco, continues to rise, the dosage
should be increased to 100 mg every one to two
hours.
Pediatric Dosage. In severe asthma (as defined under "Initial Gases") 7 mg/ kg of hydrocortisone should be given as an initial stat
dose. Another 7 mg/ kg of hydrocortisone may
be given during the next 24 hours in divided
doses. As is true in adults, there is little specific
data to direct prednisone therapy in children
within narrow dosage guidelines.
Mucolytic Agents. Hydration with appropriate
intravenous fluids and aggressive therapy of asthma . are the only two mucolytic techniques of
proven benefit. Glyceryl guacolate (Robitussin®)
is of proven uselessness and acetylcysteine (Mucomyst®) will provoke asthma. Humidified air
can be added to the ventimask if the patient is a
mouth breather, but humidity and heat are usually
no problem as long as the nose is still in the circuit.
Intubation and Ventilation.

Indications for Intubation. A rising Paco,
above 60 mm Hg, a pH below 7 .2, increasing fatigue, increasing somnolence with inability to cough
despite the therapy as outlined above are indications for intubation and ventilation.
General Considerations. The use of the cuffed
nasotracheal tube has revolutionized the respiratory care of severe asthma. Only in unusual circumstances should tracheostomy have to be done
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for asthma. Once nasotracheal intubation is accomplished and the patient is being artificially
ventilated, aggressive therapy must be continued.
Unlike the patient with chronic bronchitis and
emphysema, the patient with asthma responds
quickly and fairly predictably to therapy (primarily corticosteroids) and can be weaned from
the ventilator in 24 to 72 hours. The unfortunate
tendency is for the physician to relax following intubation of the patient. Unless the appropriate therapy is continued, weaning from the ventilator can be
prolonged by a relapse which increases the possibility that tracheostomy will need to be done.
Plan of Action. The physician should presume that with appropriate therapy and barring
serious complications, the patient can be extubated
within 48 hours. The first twelve hours that the
patient is on the ventilator should not be complicated by premature weaning procedures. The fatigued patient should be allowed to rest. His ability to cycle with the ventilator should be enhanced with diazepam (Valium®) or if this is not
immediately effective, with 5 to 10 mg of intravenous morphine (given every one to four hours
as needed). Obviously the patient cannot be simultaneously sedated for control of ventilation and
weaned from the ventilator, although this is frequently tried with disastrous results. Prednisone
100 mg every two hours should be continued
during this most important phase of therapy.

Choice of Ventilator. The tendency of a nasotracheal tube to leak, coupled with the extremely
high airway pressures (30-60 cm H 20) necessary to
ventilate asthmatics, makes pressure cycled ventilators
(Bird or Bennett) poor choices. A volume controlled
ventilator such as the Bennett MA-1 or the Emerson
postoperative ventilator is usually necessary for
effective ventilation of these noncompliant lungs.
The MA-1 enables the respiratory care personnel to
easily monitor tidal volumes and oxygen percentage of
inspired air (F1 0 , ). Both machines will intermittently
and automatically hyperinflate the patient's lungs to
reduce atelectasis. Both are dependable machines.
Complications. All of the legion of complications incident to intubation and mechanical ventilation of course can occur. The excellent prognosis for return to normal in these patients should
make their recognition and reversal all the more
important. Several complications however are more
peculiar to the asthmatic.
Pneumothorax. In the pediatric patient, the
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extremely high airway pressures needed for ventilation make this a common complication. Insertion
of a chest tube with adequate se;il is imperative
to prevent a tension pneumothorax. This is a rare
complication in adults.
Overventilation with Alkalosis. The very nature of the disease makes this complication potentially common and severe. 'fhe patient with
severe, reversible airway obstruction is connected
to an efficient ventilator, and aggressive appropriate
therapy is given. Success in therapy will almost
always result in hyperventilation, unless blood
gases are monitored frequently as the patient improves and the minute ventilation reduced.

Cardiovascular Collapse as Mechanical Ventilation is Begun. This is more common in the patient with emphysema since the high airway pressures are transmitted more readily to the heart
through abnormal lung tissue hindering right heart
filling. The asthmatic has some protection due to
the normal lung parenchyma. However, the combination of high inspiratory airway pressures,
hypovolemia, aqd a short expiration time may
rapidly reduce cardiac output even in the asthmatic. The physician must prolong expiration as much
as possible relative to inspiratory time, reduce
tidal volumes even if C0 2 cannot be lowered initially, and immediately correct the hypovolemic
state.
Weaning. Improvemeµt can be judged by a
return of the Pa co, to normal (30-40 mm Hg)
and a reduction in the percentage of oxygen necessary to maiqtain Pa 0 , within a physiologic range
(70-100 mm Hg). Reduction in airway obstruction
can be monitored by following the "effective compliance" (tidal volume divided by airway pressure
expressed as liters/ cm H 2 0).
If at the end of 12 hours, blood gases and pH
are normal and the effective compliance has
doubled, sedation should be discontinued and the
patient's ventilatory capabilities measured, using
a Wright Respirometer. If it can be determined
that the tidal volume is greater than 5 cc/ kg and
the vital capacity greater than 10 cc/ kg, a period of time off the ventilator should be monitored with blood gas measurements (arterial
puncture 15-30 minutes off ventilator with patient receiving humidified 28-30% 0 2 by means
of a Briggs T-piece). If the patient is able to
maintain a normal or reduced Paco,, extubation
should be considered. Alternately this procedure
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is repeated every 12 hours or at even shorter intervals depending upon the observed rate of improvement.
Preparing for Discharge. The exciting part
of the therapy is now over, and the tendency toward management errors increases. If the reason
for the onset of the severe episode of asthma is
known and has been corrected (infection, exposure to irritant fumes , resolved psychic trauma)
then the steroid dosage can be quickly reduced
to 100-200 mg of prednisone given as a single
daily dose, then every other day, and finally discharge of the patient on 10 or 20 mg of prednisone every other day. If the cause of the asthma
remains unknown , caution will have to be exercised in the rapid reduction of steroids.
Two major facts should be borne in mind:
1) Even large amounts of prednisone (50-100 mg)
given as a single early morning dose may be
taken by the patient for up to 30 days without
significant adrenal suppression. 2) Alternate day
prednisone therapy, again a single early morning
dose, can be given with little danger of side effects and may be continued for months.
Summary. The successful management of severe asthma involves recognition and aggressive
appropriate therapy, with rapid escalation to steroid therapy as soon as indicated. Intubation with
a nasotracheal tube and ventilation with a volume controlled mechanical ventilator should be an
available option in therapy. Tracheostomy need
rarely be done since most patients can be extubated within 72 hours .
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Ambulatory Care for Emphysema and
Chronic Bronchitis*
THOMAS L. PETTY, M.D., F.C.C.P.
Associate Professor of Medicine and Head, Division of Pulmonary
Diseases, University of Colorado Medical Center, Denver, Colorado

The immense problem of chronic airway obstruction (CAO)-emphysema and chronic bronchitis-which has now reached epidemic proportions, presents to the practitioner of medicine an
increasing number of suffering persons asking for
care. These patients are dyspneic, anxious, bewildered by their predicament, sometimes demanding and frightened about prospects for future comfortable life.
Although there has been a tremendous upsurge of interest in the field of respiratory care,
and a growing number of nebulizers, humidifiers,
physical therapy techniques and drugs, all of the
answers on emphysema care are not in. We must
admit as physicians that although we are absolutely
sure that we save many lives in the organized intensive respiratory care unit in the case of acute
respiratory failure (3, 13), no study has thus far convinced the critics of respiratory care that the natural course of CAO is altered from the standpoint
of survival. Nonetheless, today's patients cannot
wait for all the answers. They flock to hospitals,
clinics, and physicians' offices, seeking some relief of their symptoms, some hope for improvement in their status and for prolonged survival.
It is therefore mandatory for all physicians interested in chest medicine and interested in their
sick patients, to provide some form of service for

* Presented by Dr. Petty at the Symposium on Respiratory Failure, May 26, 1972, at Richmond, Virginia. Reprinted with permission from Ch est, Volume 58, pp.
441-448, October, 1970. Supported in part by USPHS Contract # 108-66-227, Chronic Respiratory Diseases Control
Program. Reprint requests to Thomas L. Petty, M.D., 4200
East Ninth Avenue, Denver, Colorado 80220.
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the growing crowd of puffers and coughers-both
pink and blue.
This communication defines a practical clinic
and outpatient treatment regimen that is applicable for most individuals suffering severe CAO with
disability.
Ambulatory Care Program.
Patient Education. The management of any
chronic disease must be based upon a high level
of patient indoctrination and education. This has
been the reason for succei;s in large measures in diabetes mellitus management where for years, the
sufferer has been instructed in nutrition, activity,
insulin dosage, self-management, evaluation of glycosuria and proper clothing, leading to the development of an adjustment to the burdens of disease
designed for a maximum of serenity in daily life.
It does not take a great deal of talent, although it
does take time, to describe the airways, the lungs,
the circulation and to explain what is wrong in
the emphysema-chronic bronchitis spectrum. The
office nurse or clinic nurse, once properly trained
herself, is a superb individual to assume the responsibility for this task. Patients receive an indepth discussion of general care with reinforcement
in specific instructions guided by the physician's
explicit prescription. These sessions are supplemented by a simple treatment manual ( 17) designed to give the patient material for serious reading which will reinforce the personal instruction
and probably develop new questions for the nurses
on revisits. We not only teach the patients about
their disease process, but what physicians, nurses,
and therapists are trying to do in their therapeutic
endeavors. We stress the specific facets in manMCV QUARTERLY 9(2): 164-172, 1973
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agement listed below with details stressed for
each individual patient.
Bronchial Hygiene. Much of therapy must
be directed at the bronchial element of disease. In
many cases we are dealing with the bronchospasm,
mucosal edema, retained secretions, and impaired
mucociliary clearance. Each patient must learn an
effective method of bronchial hygiene to be used
each day. Fundamental, of course, is the absolute
cessation of smoking. This is best handled in a
nursing session where the threat of a physician
and his authority is less traumatic to the patient.
In specific therapy, individuals are taught to
inhale a bronchodilator aerosol followed by moisture, followed by expulsive coughing on a systematic basis at least twice daily. One of the sympathomimetic amines is inhaled for a period of at
least ten deep breaths and a duration of, at times,
up to ten minutes. Isoetharine with phenylephrine
or racemic epinephrine or isoproterenol is used
for this purpose. Aerosolized bronchodilators are
delivered by a variety of devices, including a simple hand bulb nebulizer which does require some
patient coordination and strength, the newly available pump driven nebulizers 1 or simple hand
held IPPB devices which have recently been provided for the practitioner2 (fig. 1). Ordinarily the
drug is diluted with equal amounts of water with
individual adjustments based upon side effects and
apparent clinical efficacy. Bronchodilators relieve
muscular spasm, combat mucosa! edema, and probably stimulate mucociliary clearance ( 8, 10). The
use of bronchodilator drugs must become an art
with final judgment on the absolute details of therapy, a joint effort between patient and physician,
a matter which obviously requires a great trust and
orientation on the part of both.
Following the bronchodilator administration,
inhaled moisture is the next step. This may be
done by simple steaming devices, that is, a nursery
humidifier, tea kettle, facial sauna and in some
cases a more advanced nebulizer including an ultrasonic nebulizer. The choice of device is a matter of judgment based upon the ability to thin and
raise secretions . It should be said arid emphasized
that general hydration in the form of adequate
water intake is fundamental in maintaining ade1 Maxi-Myst pump driven nebulizer, Mead Johnson Co.,
Evansville, Indiana.
2 Hand-E-Vent, Ohio Medical Products, Madison, Wisconsin.
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Fig. 1-Hand held IPPB device suitable for hospital or
home use. It is used in the home with compressor pump and
has pressure flow characteristics similar to conventional
ventilators.

quate mucociliary clearance. The purpose of the
moisture, of course, is to help thin secretions,
which also facilitates mucociliary clearance. After
approximately ten minutes of moisture inhalation,
expulsive forceful coughing helps clear retained
secretions. If these endeavors are insufficient, simple postural drainage techniques over pillows in
bed often help the situation (18, 19). At times
pummeling, or so-called clapping, is useful in removing secretions (fig. 2). This is usually taught
the spouse by the physical therapist.

Fig. 2-Technique of percussion taught by physiotherapist.
This often aids mucociliary clearance.
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Breathing retrammg stressing abdominal-diaphragmatic control, allowing the abdomen to protrude during inspiration, followed by forceful
abdominal contractions during expiration, probably
helps empty the lung and improves the efficiency
of breathing ( 1, 2, 11) . These maneuvers with
exhalation against pursed lips, have been learned
by many individuals who suffer dyspnea and who
learn that this is a means of relief of symptoms.
In a clinical study the pursed-lip maneuver has
been shown to reduce the oxygen ventilation
equivalent, reduce alveolar-arterial oxygen difference and the necessary minute ventilation for
a given level of arterial oxygen tension (12).
Therefore the pursed-lip breathing maneuver enhances oxygen transport or at least is a more efficient breathing technique. This should be taught
to all patients or at least tried in patients who are
well indoctrinated in modern methods of emphysema care.
Physical reconditioning in the form of simple
daily exercises with increasing goals from the standpoint of more activity, has been shown to greatly
improve exercise ability ( 6, 22) . Most patients can
be taught to participate in comfortable exercise on
an increasing basis in spite of the fact that their
level of chronic airway obstruction may not change
a great deal in response to therapy ( 20) . Nonetheless, this training is an important activity for it
provides increased facility for daily living. Most
patients with chronic airway obstruction find dyspnea on exertion their most disabling symptom
and any improvement in comfortable mobility can
be translated into a better life. Figure 3 demonstrates the measured improved walk tolerance at
various rates and grades for an individual trained
daily for the first week and every other day for the
second week as part of a rehabilitation program.
No measurable change in ventilatory function or
blood gases (arterial) were observed during this
brief training perioda.
Oxygen. The clinical benefit of ambulatory oxygen therapy has been repeatedly demonstrated
(9, 15). In brief, oxygen is valuable for the hypoxemic bronchitic person who is markedly disabled
and suffers from heart failure. Oxygen has been
shown to reduce the level of pulmonary hypertension by reducing pulmonary arteriolar resistance and also helps combat the seco~1dary polya MVV 31 L: FEY, 0.91 L.
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WALK TOLERANCE DURING GRADED EXERCISE
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Fig. 3-lmproved walk tolerance at increasing rate and
grade following daily training for two weeks.

cythemia of the bronchitic hypoxemic state ( 9).
The development of a home based portable oxygen system has made the use of continuous ambulatory oxygen a reality. Figures 4 and 5 demonstrate
the apparatus in common use today. The lower
canister contains a liquid oxygen supply which
usually suffices for three to four days. This canister is capable of filling a sma1Ier device Which
now provides three to six hours of oxygen therapy. The duration is a function of rate of oxygen
administration controlled by a flow rate mechanism
on the device. Ambulatory oxygen provides for
additional mobility. Experience with these devices for over four years has proved the efficacy
and safety in over 200 patients with profound hypoxemia who cannot gain mobility by any other
means.
\
Pharmacologic Therapy . The weight of current evidence suggests that the immediate use of
antibiotics for specific episodes of bronchitis manifested by increasing cough, leukocytosis, elevated
temperature, and purulent appearing sputum is
effective in reducing the duration of symptoms and
fever. Since the most common invading bacterial
organisms after the original insult, which tnay be
viral, appear to be D. pneumonia and H. influenza,
the rather empiric use of ampicillin or tetracycline
seems advisable. Ampicillin is usually given in
doses of 4 g daily the first two days followed by
2 g daily for three or four days. Tetracycline is
usually given in 2 g doses daily the first two days
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Fig. 5-Patient carrying Linde oxygen walker system. Depending upon flow, three to five hours supply is available.

Fig. 4-Linde oxygen walker system. Lower container has
approximately 3ll2 days oxygen supply. This can be used
directly or used to fill the 7.5 pound canister which the
patient uses for ambulatory oxygen therapy.

followed by 1 g daily for the duration of therapy,
which usually covers five to seven days. Many
patients with CAO are provided with a supply of
antibiotics for home use to be instituted at first
signs of a deep chest infection. It is also wise, however, from the standpoint of communication and
further advice, to have these individuals contact
their physician at the time of institution of these
drugs.
Digitalis and diuretic drugs are useful in the
management of cor pulmonale with heart failure. These drugs, however, are fraught with the
difficulty of arrhythmia, but the weight of evidence in recent years indicates that an improved
hemodynamic state can be achieved with digitalizing doses of cardiac glycosides along with the
use of diuretics if adequate correction of hypoxemia is employed to provide adequate oxygenation
of the myocardium and to control the reactive pul-

monary hypertension associated with the hypoxemic state (15).
The corticosteroid drugs are definitely useful in some patients with chronic airway obstruction. Indications for their use include the bronchitic patient with marked cough, expectoration,
and repeated bouts of wheezing or choking spells
superimposed upon the chronic symptom complex. Often these individuals have significant
changes in their expiratory flow parameters as
they are observed serially. Generally, prednisone
30 mg daily for the first five days, followed by a
dose of 15 mg daily for the next five days, followed by a low maintenance dose ·of 5 to 10 mg,
with decisions for further therapy guided by measurements of expiratory flow in the form of forced
expiratory volume in one second (FEV1 ) or maximum mid-expiratory flow (MMEF). A certain
number of patients with apparent chronic irreversible airway obstruction actually have a reversible component of disease if observed carefully
under steroid therapy (14).
Oral bronchodilators may be useful in an occasional patient. The only harm of the ephedrinecontaining drugs aminophylline, amytal, and ephedrine HCl (Amesec®), theophylline, phenobarbital, ephedrine HCl (Tedra!®), and so forth,
is occasional urinary tract obstruction. Although
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these drugs are not very effective, they are frequently used by patients for reasons good or bad.
Soluble xanthines in the form of oxtriphylline
(Brondecon®) or choline theophyllinate (Choledyl®) may also prove useful in some patients.
The expectorants such as saturated solution
potassium iodide and guaiacolate have not been
proved by critical study to be effective in patients
within this spectrum. Nonetheless, they may be
used for apparent symptomatic benefit for short
periods but should not be an agent of prolonged
use. Polyvalent influenza vaccine should be given
each fall for wh atever protection is afforded.
Occupational Therapy, Hobbies, and Change
of Life Style. If life is to be worthwhile for the
emphysema-bronchitis patient, it has to have meaning. The details of therapy enumerated above
should not be excessively demanding from the
standpoint of time and should be applied in a systematic manner to allow patients to lead a happy
and hopefully productive life. A number of patients can be returned to work. Return to work,
of course, has to do with many factors and is basically based upon the energy requirement of the
job, the patient's physiologic resources, and the
patient's personal motivation to maintain a gainful status ( 16). Certainly the provision of ambulatory oxygen therapy is a great aid for some patients (15, 16). Additional oxygen provides for
additional activity and improvement in work capacity while on the job.
For those not so fortunate, occupational therapy in the form of hobbies is tremendously important. Many patients have a longing or desire
to paint, write, garden, golf, or simply walk around
a bit. This should be encouraged by the total application of the program described above.
Effectiveness of Today's Ambulatory Care Program. Although this is difficult to assess with cool
scientific certainty, because no clinical care program ever is totally controlled, a number of statements can be made based upon contemporary
knowledge about the effectiveness of organized
care for CAO.
Symptomatic Impro vement. Most patients
seek medical care because of adverse symptoms.
There is no question that the development of comprehensive care programs has greatly improved
the patients subjective feeling of well being. For
example, Table 1 shows the patients' clinical assessment at one and two years following entry
into the comprehensive rehabilitation program
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TABLE 1.
SUBJECTIVE ANALYSIS OF SYMPTOMS

Worse
Same
Better

One Year

%

Two Years

%

17
36
76

13

18
27
39

21
32
47

28
59

which has been described in this report. The vast
majority of patients remain clinically better or at
least the same up to two years and in many cases
longer.
The application of care principles described
above can be assessed by a reduction in hospital
needs. A small group of patients requiring hospitalization for respiratory causes was selected, and
the need for hospitalization following entry into a
comprehensive care program was compared to
the patients' prior hospital needs. In brief, Table 2
shows that the total number of patients requiring
hospitalizations was reduced, the total number of
hospital days was reduced, and the average stay
per patient reduced over a one year period compared to the patient's previous performance. It
must be admitted that the clinic and outpatient
nature of the program emphasized independent
existence in order to minimize hospital needs.
This makes absolutely no difference, however, and
the facts speak for themselves, that is, 326 hospital days saved in this small group of patients.
One has only to multiply the number of hospital
days saved by the average cost of hospitalization
today to gain a quick assessment of a tangible
economic saving provided by ambulatory care
methods.
Return to work in an aging population is not
common ( 16). Nonetheless, certain individuals

TABLE 2.
REDUCTION IN HOSPITAL DAYS DURING FIRST YEAR
OF PROGRAM COMPARED WITH PREVIOUS YEAR*

Total hospital days
Number of patients hospitalized (from group)
Average hospitalized
patients

Year Before
Entry

First Year of
Program

868

542

34

25

25.5 ± 39.8

21.7 ± 30.2

* Previously reported (20).
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can return to gainful employment and, in some,
this may represent a striking 'improvement over
past performance. Most individuals who can return to work or at least maintain their level of
gainful employment are rewarded by a continued
sense of pride over their productive state.
Physiologic Changes. One hundred and eightytwo patients were evaluated for CAO and entered
into the comprehensive care program which is re-
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ported here. They were selected on the basis of having irreversible airway obstruction with expected
pulmonary function deterioration with age ( 4, 5,
6, 7, 9, 11, 12, 14, 15, 16, 20, 21, 22). The overall physiologic changes in our series suggest that
the expected pulmonary function deterioration is
retarded. For example, patients at risk for one
and two years are the subjects of Tables 3 and 4 4 • It
4

Symbols explained in Tables 3 and 4.

TABLE 3.
CoMPARISONS: PRELIMINARY VERSUS ONE YEAR
Preliminary

One Year
p

Mean

SD

No.

2.66
1.00
.44
38.5

.80
.39
.23
51.1

120
120
120
118

2.63
. 95
.41
37.3

.81
.49
.31
19.4

All Patients
pH
Pco,
Po,
o, sat.
Dist. walked*
Stairs
Work on stairs

7.40
40.2
57 . 2
87.5
609.8
42.3
581.6

.04
8.3
8.2
6.3
570.0
23.5
304.0

109
108
95
109
91
59

7.40
43 . 6
60.1
88.8
1280 . 3
68.3
874.8

.04
11. 7
11.5
5.8
862.6
32.4
438.6

.0002
.025
. 05
<.0001
<.0001
< .0001

Non o, Patients
pH
Pco,
Po,
o, sat.
Work
Dist. walked*
Stairs

7.40
38.8
59.0
88.8
626.0
671.5
49.7

.04
7.4
7.4
4.7
323.5
616.6
20.9

73
73
67
73
44
67
52

7.40
39.4
61.2
90.0
956 . 1
1449.1
76.2

.04
6.0
9.1
4.1
457.1
906.9
28.6

.05
.02
< .0001
< .0001
< .0001

7.40
43.0
53.1
84.8
451. 3
437.5
36. 7

.04
9.2
8.7
8.1
192.3
370.9
18.3

36
35
28
36
15
24
16

7 . 38
52.5
57.4
86.4
636.1
809.2
54.6

.04
15.2
15.7
7. 9
273.2
487.1
28.6

vc
FEV1
MMF
MVV

77

Mean

SD

o, Patients
pH
P co,
Po ,
o, sat.
Work
Dist. walked*
Stairs

vc

- Vital capacity (liters)
FEY,
- Forced expiratory volume (liters/ second)
MMF
- Maximal mid expiratory flow (liters / second)
MVV
- Maximal voluntary ventilation (liters / minute)
pH
-Expression of hydrogen ion concentration (Negative Lung Volume)
- Carbon dioxide tension in arterial blood
Pco,
- Oxygen tension in arterial blood
Po,
o, sat.
- Oxygen saturation in arterial blood
Distance walked- On treadmill (various increasing rates and grades)
Stairs
- Number walked until dyspneic
Work
- Kilogram meters vertical work on stairs
* Various increasing rates and grades.

.01
< .0001

.025
.01
.01
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TABLE 4.
COMPARISONS: PRELIMINARY VERSUS Two YEAR
Preliminary

Two Year
p

Mean

SD

No.

2.73
1.04
.46
41. 7

.80
.42
.24
15.6

78
78
78
78

2.65
1.00
.43
38.5

.89
.58
.40
23.2

All Patients
pH
Pco,
Po,
02
Work
Dist. walked*
Stairs

7.40
39.0
58.7
88.2
612.8
789.7
45.1

.04
7.3
8.3
5.9
358.4
557.5
24.9

73
73
63
72

29
41
34

7.40
41.9
61.4
89.3
939.6
1276.8
73.6

.04
9.0
11.1
5.1
608.1
794.3
38.3

.0001
.001
.0001

Non 02 Patients
pH
Pco,
Po,
02 sat.
Work
Dist. walked*
Stairs

7.40
37.4
60.0
89.3
663.0
773 . 5
50.3

.04
5.6
7.8
4.6
366.8
578.2
24.1

52
52
49
52
24
31
25

7.41
38.9
60.2
89.6
1064.2
1429.4
79. 6

.04
5. 3
8.0
4.0
593.2
801.8
36.8

.0001
.0002
.0001

02 Patients
pH
Pco,
Po,
02 sat.
Work
Dist. walked*
Stairs

7.40
43.1
54.5
85.5
371. 7
839.7
39.3

.05
9.2
9.1
7.8
194.8
513.1
15.7

21
21
14
20

7.40
49 .2
65.4
88.4
341. 7
803.6
50.0

.03
11. 8
18.2
7.3
159.0
576.7
43 . 1

vc
FEV1
MMF
MVV

5
10

7

Mean

SD

.002

.01
.025

VC
-Vital capacity (liters)
FEY,
- Forced expiratory volume (liters/second)
MMF
-Maximal mid expiratory flow (liters / second)
MVV
-Maximal voluntary ventilation (liters / minute)
pH
- Expression of hydrogen ion concentration (Negative Lung Volume)
Pco,
-Carbon dioxide tension in arterial blood
Po,
-Oxygen tension in arterial blood
0 2 sat.
- Oxygen saturation in arterial blood
Distance walked- On treadmill (various increasing rates and grades)
Stairs
- Number walked until dyspneic
Work
- Kilogram meters vertical work
* Various increasing rates and grades.

is apparent that ventilatory function abnormalities
do not change significantly. Oxygen tension and
saturation are significantly increased at one year.
Carbon dioxide rises occur only in the oxygen
patients, but not to an important degree since pH
remains normal (compensated).
It is probably most noteworthy that in spite

of the fact that the patients essentially remain
about the same from a physiologic standpoint, they
have not deteriorated at the expected rate. Moreover, it may be quite important that increased exercise tolerance is sustained for periods up to two
years.
Mortality. Within a 3.5 year period, 56 pa-
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Trauma Resulting 1n Respiratory Failure*
JAMES W. BROOKS, M.D.
Professor of Surgery, Thoracic and Cardiovascular,
Medical College of Virginia, Health Sciences Division of
Virginia Commonwealth University, Richmond, Virginia

Respiratory failure may occur secondary to
thoracic trauma. Several important conditions develop as a result of chest injuries and may occur
singly, or in combination, in patients with injuries
from any cause. Unrecognized and therefore without proper management, the results are necessarily
poor. If recognized and their mode of production
is understood, treatment may be simple. These conditions are:
1) Retention of bronchial secretions with inadequate pulmonary aeration caused by:
a. Severe chest wall pain
b. Abnormal mobility of the chest wall
c. Pulmonary contusion
d. Depression of the cough reflex, through
1. Unconsciousness
2. Excessive opiates
2) Open chest wall with "sucking wound"
phenomenon
3) Flail chest wall
4) Pneumothorax, simple or tension
5) Hemothorax
6) Hemopneumothorax
7) Ruptured diaphragm
8) Ruptured bronchus
9) Non-pulmonary injuries causing marked ventilation problems
Ribs are the most frequently injured structures in the chest area and must be taken into
consideration with nearly all thoracic trauma cases.
The presence or absence of preexisting pulmonary disease and the extent of injury will govern the amount of difficulty encountered after
chest injury. A small injury may cause marked
derangement of pulmonary function in the patient

* Presented by Dr. Brooks at the Symposium on Respiratory Failure, May 26, 1972, at Richmond, Virginia.
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having preexisting chronic pulmonary disease.
Since adequate treatment of these conditions will
correct the resulting cardio-respiratory disturbances
and thereby aid in resuscitation of the patient,
each condition will be discussed in some detail.
Chest wall pain may have serious consequences in injuries which otherwise would be of no
great importance. Pain may effectively immobilize the chest wall, thereby making cough ineffectual. This results in retention of tracheobronchial secretions and/ or aspirated material.
The accumulation of such material in the bronchi
interferes with pulmonary ventilation and leads to
atelectasis and perhaps even to suppurative pneumonitis. If inadequately treated, such patients may
actually go on to asphyxiation. Recognition of
such a situation is not difficult. Cough is ineffectual and auscultation reveals moist rales and/or
rhonchi widely distributed over both lungs. Dyspnea and cyanosis may develop.
Treatment is directed toward relief of the
chest wall pain and cleaning the airway of secretions. Adhesive strapping is inadvisable since it
leads to poor ventilation, retained secretions, atelectasis, and pneumonia. Mild analgesics or cautious administration of narcotics is helpful. Voluntary, periodic cough and breathing exercises should
be encouraged and advised. Added to these is the
routine use of intermittent positive pressure breathing apparatus to assist full lung ventilation. Frequent position change will aid the normal drainage
of the bronchi.
Patients with retained secretions should have
immediate and repeated aspiration by nasotracheal catheter (fig. 1). Tracheal suction is easily
done, and physicians treating patients with thoracic injuries must familiarize themselves with its
technique. Using a fairly stiff, slightly curved,
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sive bronchial secretions, especially in those who
have difficulty in evacuating these secretions. Opiates reduce the cough reflex and slow or stop
cilia action. They also slow or prevent patient
activity, thus promoting stasis.
The importance of an open, adequate airway cannot be overemphasized. The temporary
use of an orotracheal or nasotracheal tube (up to
72 hours) may be necessary and advisable in the
early management of chest trauma cases. In patients with serious cervical or facial injury, or in
any condition where suction or bronchoscopy is not
feasible, or where excessive irritation has been
produced by gas or smoke, it is advisable to perform a tracheostomy so that catheter aspiration
can be adequately accomplished.
Open chest injuries produce profound disturbances in intrathoracic physiology. Because of
the opening in the chest wall, negative intrapleural
pressure is replaced by atmospheric pressure. A
number of factors determine the severity of the
effects on cardio-respiratory physiology, the most
NORMAL RESPIRATION

INSPIRATION

EXPIRATION

Fig. 1-A. Illustration of nasotracheal suction as an effective stimulus to cough. B. Suction is applied to the
catheter for removal of resultant secretions.

catheter (#16-18 French), the patient is placed
in the sitting or semi-sitting position with the
back supported and the head and neck dorsally
extended. The lubricated catheter is quickly passed
through the nose into the pharynx without suction attached. The patient is instructed to take a
deep breath and during inspiration the catheter
is passed into the trachea. Success is signified
by violent coughing and hoarseness. Suction is
applied intermittently as the catheter is passed
into the tracheobronchial tree.
In some patients effective aspiration can be
accomplished only by means of the bronchoscope.
Oxygen is administered as an aid to these
measures used to clean the airway of secretions but
cannot serve as a substitute.
It should be stressed that opiates must be
used with particular care in patients with exces-
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Fig. 2-Diagram of adverse effects of open pneumothorax.
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Fig. 3-A. Open thoracic wound. B. Emergency closure to stop sucking of air into pleural space.

important being the size of the opening in the
chest wall. Small openings are, in general, tolerated better than large ones. If the size of the
opening approaches or exceeds the size of the
trachea, the patient may get into serious difficulty.
Other important factors are the type of wound
and the mobility of the mediastinum. If the
wound allows air to enter the pleural space but
does not permit it to escape, the patient's condition deteriorates more rapidly. Since the mediastinum is usually quite mobile, open pneumothorax generally leads to a shift of the mediastinum
to the opposite side with compression of the contralateral lung as well as the lung on the side of
injury. The swing of the mediastinum with each
respiratory cycle causes poor air exchange and
also interferes with the return of venous blood
to the heart (fig. 2).
Open wounds must be effectively closed
as soon as possible. As an emergency measure, a
simple occlusive dressing of vaseline gauze is
adequate (fig. 3). When the patient has been
removed to a location where facilities are adequate, the wound is debrided and an airtight,

pleuro-muscular closure is done. A large catheter
is inserted through an intercostal space into the
pleural cavity and is connected to a water-seal
arrangement (figs. 4 and 5).
If one or more ribs are broken in two or

B

Fig. 4-Trochar method of inserting chest drainage tube.
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Fig. 5- Single tube and double tube drainage of air and fluid from the pleural space.

more places (fig. 6), the stability of the chest
wall is interfered with and a "flail chest wall" results (fig. 7). This "flail" area results in paradoxical chest wall motion with respiration. The
amount of respiratory difficulty resulting from an
area of "flail" will depend upon the preexisting
lung condition and the size of "flail." Small areas
of "flail" in the chronic lung patient with emphysema may be most devastating. During inspiration,
the unstable portion of chest wall will become depressed preventing fresh air from entering that
area of lung involved and expressing "stale air"
(low in o~ and high in co~) to other areas of
both lungs, thus preventing full access of fresh
air to all lung areas. The opposite occurs during
expiration, with the outward protrusion of the unstable chest wall section. This draws more "stale
air" into the affected area of lung and prevents
full exhaling of the "stale air." Not only are respiratory problems present with a "flail chest,"
but the swinging back and forth of a virgin mediastinum alters and slows blood flow into the right

side of the heart, in some cases bringing about
shock due to poor inflow to the heart and thus
poor outflow from the left ventricle. Paradoxical
chest wall motion may be temporarily managed
with a bulky dressing to stop paradoxical motion but is most effectively treated by tracheostomy and assisted ventilation with an intermittent
positive pressure apparatus (figs. 8, 9, and 10).
Pneumothorax resulting from injury to the
lung parenchyma allows escape of air through the
visceral pleura into the pleural space and may
cause severe, sudden respiratory distress. Traumatic collapse of lung is far more significant in
bringing about respiratory failure in the individual with preexisting lung disease than in the
healthy individual with no previous lung disease.
This air should be promptly removed by the insertion of an intercostal drainage tube and connection to underwater suction drainage (fig. 11).
In the post-traumatic patient, aspiration of pneumothorax which is greater than 15 to 20% is
generally not satisfactory because it is not as com-
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Fig. 6-IJlustration of unstable section of chest wall due to
multiple rib fractures.
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Fig. 7-Diagram showing effect flail chest wall.

plete, continuous, or efficient as the insertion of a
tube for 24 to 72 hours. If the pneumothorax is
bilateral, immediate prompt attention to the reexpansion of the lungs is essential. Tension pneumothorax results when a ball valve type of injury
to the lung parenchyma occurs. Air can readily
escape into the pleural space but not pass back
and forth through the opening. Thus, positive
pressure is built up in the side of injury such that
there is total collapse of the ipsilateral lung, widening of the intercostal spaces, depression of the
diaphragm, and displacement of the mediastinum
causing further embarrasement to the more normal contralateral lung. Immediate relief of this tension is essential to prevent respiratory failure.
Temporary benefit can be achieved using a large
bore needle until the chest tube is assembled and
inserted. Not only are the respiratory effects of
tension pneumothorax most devastating but so
are the circulatory effects with torsion of the great
veins in the mediastinum diminishing flow of
blood to the right heart and thus influencing out-

flow from the left ventricle and shock because of
poor output.
Loss of blood into the pleural space giving
rise to a hemothorax may also cause the same
problem as pneumothorax. The blood loss brings
about peripheral circulatory problems, but in addition, the collapsed lung may lead to respiratory failure. The blood must be removed continuously to prevent pulmonary difficulties and
replaced by tranfusion for the circulatory effect
(fig. 12). If blood loss exceeds 1,500 to 2,000 cc
in an hour or two after the injury, thoracotomy is
frequently necessary to bring about hemostasis
and prevention of continued respiratory difficulties. If the blood from the pleural space is not
properly, adequately, and efficiently removed,
a coagulum will form over the collapsed lung causing its entrapment and possible need for decortication (fig. 13) . Therefore, prompt removal is
important for the immediate as well as long-term
respiratory benefit.
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Fig. 8-Diagram of temporary bulky chest dressing to
stablize flail chest wall.

Fig. 9-Cuffed tracheostomy tube and apparatus necessary
for connections to assisting intermittent positive pressure
machine.

Fig. 10--Patients with face mask and tracheostomy attachments using intermittent positive pressure machines.
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Fig. 11-Chest tube inserted for drainage pneumothorax.
Fig. 12-Chest tube inserted for drainage hemothorax.

Patients with massive trauma may have a
ruptured bronchus. Such injury leads to extravasation of air into the mediastinum and pleural
space with marked dyspnea and hemoptysis. The
presence of mediastinal, pleural, and subcutaneous
air in a patient with hemoptysis at the time of
massive injury strongly suggests the possibility of
a ruptured bronchus. Prompt diagnosis and repair
is essential. The diagnosis can be made by bronchoscopy, and this examination should be done
promptly after the suspicion of the possibility of
such an injury. Once the diagnosis has been made,
prompt operative exposure and closure of the defect is essential.
Massive blunt trauma may rupture the diaphragm. The left diaphragm tends to rupture far
more frequently than the right. Under these circumstances, intestinal contents from the positive
pressure peritoneal cavity are forced into the negative pressure pleural space bringing about collapse of the ipsilateral lung tissue and shift of the

mediastinum and heart to the opposite side. The
amount of respiratory embarrasement is proportional to the amount of peritoneal contents in the
pleural space and the antecedent lung condition.
Prompt recognition of this problem is essential,
and operative repair must be carried out promptly
if the ruptured diaphragm leads to respiratory
embarrasement.
Non-pulmonary injuries may effect the lung
itself. Of great importance in this area is the
presence in the orthopedic injury of possible fat
emboli to the lungs. If such a diagnosis is made,
pulmonary assistance is essential to the maintenance of the patient after injury even with support
from tracheostomy and positive pressure breathing apparatus. Other areas distant from the lung
which may give severe respiratory embarrasement
are spinal cord injuries which will effect diaphragm
and intercostal action. Severe brain damage may
so effect the respiratory activity that the patient's
problems will be mainly in the area of the lung.
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Fig. 13-X-ray of post-traumatic chest with retained blood
in left chest requiring decortication.

Fig. 14-Decortication of post-traumatic chest (see fig.
13 ).

In the case of brain damage good airway may
be sustained with an endotracheal tube for several days and then replaced with tracheostomy.
Facial, jaw or sinus injuries may so crowd the upper respiratory passages that tracheostomy is essential to prevent asphyxia. Severe neck injuries

causing pressure on the trachea must be managed
carefully to provide for an adequate, continuous
airway. Extensive injuries immobilizing the patient in bed for long periods of time must be
carefully observed in order to prevent atelectasis,
pneumonia, and respiratory failure.

The Adult Respiratory Distress Syndrome:
Clinical Features, Factors Infl uenci ng
Prognosis and Principles

of

Management*

THOMAS L. PETTY, M.D., F.C.C.P.
Associate Professor of Medicine and Head, Division of Pulmonary
Diseases, University of Colorado Medical Center, Denver, Colorado

DAYID G. ASHBAUGH, M.D.
Associate Professor of Surgery, University of Colorado
Medical Center, Denver, Colorado
The adult respiratory distress syndrome
(ARDS) is an important and common medical
emergency and is likely to occur in all hospitals
dealing in respiratory care. The syndrome occurs
from a variety of diffuse pulmonary injuries which
are either direct or indirect attacks on the lung
parenchyma. Once lung damage occurs, exudation
of fluid and loss of surfactant activity leads to impaired gas exchange and reduced pulmonary compliance. The syndrome presents clinically as marked
respiratory distress, tachypnea, cyanosis, refractory
hypoxemia, high inflation pressure requirements during ventilatory support, diffuse alveolar infiltrates
on chest roentgenograms and postmortem pulmonary congestion, hyperemia and hyaline membrane
formation. Principles of management include adequate support of oxygen transport, ventilation, and
circulation employing volume respirators with positive end-expiratory pressure (PEEP). During the
support phase, further pulmonary injury in terms
of fluid overload, oxygen toxicity, or infection, must
be prevented or treated. When these principles of

* Presented by Dr. Petty at the Symposium on Respiratory Failure, May 25, 1972, at Richmond, Virginia. Reprinted with permission from Chest, Volume 60, pp. 233239, September, 1971. Reprint requests to Thomas L. Petty,
M.D., 4200 East Ninth, Denver, Colorado 80220.
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management are followed, recovery often occurs in
spite of severe pulmonary injury as indicated by the
first two illustrative cases.
Recent experience has indicated that a variety
of direct or indirect pulmonary insults can lead to
a clinical picture of marked respiratory distress, diffuse pulmonary infiltration on x-ray examination,
impaired effective pulmonary compliance, marked
impairment in oxygen transport1 in spite of ventilatory assistance, pulmonary congestion, and hyaline
membrane formation ( 1). This clinical picture, which
arises from unrelated pulmonary insults, has been
termed the adult respiratory distress syndrome
(ARDS) ( 1 ) . The response of the lung to a variety
of pulmonary insults has been the subject of a recent conference sponsored by the National Academy
of Sciences. It is apparent on reviewing the conference proceedings that this clinical syndrome is
encountered frequently in both civilian and military
hospitals (9).
This report redescribes the adult respiratory
distress syndrome and discusses factors which ini Impaired oxygen transport is defined as an increased
inspired-arteriolar oxygen tension difference (similar to increased alveolar-arterial tension difference) . Normally this
is approximately 50 mm Hg (difference between inspired
and arterial tensions with an adequate alveolar ventilation
for CO.).
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ftuence prognosis and presents principles of management.
The Clinical Syndrome. Patients with this
syndrome suddenly develop marked tachypnea, dyspnea, and cyanosis which is refractory not only to
nasal oxygen but also to intermittent positive pressure breathing ( 1, 2). Chest x-ray films show diffuse
alveolar infiltration, usually with a normal cardiac
silhouette (see x-ray films of three illustrative cases).
The difference between inspired and arterial oxygen
tensions is markedly increased ( 1, 2) (often 200 to
500 mm Hg) representing a large right to left
shunt ( 20). It must be stressed that the original
injury leading to this problem may be direct chest
trauma, indirect trauma such as shock associated
with abdominal wounds, ruptured spleen, drug
ingestions, massive aspiration pneumonia, and acute
pancreatitis with shock ( 1) . Similar clinical entities
include the syndrome of prolonged cardiopulmonary
bypass ( 4), congestive atelectasis ( 6), viral pneumonia (17), and massive fat embolism (3).
In addition, this clinical syndrome has been
equated with oxygen toxicity ( 16) or use of a
ventilator per se, and the unfortunate term "respirator lung" has been added to the already confusing
literature concerning the subject (7) .
In spite of marked pulmonary damage and
impaired oxygen transport, however, modern management has proved to be effective in certain patients2. Fatalities are usually a result of septic com2 See illustrative case examples. Our total series will be
the subject of a subsequent report.

3.17. 70
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plications including pneumonia with gram-negative
organisms, lung abscess, and occasional septicemia.
The outcome is dependent upon the nature and degree of the original pulmonary injury and the presence or absence of further superimposed pulmonary
damage (1, 2).
Case Reports. The following three illustrative
cases represent two basic types of clinical response
which may occur, that is, rapid resolution with
recovery or progressive pulmonary insufficiency
leading to interstitial fibrosis and death.
Case I. The patient, a 21-year-old student,
became ill following a bout of heavy drinking which
led to unconsciousness after he attempted to prepare
some food by cooking on a gas stove. The patient
later awakened in a smoke filled room and vomited.
He became extremely short of breath with a cough
productive of reddish purulent sputum. Because of
progressive difficulty with breathing, the patient
entered the emergency room. No industrial exposure
was reported by relatives. On examination the patient
was in marked respiratory distress with tachypnea,
cyanosis, and moderate supraclavicular retractions.
His pulse was 110, respirations 38, temperature 38.8°C,
and blood pressure 103/ 70. The chest was symmetrical
and moist coarse rales were heard throughout both
lung fields with some decrease in breath sounds. The
results of cardiac examination were normal. The
chest x-ray picture revealed diffuse bilateral infiltrates
(fig. 1). (Note that in each figure factors of oxygen
administration, that is, nasal 0 2 liter flow or oxygen
tension on a ventilator- P1 0 ,-are compared to simul-

3-18-70
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Pa02 87

3-27-70
PI02 122

Pa02 63

Fig. 1 (left)-Chest roentgenograms on admission. Note oxygen liter flow wi~h concomita~t arterial oxygen ten~ions (Case .1).
Fig. 2 (center)-X-ray clearing on second hospital day. High inspired oxygen tension (462) reqmred for adequate artenal oxygenation
(Case 1). Fig. 3 (right)-Further x-ray clearing and near normal oxygen transport (Case 1).
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taneous arterial oxygen tensions-Pa 0 , ). The difference
between P1 0 , and Pa 0 , is an index of impaired gas
transport across the lung (10) (see Discussion). Initial
arterial analyses revealed Pa 0 , 33 mm; carbon dioxide
tension (Paco,) 35 mm and pH 7.435, breathing air
(Table 1). With 10 liter.s of nasal oxygen the Pa 0 ,
increased only to 38.5. The hematocrit was 523; 3
white cell count was 21,000.
The clinical impression was smoke inhalation
and possible aspiration pneumonia. In view of the
profound hypoxemia which was refractory to nasal
oxygen, an endotracheal tube was placed and a
tracheostomy performed. With 803 inspired oxygen
fraction the Pa 0 , increased to 88 mm Hg (Table 1).
On the next day Pa 0 , was 87 with 803 inspired
oxygen fraction. The x-ray picture showed slight
clearing (fig. 2). With 10 cm positive end-expiratory
pressure (PEEP) Pa 0 , elevated to 119 4 (Table 1).
This allowed the inspired oxygen fraction to be
reduced to 703 providing a Pa 0 , of 85 and later in
the afternoon 104, indicating improved oxygen
transport (Table 1). In addition to the ventilatory
management, the patient also received nafcillin,
8 g daily, hydrocortisone 600 mg intravenously daily,
and kanamycin 500 mg twice daily in view of the
possibility of aspiration pneumonia. On the following
day, the patient's Pa 0 , was 92 with an inspired
fraction of 603 via the ventilator. Rapid clearing
of the pulmonary infiltrates occurred by the third
hospital day and the patient made an uneventful
recovery (data in Table 1 indicates marked improvement in the Pr 0 ,-Pa 0 , difference which became
nearly normal on March 27, 1970; figure 3: normal
Pa 0 , is 65 to 75 mm Hg).
Comment. This case represents diffuse pulmonary
injury from smoke inhalation and aspiration of
gastric contents. Corticosteroid drugs are generally
considered desirable to combat the chemical pneumonitis from aspiration of gastrointestinal content (12)
and are also considered useful in smoke inhalation.
The antibiotics were used in the belief that some
bacterial infection may have been present. Following
initial refractory cyanosis, the patient could be
adequately oxygenated with a high oxygen fraction
(703 ) and positive end-expiratory pressure on exhalation (see Discussion). An uneventful recovery
3 Upper normal for Denver although in this case this
value may be representative of some degree of hemoconcentration.
4 Ohio 560 Respirator, Ohio Medical Products, Madison, Wisconsin.
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TABLE

INSPIRED AND ARTERIAL BLOOD GAS TENSIONS
DURING MANAGEMENT (CASE 1)

Admission 3 Hr*
Oxygen
Pio,
Pao,
Paco,

10 L
39
35

24Hr*

2Days*

7 Days

803
462
119

603
353
92
38

20.93
121

803
460
88
38

40

59
37

* Ventilatory assistance with PEEP- See text.

followed and the patient remains well five months
after the original pulmonary insult.
Case 2. Patient 2, a 34-year-old white woman,
was admitted via the emergency room with a history
of ingestion of an unknown quantity of phenobarbitol
and chlordiazepoxide along with tablets composed
of aspirin and phenacetin some 30 hours before
admission. The patient had vomited and aspirated according to her husband. She had a history of drug
overdosage on two occasions in the past.
On physical examination she was found to be
semi-stuporous and deeply cyanosed. Her blood
pressure was 110/ 70, temperature 38.2°C, respirations
30 and labored. Examination of the chest revealed
scattered bilateral rales in both axillary areas. Cardiac
examination was normal. No edema was present.
Chest x-ray picture (fig. 4) revealed extensive bilateral
pulmonary infiltrates. Initial blood gas values revealed
Pao, (on air) 34.5, Paco, 23.5, pH 7.51; with 10 liters
of oxygen (Table 2), Pa 0 , 40, Paco, 23, pH 7.49.
In addition, hematocrit was 32%, white cell
count 21,300 with 953 polymorphonuclear leukocytes, BUN 13 mg% and creatinine l.33. The
patient was managed in the intensive care unit following tracheostomy with a volume cycled ventilator
and initially required oxygen fractions of 803 to

TABLE

2.

INSPIRED AND ARTERIAL BLOOD GAS TENSIONS
DURING MANAGEMENT (CASE

Ad mission
Oxygen
P1 0 ,
Pao,
Paco,

10 L
40

23

2)

Hr*

3
Hr*

2
Days

4
Days

1003
585
70
33

803
468
116
37

503
294
159
30

303 20.93
176 121
75
92
26
30

* Ventilatory Assistance with PEEP- See text.

7
Days
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S-1-70
02 IOL
Pa02 AO

S-3-70
PI02 29'
Pa02 159

S-20-70
Discharge

Fig. 4 (left)-Bilateral pulmonary infiltration on admission. Severe hypoxemia-Pa 0 , 40 in spite of 10 L nasal oxygen flow (Case 2).
Fig. 5 (center)-Clearing pulmonary infiltrate and evidence of improved oxygen transport (P1 0 , 294; Pa 0 , 159) (Case 2). Fig. 6
(right)-Normal chest x-ray on discharge (Case 2).

1003 to effect an adequate arterial oxygen tension
(Table 2). In addition, she received intravenous
hydrocortisone 100 mg three times daily; cephalosporin and kanamycin were given for presumed
aspiration pneumonia. Her temperature elevated to
39.2°C on the first hospital day. On the second
hospital day elevated arterial oxygen tensions were
produced by an oxygen fraction of 503 (P1 0 , 294Table 2), and the oxygen fraction was lowered to
303. Marked improvement was noted upon x-ray
examination along with improved oxygen transport
(fig. 5). Thereafter an uneventful recovery occurred
over the next four days. The ventilator was discontinued on the fifth hospital day, and the patient
made further progress and was discharged on the
20th hospital day (fig. 6).
Comment. Factors of pulmonary injury included
aspiration of gastric contents following drug ingestion. The diffuse pulmonary damage presented the
picture of pulmonary edema. A longer period of impaired oxygen transport was present than in case 1,
and at times 100% oxygen was needed to effect an
adequate arterial oxygen tension. Evidence of improved gas transport occurred, and a complete recovery was achieved nonetheless.
Case 3. This patient, a 34-year-old man, was
transferred to Colorado General Hospital by air
evacuation from a resort community. The patient
had been found comatose on the floor of his
rooming house, having vomited and was hospitalized
in a local hospital with extensive bronchopneumonia

as well as numerous rib fractures from unexplained
chest trauma. Numerous bruises of the chest were
found. A tracheostomy was performed and Staphlococcous aureas, coagulase positive was isolated
from the sputum. The patient was initially managed in
the community with a pressure cycled respirator
on oxygen, which presumably provided high oxygen
fractions ( 10). It was also believed, by a careful scrutiny of input and output records, that fluid overload
had occurred. The patient was managed with furosemide which produced a brisk diuresis. Because of
a worsening chest x-ray picture, high fever, and difficulty providing adequate arterial oxygenation, the
patient was transferred to Colorado General Hospital seven days after admission to the community
hospital. On admission, the patient was alert and
cooperative and followed commands well. His blood
pressure 150/ 85, pulse 120, temperature 40°C, respirations controlled at 20. Chest examination revealed coarse rhonchi arid scattered rales throughout.
No cardiac abnormalities were present. A cardiac
gallop rhythm was not observed. The chest x-ray
film (fig. 7) showed diffuse bilateral alveolar
infiltration.
Initial arterial blood gases (Table 3) on the
respirator revealed Pa 0 , 49, produced by an inspired
oxygen fraction of 703 (simultaneously Pao, 32,
pH 7.42). With use of 10 cm positive end-expiratory
pressure by artificial ventilator, the pulmonary
oxygen transport improved as evidenced by Pao, 72,
24 hours later at the same inspired oxygen fraction
(70 % ) . These values are representative of numerous
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5-12-70
PI02 376
Pa02 77

5-20-70
PI02 583
Pa02 63

Fig. 7 (left)-Massive bilateral pulmonary infiltrations on admission with severe impairment in oxygen transport (P1 0 , 376;
Pa 0 , 77) (Case 3). Fig. 8 (right)-Terminal chest x-ray film shows diffuse pulmonary fibrosis and evidence of right-sided
pneumothorax and tube placement.

gas tensions and fractions observed throughout the
day. Arterial oxygen tensions as high as 86 were
initially achieved.
Antibiotics were continued (ampicillin and kanamycin) and large doses of corticosteroid drugs
were given (see Discussion). Strict avoidance of fluid
overload was practiced. In spite of continued respiratory support, a severe impairment of oxygen
transport across the lung remained, and on the fifth
hospital day, or 12 days after the original pulmonary injury, 65% inspired oxygen fraction was

TABLE 3.
INSPIRED AND ARTERIAL BLOOD GAS TENSIONS
DURING MANAGEMENT (CASE

Admission
Oxygen
Pio,
Pao,
Paco,

70%
405
49
37

3)

24 Hr*

5 Days*

12Days*

70%
404

65%
376

72

77
44

100%
583
63
46

38

* Ventilatory Assistance with PEEP- See text.

still required to provide a Pa 0 , of 77 mm Hg in spite
of positive end-expiratory pressure (Table 3).
The chest x-ray film (fig. 8) did not show resolution, and just before death, 1003 oxygen was required to provide an acceptable Pa 0 , of 63. The
patient died following a pneumothorax (fig. 8).
Comment. The original injury was pneumonia,
presumably bacterial, but also aspiration pneumonia
was a possibility. Further injury may have been
high oxygen ventilation in the original hospital as
well as fluid overload (see Discussion).
At no time in our institution did excessive
arterial oxygenation occur, and all efforts were made
to minimize the inspired oxygen tension that would
still provide adequate arterial oxygenation. Nonetheless, the patient's course was one of progressive
pulmonary infiltration, inceasing pressure requirements on the ventilator (up to 75 cm inflation pressure5) for a tidal volume of 700 ml (effective compliance 9 ml per centimeter normal; 40 to 60 ml
per centimeter). Permission for postmortem examis Ohio 560 Respirator, Ohio Medical Products, Madison, Wisconsin.
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nation was not obtained. The x-ray picture and
markedly reduced effective compliance suggested
the development of pulmonary fibrosis, a response
which commonly occurs in fatal forms of this syndrome.
Theories of Pathogenesis. It appears from our
clinical experience of over 40 cases, as well as the
three illustrative cases cited in this report, that the
adult respiratory distress syndrome is basically a
nonspecific response to a variety of pulmonary injuries. The injury may be direct chest trauma or the
pulmonary effects of other injurious agents as well
as shock (9). After damage to the alveolar capillary
membrane, very likely, exudation of fluid occurs
into the alveolar spaces ( 8). This causes interference
with surfactant activity (8). It is likely a combination
of alveolar and/ or interstitial fluid as well as the
effects of decreased surfactant activity leads to poor
effective compliance demonstrated by high pressure
requirements for an adequate tidal volume as illustrated by case 3, and a problem common to all
three illustrative cases.
The ultimate outcome is dependent upon three
factors: a) the degree of original injury, b) the
effectiveness of respiratory support and c) the prevention of further pulmonary injury. The majority
of patients can be adequately supported by the use
of constant volume ventilators through use of the
controls described below. It is likely that fluid overload may compound the problem. Once the alveolar
capillary barrier is injured, and vascular integrity
lost, expansion of the circulating blood volume may
allow outpouring of fluid into alveolar spaces with
resulting pulmonary edema and impairment in
oxygen transport.
An additional contributing factor in the development of progressive stiff lungs is the possibility of
oxygen toxicity (11, 19). All of the facts on oxygen
toxicity are not known at the present time; however,
the weight of evidence suggests that long-term exposures of oxygen in fractions higher than 40% to
50% in certain cases, may be harmful ( 11, 19). On
the other hand, our experience, as well as that of
others, has shown that in states of profound hypoxemia, 100% oxygen inspired fraction may be
required for periods of several days with recovery.
Questions remain concerning the nature of the
damaging effects of high oxygen and whether this
is a function of alveolar or arterial oxygen tension.
Recent evidence suggests that at atmospheric pressures high alveolar oxygen tensions are potentially

damaging ( 15). In principle, one should minimize the
inhaled oxygen fraction as much as possible (see
below).
Superimposed infection represents a common
and serious complication of acute respiratory distress. Sepsis from burn wounds or peritonitis may
precipitate respiratory distress, and if the infection
cannot be controlled, death may occur even though
respiratory failure is adequately treated. In patients
surviving for longer periods of time, secondary
bacterial pneumonias are likely to occur, and these
are often due to resistant gram-negative organisms
such as Pseudomonas aeruginosa and KlebsiellaAerobacter species.
While this problem continues to be a major
obstacle in the care of patients, it can be minimized
by proper precautions and use of antibiotics. Careful
and repeated cultures of sputum, urine, stool, and
wounds alert the physician to early changes in
flora and provide sound data for the selection of
appropriate antibiotics. Narrow spectrum highly
specific antibiotics are preferred over broad spectrum
antibiotics. The latter will often eradicate normal
flora and allow secondary invasion of highly resistant
organisms. Attempts at isolation of these patients are
of little value since the organisms causing pulmonary
infection are almost always of endogenous origin
from another infected site.
Principles of Management. Principles of management are listed in Table 4. Management includes
support of ventilation and gas exchange, minimizing
further pulmonary damage, and ancillary therapeutic
maneuvers.
We have learned that high tidal volume ventilation with both inspiratory plateau and positive endexpiratory pressure (PEEP) improves oxygen transport across the lung (see figure 9 for pressure wave
form of inspiratory plateau and PEEP compared
TABLE 4.
ARDS
1. Prevent alveolar collapse and maintain oxygenation
a. Tracheostomy
b. Volume respirator
c. Oxygen control
d. Positive end-expiratory pressure (PEEP)
MANAGEMENT PRINCIPLES IN

2. Prevent further injury
a. Oxygen control
b. Fluid restriction
c. Antibiotics for specific infections
d. Corticosteroid drugs

PETTY AND ASHBAUGH: ADULT RESPIRATORY DISTRESS SYNDROME

INSPIRATORY PLATEAU AND POSITIVE END EXPIRATORY PRESSURE
OHIO 560

FLOW
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TABLE 5.
ADULT REsPIRATORY DISTRESS SYNDROME
(IMPROVED OXYGEN TRANSPORT WITH lNSPIRATORY
PRESSURE* AND POSITIVE END-EXPIRATORY
PRESSURE-PEEP)
44-year-old man-multiple trauma, liver laceration 40 units
whole blood, 8 liters Ringer's lactate

2 P.M.
in OR

4P.M.
Vol Resp
lOOOml TV

570
81
27

345
82
25

VOLUME

inspirotory plateau

,/
PRESSURE
0 cm
positive end expiratory pressure

10 cm

Fig. 9-Modified pressure wave forms showing inspiratory
plateau and positive end-expiratory pressure (arrows).

to normal pressure wave form, figure 10). The
effects of inspiratory plateau and positive end-expiratory pressure are additive in certain patients; this
is demonstrated in Table 5.
Our clinical ( 1, 2) and laboratory experience

FLOW, VOLUME AND PRESSURE CURVES
OHIO 560 VENTILATING DRAGER ARTIFICIAL THORAX

FLOW

VOLUME

PRESSURE

EFFECTIVE

COMPLIANCE

EFFECTIVE AIRWAY RESISTANCE
FLOW SETTING

19cc/cm

Pio,
Pao,
Paco,

5 P.M.
4:30 P.M.
Insp
Insp Hold
Plateau Positive End-exp
2 sec
Plateau 10 cm

+

345
101
23

+

345
151
25

* Courtesy of D. Boyd Bigelow, M.D., Chief of
Respiratory Diseases, St. Anthony's Hospital, Denver,
Colorado.

(20) indicates that PEEP6 is fundamental in improving oxygenation by decreasing the alveolar arterial
oxygen tension difference. The inspiratory plateau
may have similar value, but this has provided a lesser
improvement in oxygenation than PEEP in our
recent experience. This ventilator capability is only
available as a standard feature on one machine in
common use today7 .
PEEP will allow improved oxygen transport
of lower inspired oxygen fractions on most occasions ( 1, 2). It is likely that the use of high pressure
constant volume ventilation, inspiratory plateau, and
end-expiratory pressure all provide local tamponade
of circulation to areas of poor ventilation, and these
techniques maintain alveolar stability by preventing
alveolar collapse on expiration (8, 14). It is clear
that PEEP increases the functional residual capacity
and reduces right to left shunting (13, 14, 20). Endexpiratory pressures of 5 to 15 cm H20 are used,
and in clinical situations no apparent adverse effect
on venous return and cardiac output can be noticed.
It is likely that this small back pressure is dissipated
across the stiffened lung and therefore is not "felt"
in the pulmonary circulation ( 20).

56cm/ L/ . . c

2

Fig. 10-Flow and pressure wave forms using Ohio 560
ventilator and artificial thorax. Note square wave form
(flow); volume signal electrically integrated from flow signal. Inspiratory flow wave oriented upward and expiratory flow wave downward.

e PEEP has also been termed CPPB (continuous positive pressure breathing) in earlier reports. We now believe
CPPB is a confusing term since this designation was first
advanced to refer to breathing against a fixed pressure head,
and did not originally refer to both positive inspiratory and
expiratory pressures by a ventilator (5).
1 Ohio 560 Respirator, Ohio Medical Products, Madison, Wisconsin.
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In addition, the possibility of fluid overload

should be minimized by recognizing the tendency
toward fluid retention during artificial ventilation
and the possibility of transudation of fluid into alveolar spaces in the face of an expanded circulatory
volume (18).
Clinical experience indicates the use of corticosteroid drugs is highly beneficial in patients with
the adult respiratory distress syndrome. Evidence
supporting the use of corticosteroid drugs is based
both on theoretic considerations and clinical observations. Corticosteroid drugs are known to combat
the effect of fat found in the lungs in the respiratory
distress syndrome associated with massive trauma
( 9). Corticosteroids have been shown to be effective
both clinically and in laboratory models of fat
embolism (3, 21). Also, evidence that corticosteroid
drugs inhibit adherence of leukocytes to the pulmonary vascular bed in hemorrhagic shock has recently
been presented (22) . Adherent leukocytes may cause
pulmonary damage by the release of proteolytic
enzymes. Finally, corticosteroids may enhance the
secretion of surfactant, which is invariably absent
in lungs with the adult respiratory distress syndrome
( 1) and which is needed to maintain alveolar stability
(8) .

Specific pulmonary and other infections must
be managed with appropriate antibiotics. We believe corticosteroids are effective in aspiration
pneumonia probably by correcting the inflammatory
effects of acid gastric juices on the lung ( 12).
Penicillin is effective against mouth organisms and
is probably the antibiotic of choice. Kanamycin is
effective against a broad spectrum of gram-negative
organisms.

3. ASHBAUGH, D. G. AND PETTY, T. L. The use of corticosteroids in the treatment of respiratory failure associated with massive fat embolism. Surg. Gynec. Obstet.
23:655, 1966.
4. BAER, D. M. AND OSBORN, J. J. The post perfusion pulmonary congestion syndrome. Amer. J. Clin. Path. 34:
442, 1960.
5. BARACH, A. L., MARTIN, J., AND ECKMAN, M . Positive
pressure respiration and its application to the treatment
of acute pulmonary edema. Ann. Intern. Med. 12:754,
1938.
6. BERRY, R . E. L. AND SANISLOW, c. A. Clinical manifestations and treatment of congestive atelectasis. Arch.
Surg. (Chicago) 87:153, 1963.
7. Case Records of the Massachusetts General Hospital.
New Eng. J. Med. 276:401, 1967.
8. CLEMENTS, J. A. Pulmonary surfactant. Amer. Rev.
Resp. Dis. 101:984, 1970.
9. EISEMAN, B. AND ASHBAUGH, D. G. (eds.) Pulmonary
effects of nonthoracic trauma. J. Trauma 8:624, 1968.
10. HARRIS, T. M., GRAY, M., AND PETTY, T . L. Monitoring
inspired oxygen pressure during mechanical ventilation.
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11. HYDE, R . W. AND RAROSON, A. J. Unintentional iatrogenic oxygen pneumonitis-response to therapy. Ann.
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12. LEWINSKI, A. Evaluation of methods employed in the
treatment of the chemical pneumonitis of aspiration
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Bedside Assessment of Left Ventricular Function 1n
the Respiratory Intensive Care Unit*
CLIFTON L. PARKER, M.D.
Cardiopulmonary Research Fellow, Medical College of Virginia,
Health Sciences Division of Virginia Commonwealth University,
Richmond, Virginia

The measurement of the central venous pressure is a widely used technique for gaining information concerning the relationship of the blood volume
as it relates to cardiac function. This concept has
been widely popularized, and the central venous pressure measurement is extremely useful; however, it
has too frequently been thought to be a direct measurement of cardiac function.
The normal value of the central venous pressure is 6 to 12 cm of water as measured vertically
from the midaxillary line, preferably with the patient in a supine position. The tip of the catheter,
·if properly placed, is either in the superior vena cava
or the right atrium. The pressure measured is obviously the mean value of the pressure in that particular vascular compartment. If we are to use the
central venous pressure as a measurement of left
heart function, we are really interested in the relationship of the superior vena cava or right atrial
pressure to the left ventricular end diastolic pressure
or the pulmonary capillary wedge pressure.
It is known that the mean right atrial pressure
does not always accurately predict the mean left
atrial pressure, and it is in reality the left atrial
pressure that constitutes the filling pressure for
the left ventricle and is the more important measurement. It is known that acute left ventricular failure may give rise to increased pulmonary
capillary wedge pressure with pulmonary edema in
the presence of a normal central venous pressure .
The cardiac output is partially determined by

* Presented by Dr. Parker at the Symposium on Respiratory Failure, May 27, 1972, at Richmond, Virginia.
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the amount of fluid that is available to the cardiac
pump. Obviously, if only a small amount of fluid
is placed into the pump, it follows that only a small
amount of fluid can be ejected. It has been found
that the central venous pressure measurement
gives a good indication of the peripheral venous
capacity and the state of the blood volume. If
there is a low central venous pressure or low
mean right atrial pressure, it generally indicates
underfilling of the peripheral circulation which
gives rise to a lowered cardiac output. An elevation of the central venous pressure usually indicates a full peripheral circulation, and this should
lead to an increased cardiac output. An elevation
of the central pressure in the presence of a normal
to reduced peripheral volume generally indicates
either a decrease in pump efficiency or an increased resistance to flow through the pulmonary
vasculature.
The indications for monitoring the central
venous pressure are:
1 ) Shock: In hypovolemic shock the central
venous pressure is an invaluable guide to effective
fluid replacement. The measurement of the CVP
often provides the means by which we are able
to wean patients off vasopressors after restoring
adequate blood volume. In septic shock, there
is frequently reduced blood volume as well as
impaired cardiac efficiency . . The central venous
pressure measurement enables us to give the patient an adequate or optimal blood volume, and
if this does not restore adequate blood pressure,
we then add Isuprel® or massive steroids to increase pump efficiency and to dilate the peripheral
vascular beds. In cardiac shock the monitoring of
MCV QUARTERLY 9(2): 190-193, 1973
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central venous pressure has lesser value than
hypovolemic or septic shock. It has been shown
that elevation of the central venous pressure may
be a relatively late sign of cardiac failure.
2) To monitor fluid therapy in patients with
cardio-respiratory disorders: Patients with histories
of congestive heart failure or chronic obstructive
pulmonary disease are at relatively greater risk
when exposed to the hazards of trauma, major
surgery, or prolonged illness with protracted vomiting or blood loss. One of the primary reasons for
this much greater risk is the difficulty in optimally
replacing the blood volume without overloading
the circulation and causing diminution in cardiac
function or interstitial edema, thus reducing pulmonary function.
3) Acute renal failure: In the presence of
acute renal failure it is essential to rule out hypovolemia as a cause. This is a completely reversible
cause, but it must be discovered and treated early
in order to avoid acute tubular necrosis. Whenever
there is any doubt as to the adequacy of the peripheral vascular volume in the presence of acute renal
failure, the central venous pressure should be measured and monitored in an effort to eliminate prerenal factors as a cause of the renal failure .
The physician who is asked to see a patient
with an elevated central venous pressure and a
cardio-respiratory problem has to consider many
factors. Pulmonary hypertension, that is, a pressure in the pulmonary artery greater than 35/ 15
mm Hg, can cause elevation of the central venous
pressure.
As you look at the causes of pulmonary hypertension (Table 1) and note the variety of disorders and the variety of treatments that would be
necessary, it is obvious that the mean · right atrial
pressure may at times be insufficient physiological
qata to enable us to arrive at a correct diagnosis.
Bedside clinicians have been measuring the
pulmonary capillary wedge pressure for years by
listening for the presence of fine inspiratory rales
at the bases of the lungs which indicate the presence of pulmonary edema. It is known that rales
and pulmonary edema do not occur unless the
wedge pressure has approached 25 mm Hg. However, it must be kept in mind that pulmonary
edema or pulmonary congestion may exist on a
basis of a pulmonary disease giving rales in the
lung bases that may be indistinguishable from those
rales heard in congestive heart failure, in which
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TABLE 1.
PULMONARY HYPERTENSION

(Greater than 35 / 15 mm Hg)
1. Elevation of pulmonary capillary pressure and / or left
atrial pressure.
a. Increased volume, fluid overload.
b. Elevated left ventricular end diastolic pressure.
c. Mitra! valvular disease.
d. Obstruction proximal to the mitral valve.
2. Decrease in total cross sectional area of the pulmonary
vascular bed.
a. Pulmonary emboli.
b. Medial hypertrophy of small arterioles.
c. Functional reduction of the pulmonary vascular bed
due to hypoxia and / or acidosis.
3. Increase in pulmonary arterial blood flow with left to
right shunts.

case the pulmonary capillary wedge pressure may
be normal or may even be reduced. Therefore, it
is obvious that a means for determining the pulmonary capillary wedge pressure at the bedside
would be useful in the management of the more
difficult cardio-respiratory problems. Formal cardiac catheterization is certainly of great help; however, it is frequently difficult to have use of the
cardiac catheterization facilities on an emergency
basis, and it is frequently very difficult to transport
the patient from the intensive care unit to the
cardiac catheterization laboratory. Bedside right
heart catheterization is now a practical procedure
using the recently perfected Swan-Ganz catheter.
The Swan-Ganz balloon tipped catheter is
a number 5 French double lumen catheter with
a small balloon at its tip that can be inflated with
0.8 cc of air or carbon dioxide. The Swan-Ganz
catheter can be inserted into the vein either percutaneously through a 12 gauge needle or via a
cutdown, and is advanced to the right atrium much
as a central venous pressure catheter is inserted.
When the pressure tracing curves, typical of the
catheter with its tip in the thoracic cage, are seen,
the balloon is inflated. The catheter is carried by the
current of blood and quickly passes through the right
ventricle into the pulmonary artery. In the original report concerning this catheter, the average
time for passage from the right atrium to the pulmonary artery was 35 seconds, and the ease of
passage has been borne out by our use of the
catheter in the respiratory intensive care unit.
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Once the catheter is in the pulmonary artery, the
balloon is left blown up, and it is then slowly advanced to the wedge position at which time the
pressure contour will damp considerably. At this
point, the balloon is deflated and the catheter is
advanced approximately another two to three centimeters. The tip now lies in a small peripheral
pulmonary artery, and with the balloon down we
can measure the pulmonary artery pressure. When
the balloon is inflated the pulmonary artery pressures are damped, and the pressure recording
then is essentially that of the pulmonary capillary
wedge pressure. This procedure does not require
the use of fluoroscopy and can be done quite safely
if the pressure pulse contours and the electrocardiogram are monitored. It has been determined
that the pulmonary capillary wedge pressures as
determined by the Swan-Ganz catheter, when compared with simultaneous direct left atrial pressure
measurements, have been approximately equal.
There have been no serious cardiac arrhythmias
reported as yet with the Swan-Ganz catheter.
There appear to be fewer cardiac arrhythmias
when using the Swan-Ganz catheter than there are
when using the regular cardiac catheter under direct
fluoroscopic control. The explanation for this probably lies in the fact that the tip of the catheter is
cushioned by the balloon. Other complications would
be those persuant to any indwelling catheter left
in position for a prolonged period of time.
I would like to describe several cases in which the
Swan-Ganz catheter and bedside measurement of
pulmonary capillary wedge pressure were invaluable
in helping us to direct therapy. The first case is that
of a 59-year-old man who was referred to the Medical
College of Virginia due to severe dyspnea. He had
been hospitalized approximately two weeks prior to
his admission because of congestive heart failure
and chronic obstructive pulmonary disease. He had
been treated with digoxin, diuretics, and bronchodilators with improvement. Following his discharge his
condition deteriorated and he developed a cough with
purulent sputum and was transferred to MCV where
he arrived with severe tachypnea and cyanosis. His
past history revealed admission to MCV three years
previously with congestive heart failure, atrial flutter,
and chronic obstructive pulmonary disease. With
cardioversion, digoxin, and the care of the lung
disease, he had improved and no specific cardiac
diagnosis was made. On physical examination on
admission, his temperature was 100.8°, his pulse was

106, his respiratory rate was 36, his blood pressure
was 120/ 80, and there was neck vein distention at
40°. Chest examination revealed that his lungs were
hyperresonant to percussion, that there was an
increased anterior-posterior diameter, and that there
were bilateral diffuse wet fine inspiratory rales.
Examination of the heart revealed a grade III holosystolic murmur maximal at the xyphoid radiating to
the axilla. There was an S-3 gallop and there was a
question of an opening snap. His liver was enlarged
and was somewhat tender. The extremities showed 1+
pitting edema. The arterial blood gases on room air on
admission showed a Po, of 29, P co, of 75, pH of
7.22, with a bicarbonate of 29. Following treatment
with a 24% ventimask the P 0 , rose to 45, the P co,
slightly improved at 70, the pH was improved at
7.31, and the bicarbonate was 34. It was felt initially
that the elevation of his neck veins and his obvious
cor pulmonale could be explained almost exclusively
by chronic obstructive pulmonary disease. However,
his chest x-ray revealed cardiomegaly, and there was
a hazy pulmonary infiltrate with increased blood
flow to the apices. This led to speculation that there
was something present other than chronic obstructive
pulmonary disease. A Swan-Ganz catheter was
inserted, and it was found that his pulmonary artery
pressure was 75/ 37 with a mean pressure of 42, and
his wedge pressure had a mean of 20. The wedge
pressure remained elevated even after his arterial
blood gases were improved. This provided sufficient
stimulus to get a formal cardiac catheterization.
Significant mitral stenosis was found and mitral
commissurotomy was performed. The patient has
done quite well following this operation.
The second case involved a 23-year-old man
admitted due to a progressively worsening cough
productive of bloody, foamy sputum. He had first
noted the cough six weeks prior to admission and
had received Lincocin ® with slight improvement.
However, he later became worse and began to cough
up bloody sputum and was referred to MCV. He
delayed his admission one week and became much
worse and was admitted in extremis. Physical examination showed blood pressure was 94/ 60, pulse was 120,
respiratory rate was 40, and temperature was 102°.
The patient was acutely ill, sitting straight up in bed,
and was exceedingly short of breath. He had palpable
cervical axillary and inguinal nodes. The neck veins
were distended, and he was coughing up a foamy,
pink sputum which was thought to be characteristic
of pulmonary edema. He had rales throughout his
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lung fields and an enlarged tender liver. Review of
his chest x-rays showed a widespread pulmonary
infiltrate, and there was a question as to whether
his cardiac silhouette had enlarged. Blood gases
showed that the Po, was 42, the Pco, was 29, and
the pH was 7.38 with a bicarbonate of 16. The initial
diagnosis was pulmonary edema with cause unknown.
In this particular case, we were unable on clinical
grounds to adequately determine whether this was
pulmonary edema on the basis of lung disease or
pulmonary edema on the basis of cardiac disease.
He was transferred to the respiratory intensive
care unit and a Swan-Ganz was passed; this showed
that the pulmonary artery pressure was 45/35 mm Hg,
and the pulmonary capillary wedge pressure was quite
low at 0 to 5 mm Hg. This information led to an
open lung biopsy which revealed noncaseating
granulomas and an interstitial pneumonia. He
was treated with isoniazide, streptomycin, ethambutal,
and solu-medrol. He was ventilated with a volume
respirator via a tracheostomy performed at the time
of lung biopsy. Over the next week his pulmonary
congestion rapidly cleared and his blood gases
returned to normal. This case demonstrates quite
graphically that pulmonary edema is not necessarily
on a cardiac basis and it may be difficult, if not
impossible, to tell at the bedside which is the primary
physiological disturbance.
The third case in which the Swan-Ganz catheter
was helpful concerns that of a young man who was
brought to our emergency room unconscious with
pinpoint pupils and irregular slow respirations. He
was immediately intubated, placed on a respirator,
and given 10 mg of nalline intravenously. He became
more responsive and was coughing up foamy sputum.
His blood gases on admission revealed a P 0 , of 35,
a P co, of 70, and a pH of 6.94 with a bicarbonate
of 14. The chest x-ray showed diffuse pulmonary
edema with a normal cardiac silhouette. The patient
at this time had a Swan-Ganz catherization performed and revealed a low pulmonary capillary
wedge pressure. This finding allowed us to push fluids
to increase his blood pressure, even in the presence
of pulmonary edema. He was continued on the
ventilator, and over the next 18 hours he was able to
be extubated; within three days he was completely
normal. At that time cardiac consultation was ob-
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tained and it was felt that there was no cardiac basis
for the pulmonary edema. We were unable to elicit
a positive history of heroin or other drug abuse.
In summary, central venous pressure measurement has greatly extended our ability to care
for severely ill patients with cardiopulmonary disorders and difficult fluid balance problems. However, the central venous pressure measurement
is essentially a measurement of the mean right
atrial pressure. It may not be a reliable indicator
of the mean left atrial pressure, which is essentially the filling pressure of the left ventricle that
determines the cardiac output and the blood pressure. There is now available, and in use at this
institution, a bedside method for determination of
the pulmonary artery and pulmonary capillary
wedge pressures. In selected cases, the data obtained with this catheter have been of great aid
in management of the patient. The ease and safety
of the procedure seems to be well documented
and should make it accepted both by the doctor
and the patient.
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The Respiratory Intensive Care Unit*
JAMES P. BAKER, M.D.
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Richmond, Virginia

Each hospital which accepts the responsibility
of providing total patient care must establish an
area capable of providing care for patients with
acute respiratory failure. This does not necessarily
have to be a respiratory intensive care unit but
may well be an area within a general intensive care
unit. The reasons for a designated area are that
nursing service personnel, who are a most important
portion of the intensive care team, must be adequately trained and experienced with the equipment
which is becoming more sophisticated and complicated. The nursing care techniques are those techniques of good nursing care and should be learned
by any intensive care unit nurse. Additionally, paramedical personnel need to be trained to provide the
type of care that is of great importance in the delivery of acute intensive care to this very ill group
of patients. A respiratory intensive care unit was
established at the Medical College of Virginia in
1967. This was initially done at the request and with
the support of the Federal Public Health system and
has been continued by the hospital following the discontinuation of grant support. The unit functions as
a patient care area; a teaching laboratory for house
staff, nurses, and medical students; and a clinical
research laboratory to study the techniques of
respiratory care and the pathophysiologic processes
which occur in patients with respiratory failure . The
unit has lent itself well to these areas while performing its primary purpose, that is, providing
superior patient care for patients with acute respiratory failure.
This unit functions within the Department of
Medicine and as a regular rotation for the second
year medical residents and for the straight medical
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interns. Each of these groups of house officers
spends one month in rotation on this service. In
addition there are medical students and house officers
who elect to spend time on this service available
most of the time. The nursing service has been
trained by the attending physicians in addition to
the senior nurses, and it has a continuing program
of review and training of respiratory care skills.
With this approach, in addition to having a physical
facility designed for respiratory intensive care, the
following patient care statistics have been generated.
There have been a total of 629 admissions of
503 patients to the respiratory intensive care unit
from October, 1967 through October, 1971. Table
1 shows the multiple types of illnesses treated which
resulted in respiratory failure. Approximately onethird of these patients have chronic obstructive
pulmonary disease and the others a myriad of problems which have resulted in respiratory failure .
Table 2 demonstrates the average bed occupancy
bed-day stay and the source of these admissions.
Table 3 demonstrates the same information for the
group of patients with chronic obstructive pulmonary
disease. There was a slightly longer stay for a patient
who had chronic pulmonary disease, but other than
this, there is no major difference in these two patient
populations.
The definition of respiratory failure varies
with investigators, however based upon a certain
level of arterial oxygen and carbon dioxide. Table 4
contains the values seen in our patients. There were
only four patients who had a Pc 0 , of less than 60
in this group of patients with chronic obstructive
pulmonary disease; thus we are effectively dealing
with a group of people who meet the critieria for
respiratory failure in most series. It can also be seen
that there was considerable improvement in the
blood gases at the time of discharge from the hospital.
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TABLE 1.
RESPIRATORY INTENSIVE CARE UNIT MCV
1967- 1971
Total Admissions
629
Total Patients
503
Diagnosis

No. Adms.

Percent

COPD
Pneumonia (complicated)
Drug Overdose
Postoperative Complication
Asthma
Muscular Dystrophy
Kyphoscoliosis
Chest Trauma
Guillain-Barre
Pulmonary Fibrosis

203
78
46
40
33
24
22
21
21
13

32.3
12.4
7.4
6.4
5.2
3.8
3.5
3.3
3.3
2.1
80%

TOTAL:
Others (2% or less)
Pulmonary Emboli
Multiple Trauma
Respiratory Arrest
Myasthenia Gravis
Laryngotracheal Obstruction
Tetanus
Burns & Smoke Inhalation
Pulmonary Malignancy
Meningitis & Encephalitis
C.V.A.
Obesity Hypoventilation
Post Partum Respiratory
Failure
TOTAL:

Cystic Fibrosis
Polymyositis
Drug Reaction
Bronchiolitis
Myxedema
Mediastinal Abscess
Reyes Disease
Massive Hemoptysis
Gunshot Wounds
Fat Emboli
Pulmonary Hemosiderosis
Cardiac Disease with
Ventilatory Failure
20%

The approach to the management of respiratory
failure is properly divided into two phases, conservative and complicated. Approximately 80% of patients who have acute respiratory failure with chronic
obstructive lung disease should be able to be

TABLE 2.
RESPIRATORY INTENSIVE CARE UNIT MCV
Acute Respiratory Failure from All Causes
(1967- 1971)
Total admissions
Number of patients
Average bed occupancy
Average bed stay
Direct admissions
Transfer admissions
126 readmissions of 43 patients

629
503
72%
10 days
55%
45%
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TABLE 3.
RESPIRATORY INTENSIVE CARE UNIT MCV
Acute Respiratory Failure with COPD
(1967- 1971)
Total admissions
Number of patients
Average bed stay
Average hospital stay after
transfer from RICU (19671970)
Direct admissions
Transfer admissions
72 readmissions of 28 patients

203
131
12. 3 days

7 . 8 days

60%
40%

managed with conservative or low-flow oxygen type
therapy as has been described elsewhere in the
symposium. Our respiratory unit sees a skewed population of patients, that is, those patients who are
refractory to or who have failed with conservative
management elsewhere in the hospital; thus, our
patient population demonstrates an unusually large
percentage of patients who require assisted ventilation. Table 5 demonstrates this fact as well as our
results of low-flow oxygen therapy in the respiratory
unit. The errors in oxygen therapy occurred early
in our experience and consisted basically of giving
patients more oxygen than necessary for management
of their problem. Approximately one-third of the
patients had a tracheostomy at the time of admission. Some of these are patients with chronic
tracheostomies and are readmissions to the respiratory unit. Others had required tracheostomy
for management prior to transfer to the respiratory
intensive care unit.
It has been interesting to us to evaluate the
results of our statistics from the mortality of patients
within the respiratory unit (Table 6) . A year prior

TABLE 4.
ACUTE RESPIRATORY FAILURE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
(1967- 1970)
Arterial Pac o ,
Discharge
Before Definitive
Therapy
47 ± 8 mm Hg
73 ± 16 mm Hg
Arterial Pao,
Admission
36 ± 9 mm Hg

Discharge
59 ± 11 mm Hg
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TABLE 5.
OXYGEN THERAPY IN PATIENTS WITH COPD
(1967- 1970)
152 Admissions
Controlled oxygen therapy
Failure
Success
Attempts
64 (77 % )
83
19 (23%)
Admissions
A. Reason for failure of low-flow 0 2
Clinical worsening with conservative
47
management
12
Intubation to facilitate management
5
Errors in 0 2 therapy
B. Management after failure of low-flow 0 2
36
Intubation (subsequent tracheostomy in 24)
28
Tracheostomy

to the development of the respiratory intensive care
unit, approximately 62 patients were seen in consultation by the attending staff, who subsequently
have run the respiratory intensive care unit. Of
these there were 27 in-hospital deaths or a mortality
of 43.5%. During the four years of operation of
the respiratory intensive care unit, there has been
a mortality of less than 10% . In the patients with
chronic obstructive pulmonary disease, there was a
mortality of less than 90 % over the four years.
This is compared in Table 7 to the mortality of
patients admitted to the Medical College of Virginia
hospitals with chronic obstructive pulmonary disease
and a Pco, above 59 mm of mercury during the
year prior to opening of the respiratory intensive
care unit. As can be seen, there was reduction in
mortality in this group of patients, which is a roughly
comparable group to the people managed within the
respiratory unit of from 47 to 8.9%.
The cause of death of patients within the respiratory unit is listed in Table 8. Of major importance
here, one must note that sepsis was responsible for
18 of the 60 deaths. This is generally complicated

TABLE 6.
MORTALITY IN PATIENTS WITH ACUTE
RESPIRATORY FAILURE
Admissions Deaths Mortality
One year prior to RICU
4 years RICU (19671971)

62

27

43.5%

611 *

60

9 .8%

* 18 patients excluded because of brain death on
admission

TABLE 7.
MORTALITY IN PATIENTS WITH ACUTE RESPIRATORY
FAILURE AND COPD
Admissions Deaths Mortality
1. One year prior to

RICU
Patients with COPD
and Paco, 60 mm Hg
or greater
2. Four years RICU
(1967-1971)

45

21

47 %

203

18

8.9%

sepsis of gram negative etiology and indicates that
pulmonary infection is a major cause of death in
patients with respiratory failure. The cardiovascular
failure is a complex of etiologies involving acute
cardiac standstill or ventricular tachycardia as
well as central and peripheral cardiovascular failure
with unresponsive hypotension.
As is indicated in the foregoing paragraphs
and tables, the respiratory intensive care unit at the
Medical College of Virginia provides, in addition to
an outstanding patient care service, the opportunity
for a large number of our house officers, medical
students, graduate nurses, and nursing students to
become familiar with the techniques and equipment available for the management of acute respiratory failure. The application of these techniques
has led to a remarkable reduction in the mortality
in this group of very ill patients. These techniques
are explained by others and are included in this
symposium and may be applied to any hospital.

TABLE 8.
RICU DEATHS
(1967- 1971)
Cause

Number

Cardiovascular failure
Sepsis
Ventilatory failure
Technical problems with
artificial airways
Bleeding abnormalities
Myocardial infarction
Renal failure
Hepatic failure
Pulmonary emboli

25
18
5

TOTAL:

60

3

3
2

2
1
1
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Before prescribing, please consult
complete product information, a summary of which follows:
Indications: Tension and anxiety

states, somatic complaints which are
concomitants of emotional factors; psychoneurotic states manifested by tension,
anxiety, apprehension, fatigue, depressive symptoms or agitation; symptomatic
relief of acute agitation, tremor, delirium
tremens and hallucinosis due to acute
alcohol withdrawal ; adjunctively in skeletal muscle spasm due to reflex spasm to
local pathology, spasticity caused by
upper motor neuron disorders, athetosis,
stiff-man syndrome, convulsive disorders
(not for sole therapy).
Contraindicated: Known hypersensitivity to the drug. Children under 6
months of age. Ac ute narrow angle glaucoma; may be used in patients with open
angle glaucoma who are receiving appropriate therapy.
Warnings: Not of value in psychotic
patients. Caution against hazardous
occupations requiring complete mental
alertness. When used adjunctively in convulsive disorders, possibility of increase
in frequency and/ or severity of grand mal
seizures may require increased dosage of
standard anticonvulsant medication;
.JJ,.....,,.._-Lll.~
abrupt withdrawal may be associated
with temporary increase in frequency
and/ or severity of seizures. Advise
against simultaneous ingestion of alcohol
and other CNS depressants. Withdrawal
symptoms (similar to those with barbiturates and alcohol) have occurred following abrupt discontinuance (convulsions,
tremor, abdominal and muscle cramps,
vomiting and sweating) . Keep addictionprone individuals under careful surveil- "'
lance because of their predisposition to
habituation and dependence. In pregnancy, lactation or women of childbearing
age, weigh potential benefit against
possible hazard.
Precautions: If combined with other
psychotropics or anticonvulsants, consider carefully pharmacology of agents
employed; drugs such as phenothiazines,
narcotics, barbiturates, MAO inhibitors
and other antidepressants may potentiate
its action. Usual precautions indicated in
patients severely depressed, or with latent
depression, or with suicidal tendencies.
Observe usual precautions in impaired
renal or hepatic function. Limit dosage to
smallest effective amount in elderly and
debilitated to preclude ataxia or oversedation.
Side Effects: Drowsiness, confusion,
diplopia, hypotension, changes in libido,
nausea, fatigue, depression, dysarthria,
jaundice, skin rash, ataxia, constipation,
headache, incontinence, changes in salivation, slurred speech, tremor, vertigo,
urinary retention , blurred vision. Paradoxical reactions such as acute hyperexcited states, anxiety, hallucinations,
increased muscle spasticity, insomnia,
rage, sleep disturbances, stimulation
have been reported; should these occur,
discontinue drug. Isolated reports of neutropenia, jaundice; periodic blood counts
and liver function tests advisable during
long-term therapy.
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